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1.1 Neuroanatomical and neuropathological aspects of Alzheimer's disease 
In 1835 James Cowles Prichard described a syndrome he called incoherence or 
senile dementia, which was characterized by "forgetfulness of recent impres-
sions, while the memory retains a firm hold of ideas laid up in the recesses from 
times long past". 
Seventy years later the German psychiatrist Alois Alzheimer (1907) described 
the clinical symptoms and neuropathology of a patient with probably the same 
disorder. The case concerned a 51-year-old woman on her first admission to 
hospital. She suffered from severe paranoic delusions later followed by impair-
ment of short- and long-term memory, incoherence of thinking, and disturbances 
as apraxia, agnosia and aphasia while her consciousness was clear. After 4.5 
years she died in an almost entirely vegetative state, bedfast and fully incapaci-
tated due to spasticity and myoclonus. 
At autopsy Alzheimer observed a diffuse atrophy of the brain with no macrosco-
pic foci. Using Bielschowsky's silver staimngs, he could demonstrate the presen-
ce of abnormal nerve cells containing "Fibrillen", now known as neurofibrillary 
tangles (NFT), and clusters of miliary foci, now known as neuntic or senile pla-
ques (SP) in the neocortex By 1898 Redlich had described miliary sclerosis in 
two cases of senile dementia. The discovery of NFT by Alzheimer was new His 
publication was the first demonstration of specifically neuronal pathology in any 
form of mental disorder, other than that associated with syphilis. These neuro-
pathological findings with a history of presenile dementia were proposed as 
Alzheimer's disease by Kraepelin (1910) to identify a new clmicopathological 
entity with the onset before the age of 65 Later Kraepelin suggested the diffe-
rentiation of Alzheimer's disease (AD) in the presenile, and the senile form of the 
disease (SDAT) with the onset of the symptoms after the age of 65. He regar-
ded senile dementia and Alzheimer's disease as specific nosological entities on 
account of the clinical symptoms and the neuropatholocical findings although 
Kraepelin knew that Alzheimer had adjusted his original views when he observed 
that neurofibrillary tangles also frequently encountered in the cerebral cortex in 
severe cases of senile dementia (Alzheimer, 1911) and concluded that AD and 
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senile dementia are probably manifestations of the same process. 
The fact that tangles could be found in Parkinson's disease, in amyotrophic 
lateral sclerosis, and in a number of chronic degenerative brain disorders and the 
recognition that senile plaques also occurred in non-demented elderly people 
(Grunthal, 1927) as well as in epilepsy undermined the idea of a qualitatively 
specific lesion. The neuropathological hallmarks of AD became so debased that 
it was felt that the disease could only be defined in terms of its clinical pheno-
menology (Jervis and Saltz, 1936) In 1967, Roth et al showed that abundant 
cortical plaques clearly demarcated dementia from normal cognitive function in 
the absence of any other demonstrable pathology and they defined a quantitati-
ve relationship between the degree of cognitive impairment and plaques count 
post mortem. They suggested a certain threshold of lesions above which the 
clinical symptoms of dementia are apparent and which may vary in different 
individuals Tomlinson et al. (1970) showed that the gradation of neurofibrillary 
tangles was also significantly correlated with dementia scores and a similar 
threshold was manifest. However, they found some discrepancies between 
psychological and pathological measures, some subjects with no history of de-
mentia were found to have high plaque scores and in some demented subjects 
only a few plaques were seen These studies (Roth et al., 1968; Tomlinson et 
al., 1970) re-established the place of the classical structural lesions described by 
Alzheimer and the authors stressed indirectly the need to come to an accurate 
diagnosis of Alzheimer's disease. 
Recently, in 1984 consensus has been reached on the clinical criteria for proba-
ble Alzheimer's disease which include insidious onset and progressive impair-
ment of memory and other cognitive functions with an intact consciousness and 
no presence of systemic or brain diseases that could account for the decline 
(McKahnet al., 1984). 
Two of the most important systems of classification and nomenclature used for 
the diagnosis of probable Alzheimer's disease are derived from the "Diagnostic 
and Statistical Manual of Mental Disorders (DSM-III-R)" and the "National Institu-
te of Neurological Communicative Disorders and Strokes and the Alzheimer's 
Disease and Related Disorders Association (NINCDS-ADRDA)". With the 
NINCDS-ADRDA diagnostic criteria a misdiagnosis rate of 12-19% is reached 
(Tierney et al., 1988). 
To come to a definite diagnosis of Alzheimer's disease the clinical diagnosis 
"probable Alzheimer's disease" should be confirmed by histopathological eviden-
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ce, especially by evaluating the number of senile or neuntic plaques and of neu­
rofibrillary tangles in cortical and subcortical regions (Khachatunan, 1985) 
The morphologic alterations in Alzheimer's disease were first associated with the 
cerebral cortex (Alzheimer, 1907) However, Hooper and Vogel (1976) studying 
the limbic system, showed that the septal area, the fornix, the mamillary bodies, 
and especially the hippocampus and amygdala are also involved. They even 
spoke of "limbic dementia" to stress the involvement of the limbic structures in 
Alzheimer's disease 
In later studies the pathological evaluation of the amygdaloid complex in Alzhei­
mer's disease revealed a decrease of total amygdaloid area (Brady and Mufson, 
1990), a specific topographic distribution of neuntic plaques and tangles ( К ro­
mer Vogt et al., 1990), neuronal atrophy, and severe loss of neurons (Herzog 
and Kemper, 1980; Kemper, 1983), suggesting that the amygdala is indeed a 
major area of predilection of neuropathological changes in Alzheimer's disease 
even with a predictive pattern of pathology Mann et al , (1987) documented 
the presence, topography, and distribution of SP and NFT within the brains of 
non-demented people. The mam finding emerging from this study was that the 
SP and NFT are more likely to occur in the amygdala and hippocampus than 
within the neocortex or nucleus basalis of Meynert, in some cases these lesions 
were even restricted to the hippocampal formation and/or amygdala. In studies 
on Down's syndrome patients, in whom the AD-type neuropathology is found in 
nearly all individuals over the age of 50 and in whom the appearance of neuro­
pathological changes of Alzheimer's disease can thus be predicted, Wisniewski 
et al , (1985) also found an early and severe involvement of SP and NFT in the 
amygdala and the hippocampus. These two studies (Mann et al , 1987 and 
Wisniewski, 1985) may include preclinical and subclinical Alzheimer's disease 
patients and therefore have implicatons for the time course and regional acquisi­
tion of NFT and SP in aging and Alzheimer's disease These findings suggest 
that the hippocampus and amygdala are sites of early critical involvement in 
Alzheimer's disease as others already postulated (Hyman et al , 1984, Ball et al , 
1985, Braak and Braak, 1985) The hippocampus and the amygdaloid complex 
constitute, together with other structures such as the fornix, ungulate gyrus, 
septal nuclei, and mamillary bodies the limbic system which plays an important 
role in emotion, memory, and learning Disturbances in these modalities, impair­
ment in short- and long-term memory, desorientation in time, place and person, 
and personality changes are the main clinical symptoms of Alzheimer's disease. 
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It is very likely that these disturbances are closely related to the neuropathologi-
cal changes in this disease However, the question whether the intraneuronal 
degeneration and/or the plaque formation is sufficient in itself to derange mental 
function remains unsettled. 
The suspicion that SP and NFT must be in some way directly responsible for the 
clinical expression of AD began to give way when it was discovered that there 
was a selective cell loss of cholinergic neurons in the nucleus basalis of Meynert 
in AD (Davies and Maloney, 1976, Whitehouse et al., 1981, Bartus et al., 1982) 
which led to the so-called cholinergic hypothesis This hypothesis postulates a 
relation between the alterations in the basal forebrain neurotransmitter-specific-
cell-system and cognitive impairment in AD These alterations could be. signifi­
cant cell loss, NFT and SP, and changes in cholinergic markers (Bartus et al., 
1982). For some authors (Coyle et al , 1983), supporting the cholinergic hypo­
thesis, the SP and NFT simply represent some pathological epiphenomena quite 
unrelated to the pathophysiology of Alzheimer's disease. Soon, similar deficien­
cies were demonstrated in other neurotransmitter specific cell systems projec­
ting to the neocortex, ι e the noradrenergic innervation from the locus coeruleus 
(Marcyniuk et al , 1986), the dopaminergic innervation from the ventral tegmen­
tum (Mann et al., 1986b), and the serotonergic innervation from the nucleus 
raphes dorsalis (Rossor and Iversen, 1986). Other studies (reviewed by Husain 
and Nemeroff, 1990) revealed a consistent reduction in concentration of two 
neuropeptides, somatostatin and neuropeptide Y, in the hippocampus and neo 
cortex of AD patients. It is now more and more accepted that AD is not primari­
ly a disorder of central cholinergic neurotransmission, nor indeed an abnormality 
of any single transmitter system, but reflects a widespread morphological dege­
neration in the brain with cell loss and shrinkage that affects several neurotrans­
mitter systems (Mann, 1986a, Remikainen et al., 1990). However, the spread of 
the disease is not at random, well defined areas and pathways are affected 
whereas others are not In addition to mapping the topography of pathological 
changes in AD, analysis of additional features of cortical anatomy is essential 
For instance, even within a severely damaged area, such as the anterior parahip-
pocampal gyrus, not all of the neurons are affected by NFT In fact the distribu­
tion is laminar, involving one cell layer whilst leaving the immediately adjacent 
layers unaffected. Similarly, in the hippocampal tangles are found largely in the 
CA1 region and in the subiculum of the structure, leaving the adjacent CA2/3 
regions unaffected (Van Hoesen et al , 1986; de Vries, 1990). 
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There seems to be a cell-specific pathology in the hippocampus; the large projec-
ting neurons appear to be particularly involved (Van Hoesen et al., 1986). The 
relationship between NFT and neuronal degeneration in the course of AD and 
aging is unclear. Although the loss of neurons in the temporal cortex and hippo-
campus appears to be closely associated with the process of neurofibrillary 
degeneration, this correlation was not found to be significant in non-cortical 
structures such as the locus coeruleus and the nucleus basalis of Meynert (Mann 
et al., 1985a; Bondareff et al., 1989). As stated earlier the hippocampus and 
the amygdala are the only regions in normal aging where SP and NFT may be 
found and it could therefore be that these structures represent the initially affec-
ted sites in Alzheimer's disease. Why the dorsomedial temporal complex, formed 
by the hippocampal formation including the entorhinal cortex and amygdaloid 
complex, appear to be the first and most severely affected regions in AD is un-
clear. Pearson et al (1985) observed that the bulbus olfactonus is heavily affec-
ted in Alzheimer's disease, and proposed the hypothesis that the olfactory sys-
tem may be the initial site of involvement in these conditions with spread of the 
disease along the olfactory pathways to the amygdala, the hippocampus and 
ultimately to the neocortex (the so-called olfactory hypothesis). Since in non-de-
mented persons younger than sixty-five involvement of the entorhinal cortex or 
the hippocampus was observed in absence of NFT and SP in the olfactory bulb, 
whereas the opposite was never seen, it would be more likely that the spread of 
the disease along fibres systems in the brain occurs in the reverse direction, i.e. 
from the limbic structures to the olfactory centres (Mann et al , 1988). 
Mann (1985c) postulated that the site of the primary lesion in Alzheimer's dis-
ease lies within the cortex including the amygdaloid complex and hippocampus 
and he considered the damage in the subcortical areas (projecting to the cortex 
and amygdala) as secondary Specifically affected areas of the hippocampal 
formation, and of the amygdaloid complex, (Brashear et al., 1988, Tsuchiya and 
Kosaka, 1990), can be related to the mterconnectional anatomy of these two 
structures. The intrinsic and interlocking connections in these areas are des-
troyed to such an extent that the hippocampus and amygdaloid complex are 
deprived of their major input and output links to the cortex and to some subcor-
tical structures (Van Hoesen and Hyman, 1990). It is likely that the neuropatho-
logical changes in particular regions in the hippocampus and amygdaloid com-
plex may contribute to early characterizing symptoms such as impairment of 
memory and intellectual decline in AD 
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1 2 Aim of the study 
Summarizing it can be stated from a neuroanatomical and neuropathological 
point of view that Alzheimer's disease is histopathologically characterized by the 
presence of numerous SP and NFT in some well defined cortical and subcortical 
regions. The spread of the disease is not at random and particular neuronal 
populations in well defined areas and pathways are affected. 
The relationship between the degree of dementia and the number of tangles and 
plaques seems to be obvious (Blessed et al., 1968; Tomlinson et al., 1970). 
However, when the progression of the lesions in AD is examined in frontal and 
temporal neocortex (Mann et al., 1988) both at biopsy and autopsy, a balance 
between the formation of new lesions and the dissolution or destruction of alrea-
dy existing NFT and SP may develop If so, densities of NFT and SP may only 
serve as markers for the presence of the disease and fail to assess its severity. 
Neuron loss in the affected areas may give a better prediction of the cognitive 
impairment; indeed, in several studies a strong possitive correlation has been 
found between the loss of pyramidal cells, synaptic loss and dementia (Neary et 
al , 1986; Hamos et al., 1989). 
In the research program of the "stuurgroep veroudering en verouderingsziekten 
van het centrale zenuwstelsel (VVZCZS)" the normal and pathological changes, 
in old age and Alzheimer's disease, were systematicly and qualitatively planned 
to be studied in five different structures. The analyses of four of these viz.· the 
neocortex (Broere, 1990), the hippocampal formation (de Vries, 1990), the 
nucleus basalis of Meynert complex and adjacent structures (Vogels, 1990), and 
the brainstem monoammergic structures (van Domburg, 1990) have been com-
pleted. In this thesis the results of the fifth and final study, devoted to the 
amygdaloid complex, will be presented In the light of the above proposed the-
ses (Mann, 1985, Mann et al. 1988, Van Hoesen and Hyman, 1990), emphasis 
is put on the quantification of the neuron loss, the vulnerability of certain sizes 
of neurons, and the hodology of the amygdaloid complex. An answer to the 
following questions will be attempted 
1 Is it possible to define the boundaries of the human amygdaloid com-
plex and its subdivisions7 
2. Do the total volume of the complex and the volume of its subdivisions 
change during aging and in Alzheimer's disease? 
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3 Is there a significant neuron loss in Alzheimer's disease and are some 
cell populations more affected then others7 
4 What are the distribution profiles of the neuropathological markers of 
Alzheimer's disease (AD), neurofibrillary tangles (NFT) and senile pla-
ques (SP), in the amygdaloid complex and do there distribution profiles 
differ from those observed in age-matched controls7 
5. Can the various neuropathological phenomena observed in the amyg-
daloid complex in AD be correlated with each other7 
6 Is it possible to correlate the neuron loss, SP and NFT in the amygda-
loid complex with the neuropathological changes observed in other 
brain regions affected by AD7 
7. Can the data collected on the neuropathology of the amygdala in AD 
be related with the molecular pathology of Alzheimer's disease? 
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CHAPTER 2 
THE AMYGDALOID COMPLEX 
The amygdaloid nuclear complex or amygdala is a heterogenous gray cell mass 
located subcortically in the rostromedial part of the temporal lobe. In the next 
sections some aspects of the amygdala will be briefly discussed. 
2.1 Survey of the nomenclature of the amygdaloid complex 
The name of the corpus amygdaloideum is derived from the Greek word for al­
mond (αμυγδαλον) to which Burdach (1819) compared its shape. He introdu­
ced this name at the beginning of the 19th century and described the human 
amygdaloid complex as follows: "Diese Vorderwand des Unterhorns enthält den 
Mandelkern (Nucleus Amygdalae). Dieser ist ein in die Marksubstanz der Vorder-
wand eingeschlossener Kern grauer Substanz. Er ist von allen Seiten abgerundet, 
unten dicker, oben dünner. Seine hintere Fläche ist platter, bloss von dünner 
Markschicht überzogen und streckt sich daher auch gegen das Unterhorn zu, zu-
weilen deutlich hervorspringend, aus; seine vordere Fläche ist mehr gewölbt. Er 
hat eine eigene Farbe, is mehr gelblich als der Linsenkern und hat ein besonderes 
festes Gewebe. Zuweilen sieht man auch Markstreifen in ihm. Er liegt im Über-
gang des Unterlappens zur Insel unter dem markigen Boden des Linsenkerns und 
unter der Vormauer". 
Burdach only paid attention to the macrostructure and not to the microstructural 
subdivisions and connections of the complex. 
Classical authors such as Meynert (1872, various mammals), Ganser (1882, 
mole), and Kölliker (1896, rabbit) mentioned the amygdala in their reports but 
only roughly described some of its constituent cell masses, which probably 
corresponded to the cortical, central, lateral, and basal nuclei. Little was known 
about the function of the complex: generally it was considered part of the olfac-
tory system. 
Völsch (1906, hedgehog, mouse; 1910, ferret) presented the first detailed de-
scription of the amygdala. He divided the complex into ten subdivisions to which 
he assigned characters such as T, M, T' etc. (Table 2.1). The sublenticular nu-
cleus D (now known as the nucleus medialis of the amygdala) was tentatively 
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considered to be part of the complex. The adjacent complex E (the nucleus 
centralis of the amygdala) was not involved in his panellation. He also described 
some small sized groups of neurons with heavy pigmentaton К (the intercalated 
masses). This classical report formed the starting point for all later studies on 
the amygdaloid complex. 
Table 2.1 
Nomenclature of the subdivisions of the amygdaloid complex 
Brockhaus ' 3 8 Johnston ' 2 3 Crosby & Humphrey ' 4 1 
A m y g d a l e u m p r o t u n d u m lateral nucleus 
laterale 
nucleus amygdalae lateralis (L) 
A m y g d a l e u m prof und urn lateral part of the nucleus 
intermedium basalis 
nucleus amygdalae basalts pars lateralis 
(BU 
A m y g d a l e u m profundum medial part of the nucleus 
mediale basalis 
nucleus amygdalae basalis accessonus 
(BA) 
Amygdaleum profundum nucleus amygdalae basalis pars medialis 
(BM) 
D Supraamygdaleum superfi medial nucleus 
cíale 
nucleus amygdalae medialis (ME) 
} 
anterior amygdaloid area (AAA) 
nucleus amygdalae centralis (CE) 
Amyda leum intercalatum intercalated masses intercalated cell masses (I) 
(lateral part Π 
S u p r a a m y g d a l e u m profun central nucleus 
E 2
 J dum 
(medialis) 
К 
} A m y g d a l e u m superficiale cortical nucleus 
nucleus of the lateral 
olfactory tract 
nucleus amygdalae cortiealis (CO) 
nucleus of the lateral olfactory tract 
(NLOT) 
Subzona p r a e a m y g d a l a e cortico-amygdaloid transition area 
( С Т А ) 
A m y g d a l e u m p r o f u n d u m 
ventrale 
nucleus basalis superficialis (BS) 
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Ariens Kappers (1907, 1921), Kuhlenbeck (1924), Foix and Nicolesco (1925) 
considered the phylogeny and the ontogeny of the primate amygdala but their 
observations did not yield a better understanding of the anatomy of the com-
plex. 
Johnston (1923) studied the amygdala in reptiles, opossum, rabbit, bat, maca-
que and human foetal brains, elaborating on the findings by Volsch His panella-
tion was based on his interpretation of the origin and phylogenetic age of the 
various parts In his view the nuclei fall into two distinct groups a primitive or 
phylogenetically hardly changing corticomedial group, comprising the nucleus 
centralis, nucleus mediahs, and the nucleus corticahs and the nucleus of the late-
ral olfactory tract; and a "progressive" and phylogenetically younger basolateral 
group, including the nucleus lateralis and the nucleus basalis By considering the 
nucleus centralis one of the chief parts of the complex he extended the de-
scription given by Volsch (1907) 
Crosby and Humphrey (1941) studied the structure of the amygdaloid complex 
in monkey and man, and found that Johnston's classification was also applica-
ble to their subdivision but they used a slightly different nomenclature In con-
trast to Johnston they considered the anterior amygdaloid area and the corticoa-
mygdaloid transition area separate nuclear cell masses The anterior amygdaloid 
area is an undifferentiated structure with no clear demarcation situated, as its 
name implies, in the rostral part of the amygdala Johnston considered the 
anterior amygdaloid being part of the nucleus centralis The corticoamygdaloid 
transition area is located between the nucleus corticalis and the cortex pirifor-
mis; this region was considered by Johnston a part of the nucleus basalis 
Crosby and Humphry were the first to consider the anterior amygdaloid and the 
corticoamygdaloid areas important subdivisions of the nucleus amygdalae and in 
this way they provided the basis for the most commonly used terminology in 
primates concerning the amygdaloid complex 
At about the same time, a detailed study of the human amygdala was published 
by Brockhaus (1938) This author used a nomenclature which differed conside-
rably from that of Johnston (1923) and of Crosby and Humphry (1941). More-
over, he limited his study to the amygdaloid complex proper and excluded the 
penamygdaloid areas. The description given by Brockhaus has been confirmed 
and extended by several later investigators like Uchida (1950, several mammals) 
and Koikegami (1963a, 1963b, several mammals including man). These last au-
thors, following the German tradition of that time, presented a panellation of 
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the amygdaloid complex into many small subdivisions. A survey of the nomen-
clature used by various authors is presented in Table 2 . 1 . 
The investigators mentioned so far relied almost exclusively on the Nissl tech-
nique in determining nuclear subdivisions of the complex. Minor differences in 
size, shape, and density of neuronal penkarya of a particular group of cells in 
sections stained according to that technique may easily lead to differences in 
subdivision. A striking example can be found in the descriptions given by Brock-
haus (1938) and Crosby and Humphry (1941) The former subdivided the nu-
cleus basalts superficialis into three different parts, in contrast to the simple nu-
cleus mentioned by the latter authors. 
The advent of new histochemical techniques, especially for the demonstration of 
acetylcholinesterase (Girgis, 1968, Svensen and Bird, 1985), and the develop-
ment of tract tracing techniques entertained great hopes of confirming certain 
boundaries and for establishing a consistent nomenclature, which might be appli-
cable between species 
Unfortunately, although the acetylcholinesterase (AChE) staining is sometimes 
very helpful in defining boundaries, for example between the nucleus lateralis 
and the nucleus basalis lateralis, in other areas the Nissl staining and the AChE 
technique are not particularly complementary, which makes interpretation very 
confusing Other approaches used to classify the subdivisions include, 1. the 
denditric architecture in Golgi impregnations (Hall, 1972, Kamal and Tombol, 
1975; McDonald, 1982) and in Golgi de-impregnation technique combined with 
lipofuscin assessment (Braak and Braak, 1983); 2 differences in the localization 
of classical neurotransmitters, dopamine, norepinephrine and serotonine (Fallon, 
1978 et al, 1981), 3. the differential distribution of neuropeptides thoughout the 
subdivisions of the amygdala (Roberts et al , 1982, Nitecka and Ben-An, 1987; 
Amarai and Bassett, 1989a, Amarai et al , 1989b) 
Recently, Sims and Williams (1990) presented a revised scheme of the anatomi-
cal panellation of the human amygdala based upon serial analysis using four dif-
ferent staining techniques, viz. Nissl-stam and staimngs based on the presence 
of myelin, acetylcholinesterase, and nicotinamide adenine dinucleotide phospha-
te diaphorase (NADPH-d). With the last technique a Golgi-like staining of the so-
ma and processes of a subpopulation of cells in some nuclei could be obtained. 
The compartments, revealed by the histochemical methods, correspond to the 
divisions as defined by the classical Nissl and myelin stains. Based on the varia-
tion of the staining intensity within the nuclear subdivisions Sims and Williams 
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suggested a further structural panellation with potential functional significance. 
Although this approach allowed a better delineation for some nuclei, for instance 
the nucleus centralis and nucleus lateralis, the panellation of the amygdaloid 
complex proposed by Crosby and Humphrey (1941) remained unchanged. 
In chapter 4 a description of the macroscopy and of the subnuclei of the amyg­
daloid complex will be presented. The description of the subdivisions is mainly 
based on the study by Crosby and Humphrey (Table 2.2). 
Table 2.2 
Panellation of the amygdaloid complex based on Crosby & Humphrey (1941) 
I Baso-lateral amygdaloid group: 
nucleus lateralis (L) 
nucleus basalis lateralis (BL) 
nucleus basalis medialis (BM) 
nucleus basalis superficialis (BS) 
nucleus basalis accessonus (BA) 
nucleus mtercalatus (I) 
II Cortico-medial amygdaloid group: 
nucleus corticahs (CO) 
nucleus medialis (ME) 
corticoamygdaloid transition area (СТА) 
nucleus of the lateral olfactory tract (NLOT) 
nucleus centralis (CE) 
anterior amygdaloid area (AAA) 
2.2 The morphogenesis and histogenesis of the amygdaloid complex 
In mammals, the amygdala is divided into two major subdivisions (Johnston, 
1923; Humphrey, 1968) viz. the corticomedial and the basolateral part. This 
partition is a result of different morphogenesis (Humphry, 1971). Futhermore, 
differences in cytoarchitecture (Braak and Braak, 1983), connectivity (Klinger 
and Gloor, 1960; Nauta, 1961; Herzog and Van Hoesen, 1976, Krettek and 
Price, 1977 a,b), function and transmitter innervation (Fallon et al., 1978; Woolf 
and Butcher, 1982) between the two parts have also been reported. In the follo­
wing a brief description of the morphogenesis and histogenesis of the human 
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telencephalon including the amygdaloid complex will be given. 
During the development of the telencephalon the lateral walls become subjected 
to a strong evagination, dorsally, rostrally, and caudally, which leads to the 
formation of the two lateral hemispheres with their ventricles as lumen. Basally 
their walls soon start to thicken Within the telencephalon of embryos of 5 to 6 
weeks, the cerebral hemisphere can be subdivided into a thin-walled palliai re-
gion and a subpalhal region with an elevated area forming two longitudinally 
oriented ventricular ridges viz the medial and the lateral ventricular ridge 
(Johnston, 1923; Humphrey, 1968; Lammers, 1976). The first griseum distin-
guishable in this region is the globus pallidus formation. It is located in the 
rostral two thirds of the medial ventricular ridge and extends in later stages of 
development into the wall of the third ventricle At the age of 6.5 weeks, the 
amygdaloid complex starts to differentiate in the caudal one third part of the 
medial ventricular ridge and soon, 7 to 8 weeks, all the subdivisions of the 
centromedial complex can be recognized (Muller and O'Rahilly, 1990). The 
differentiation of the rest of the amygdaloid nuclei viz. the basolateral complex, 
starts later, at the age of 9 weeks. By 25 weeks the amygdala completes its 
differentiation and all of the subdivisions can be recognized. 
The massive outgrowth of the capsula interna, especially after 6 weeks, greatly 
influences the topographic relationship between the amygdaloid complex and the 
striatum. The amygdaloid complex arches ventrally and the stria terminals (ap-
pearing at 13 weeks) connecting the complex with the preoptic and rostral hy-
pothalamic area, becomes more bended in its course With the development and 
outgrowth of the inferior horn of the lateral horn ventralward, the amygdala is 
rotated medially as well. The final position of the amygdala is anterosupenor to 
the inferior horn of the ventricle. 
2.3 Connections of the amygdaloid complex 
2.3 1 Introduction 
The understanding of the amygdaloid connectivity has greatly increased during 
the last decades due to the introduction of newly developed tracing procedures 
based on anterograde axonal transport of radioactivily labeled amino acids and 
retrograde and anterograde axonal transport of horseradish peroxidase (HRP) and 
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leucoagglutinin from Phaseolus vulgaris. 
These new techniques have helped to provide a much more accurate view of the 
amygdaloid connections in the nonhuman primate brain than could be demon-
strated with axon degeneration techniques (Nauta, 1962). 
In this chapter the connections of the nonhuman primate brain will be described. 
Most data have been obtained from studies performed in the monkey brain. 
2.3.2 Fibre systems related to the amygdaloid complex 
Three large fibre bundles connect the amygdaloid complex with other parts of 
the brain; 1) the lateral olfactory tract, 2) the ventral amygdalofugal pathway 
and 3) the stria terminals (Fig. 2.1). 
3 A 
Fig. 2.1 
Fibre bundles connecting the amygdala; (A) the lateral olfactory tract, IB) the 
ventral amygdalofugal pathway, (CI the stria terminalis. 1, amygdaloid complex; 
2, cortex prepiriformis; 3, bulbus olfactorius; 4, nucleus gyri diagonalis; 5, 
nucleus interstitialis stria terminalis; 6, nucleus mediani thalami; 7, nucleus peri-
peduncularis; 8, nucleus ventromedia/is hypothalami; 9, area tegmentalis centra-
lis; 10, substantia nigra; 11, griseum centrale mesencephali; 12, nucleus raphe 
dorsalis; 13, nucleus parabrachialis lateralis; 14, locus coeruleus. 
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The lateral olfactory tract connects the olfactory bulb with the amygdaloid 
complex but also with other parts of the brain The ventral amygdalofugal path-
way is a large and complex system of fibres The amygdalofugal fibres arise 
dorsomedially from the amygdala and travel either in a rostromedial direction 
through the sublenticular regions of the substantia innominata and the substan-
tia perforata anterior to reach rostral striatal structures including the nucleus 
accumbens and olfactory tubercle, or in a more caudomedial direction to enter 
the hypothalamus. A certain proportion of the amygdalofugal fibres terminate in 
the hypothalamus, others reach their destination in the thalamus, and still others 
continue into the brain stem. 
The stria terminalis (ST) is a compact bundle which emerges medially from the 
caudo-dorsal part of the amygdaloid complex to take an arching course along 
the entire telodiencephalic border; approaching the region of the anterior com-
missure it becomes embedded in the gray matter of the paraseptal division of 
the bed nucleus of the stria terminalis (BNST). On reaching the anterior commis-
sure this bundle splits into three components which are designated according to 
their position with respect to the anterior commissure or their targets in the 
basal telencephalon and diencephalon: 
1. The precommissural component. 
2. The commissural component. 
3 The stria terminalis and fornix components. 
2.3.3 Afférents to the amygdaloid complex 
The afferent connections of the amygdaloid complex can be grouped into the 
following categories: 
1 Fibres originating from the olfactory system. 
2. Projections from various areas of the cerebral cortex. 
3. Projections from the hippocampal formation. 
4·. Fibres arising from the magnocellular basal forebrain complex. 
5. Afférents from the hypothalamus. 
6. Afférents from the bed nucleus of the stria terminalis. 
7. Thalamic afférents. 
8. Afférents from the brain stem and spinal cord. 
These fibre categories will now briefly be discussed 
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2 3 3.1 Fibres originating from the olfactory system 
For a long time the amygdaloid complex has been considered to be closely 
related to the olfactory system. Experimental anatomical studies (Whitlock and 
Nauta, 1956) have given evidence for sensory inputs from the diencephalon and 
neocortical areas of the telencephalon but none of these are as direct as those 
from the olfactory system. 
Olfactory bulb axons project directly to the amygdala and course through the 
lateral olfactory tract (Turner et al , 1978; Allison, 1954) to terminate in the 
nucleus corticalis (Fig 2.1). These structures can thus be considered parts of 
the primary olfactory cortex (Turner et al., 1978). Indirect olfactory projections 
come from the prepinform and the entorhmal cortex (Russchen, 1982a, cat. De 
Olmos et al , 1985, rat) and these too terminate in the nucleus corticalis. In the 
rat and cat (Krettek and Price, 1977b; Luskin and Price, 1983, rat) it was shown 
that olfactory fibres originating from these cortices terminate in the deep nuclei 
of the amygdala viz the nucleus basalis mediahs, the medial and lateral subdivi-
sions of the nucleus centralis, the nucleus corticalis, and the nucleus mediahs. 
2.3.3 2 Projections from various areas of the cerebral cortex 
Whitlock and Nauta (1956), using degeneration techniques, were the first inves-
tigators to observe that the amygdaloid complex receives afférents from the 
temporal cortex The introduction of axonally transported tracers helped to 
provide further evidence for the interconnection of the two structures (Amarai 
and Price, 1984, Tigges et al , 1983, Ottersen, 1982, rat; Russchen, 1982a, 
cat) 
Most of the cortico-amygdaloid connections are bidirectional. However, there are 
also projections from the amygdaloid complex to some areas, for example the 
primary visual, auditory and somatic sensory cortices (see section 2.4), that do 
not appear to be reciprocated by cortico-amygdaloid projections. 
The dominant cortical inputs to the amygdaloid complex arise from the anterior 
and inferior parts of the temporal lobe, the insula, and the orbitofrontal cortex 




Olfactory and cortical afferent connections to the amygdaloid complex. 
The temporal cortical regions which project principally to the lateral and basa 
nuclei of the amygdaloid complex (Fig 2 2) include the inferior temporal cortex 
(areas 21 and 22), the superior temporal gyrus (area 22), the temporal polai 
cortex (area 38) as well as the temporal operculum (Herzog and Van Hoesen, 
1976; Turner et al., 1980; Van Hoesen, 1981, Amarai and Price, 1984; Inaust 
and Amarai, 1986; Barnes and Cipollini, 1988). The dorsomedial surface of the 
supratemporal pole (area 35) and ventromedial aspects of the pole of the tempo-
ral lobe (area 36), send projections to both the large-celled and the small-celled 
divisions of the nucleus basalis accessonus, the nucleus basalis medialis, the 
nucleus lateralis, and the nucleus centralis (Inausti et al., 1986). The intercon-
nections between the amygdala and the insular cortex are among the most 
intensive ones. These fibres form a well defined fascicle (fasciculus amygdaloin-
sularis of Klinger and Gloor, 1960). The afférents end in practically every amyg-
daloid nuclear group with the exception of the nucleus basalis lateralis (Aggleton 
et al., 1980; Friedman et al., 1986; Inausti et al., 1987). 
Afférents from the prefrontal cortex to the amygdaloid complex arise in the 
orbital and medial surfaces of the prefrontal cortical regions. These areas are 
primarily located on the orbital (areas 11 , 12, 13, and 14) and medial (areas 24, 
25, and 32) surfaces of the prefrontal cortex (Aggleton et al., 1980; Van Hoe-
sen, 1981; Russchen, 1986a). These projections terminate in the magnocellulai 
portion of both the nucleus basalis lateralis and nucleus basalis accessonus 
(Aggleton et al., 1980) and the nucleus lateralis (Barbas and De Olmos, 1989). 
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The nucleus centralis and nucleus corticalis are regions of relatively very light 
liferent termination. 
1.3.3.3 Projections from the hippocampal formation 
Mthough early studies (Johnston, 1923; Hilpert, 1928) based on the examina-
ion of fibre-stained obduction material obtained from monkey and human brains 
¡uggested the existence of fibres interconnecting the amygdaloid complex and 
he hippocampus, these two centres have long been considered mutually unrela-
ed entities. This vision was further supported by Nauta (1961) who was unable 
о expose, using his silver degenerating technique, any connection between the 
jmygdaloid complex and the hippocampal formation. New tracing techniques 
lowever have given evidence for abundant bidirectional pathways (Krettek and 
'rice, 1974b, rat; Veening, 1978, rat; Ottersen, 1982, rat; Room and Groene-
wegen, 1986, cat; Aggleton, 1986). 
Hippocampal afférents to the amygdaloid complex. FD, fascia dentata; PRES, 
ìresubiculum; PROS, prosubiculum; SUB, subiculum. 
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In the present report the term "hippocampal formation" refers not only to the 
"hippocampus proper" or cornu ammonis but also includes the dentate gyrus, 
the subiculum with the presubiculum, and the entorhmal cortex (Rosene and van 
Hoesen, 1987; Price et al., 1987). In the monkey the entorhmal cortex extends 
from the fundus of the rhinal sulcus medially and dorsally, to the corticoamygda-
loid transiton area rostrally and more caudally to the parasubiculum; the entorhi-
nal cortex corresponds to Brodmann's area 28 (1909). The fibres originating 
from the hippocampal formation run in a diffusely arranged fibre stream, the 
angular bundle, through the deep cell free zone of the uncal part of the cortical 
transition area to the amygdaloid complex. However, there is some evidence 
that the nucleus centralis may also receive a projection via the fornix. 
The major projections arise from the entorhmal cortex, ventral subiculum, prosu-
biculum and subfield CA1 (Ottersen, 1982, rat, Russchen, 1982b, cat; Saunders 
et al., 1988a). 
It has been confirmed that the major termination sites of the subicular and CA1 
efferents are to be found in the nucleus basalis medialis, and the nucleus basalis 
lateralis (Fig. 2.3) Minor projections were traced to the nucleus corticalis, the 
nucleus centralis, the corticoamygdaloid transition area (СТА) and the nucleus 
lateralis (Van Hoesen, 1981; Aggleton, 1986; Saunders, 1988). In addition, area 
CA1 projects to the ventral, parvicellular part of the nucleus basalis accessonus. 
The fibres arising from the entorhmal cortex terminate in the rat and cat in the 
majority of the amygdaloid nuclei In the monkey, however (Fig. 2 3), these 
fibres run through the lateral nucleus to terminate partly in this nucleus, partly in 
the nucleus basalis medialis and probably also via "en route" synapses in other 
nuclei (Aggleton, 1986). 
2.3.3 4 Fibres arising from the magnocellular basal forebrain complex 
Injections of the retrograde tracer horseradish peroxidase (HRP) into the amygda­
la revealed large numbers of labeled cells in the magnocellular basal forebrain 
complex (MCBFC). The human MCBFC consists of, according to Mesulam et al. 
(1983), the following four subdivisions, designated as Ch1, Ch2, CH3, and Ch4. 
These four cell groups are also present in the rhesus monkey and correspond as 
follows: 1) the basal nucleus of Meynert (Ch4 group), 2) the nuclei of the hori­
zontal (Ch3) and vertical (Ch2) limbs of the nucleus of the diagonal band of 
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Broca, 3) the medial septal nucleus (Chi). 
The fibres originating in the MCBFC pass to the amygdaloid complex via the 
ventral amygdalofugal pathway and are largely cholinergic (Woolf and Butcher, 
1982; Carlsen et al., 1985, 1990, rat). The majority of the projecting cells were 
found in cell clusters constituting the Ch4 region (Mesulam, 1981), especially 
the anterolateral (Ch4al), fewer in the intermedioventral (Ch4iv) and posterior 
cell (Ch4p) groups (Aggleton et al., 1987; Koliatsos et al., 1987, Kordower et 
al., 1989) Lesser intensive projections anse from the Ch3 and Ch2 region 




Subcortical afférents to the amygdaloid complex. 
The projections terminate for the most part in the magnocellular division of the 
nucleus basalts lateralis, the nucleus centralis, and the nucleus corticalis and 
also, but less densely, in the nucleus basalis medialis, the magnocellular portion 
of the nucleus basalis accessonus, and the nucleus basalis superficialis (Fig. 
2.4). The small-celled division of the nucleus basalis accessonus and the nucleus 
lateralis receive only very few projection fibres (Russchen et al., 1985; Aggleton 
et al , 1987). There is a tendency for the more laterally (Ch4al) and ventrally 
(Ch4iv) located cell groups to send heavier protections to the more lateral subdi-
visions of the amygdaloid complex, whereas the cell group constituting Ch4p 
projects more to the centrally located divisions such as the nucleus basalis 
accessonus and the nucleus basalis medialis. Afférents to the amygdala from the 
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Ch3 and Ch2 preferentially project to the ventral and medial parts of the amyg-
dala. Only the medial septal nucleus (Ch1) appears to be entirely devoid of 
bidirectional connections 
2.3.3 5 Afférents from the hypothalamus 
Modern tracing techniques have revealed that the main source of projections 
from the hypothalamus are not the anterior and preoptic regions, as was indica-
ted by Nauta in 1962 and Wakefield and Hall in 1974, but the ventromedial 
nucleus and more caudal levels of the lateral hypothalamic area (Swanson, 
1976, cat; Amarai et al , 1982; Russchen, 1982b, cat) although some fibres 
arise from other areas such as the lateral preoptic area. The fibres reach the 
amygdaloid complex via both the stria terminalis and the ventral amygdalofugal 
pathway. 
These projections terminate principally in the medial division of the central 
nucleus (Fig. 2.4), the nucleus medialis, the nucleus basalis medialis, and in the 
parvicellular divisions of the nucleus basalis accessonus (Saper et al., 1979; 
Swanson, 1976, cat; Russchen, 1982b, cat) 
2.3.3 6 Afférents from the bed nucleus of the stria terminalis 
The bed nucleus of the stria terminalis (BNST) is a rostral forebram structure 
which deserves special attention. It is sometimes considered to be part of the 
hypothalamus (Conrad and Pfaff, 1976, rat), septum (Swanson and Cowan, 
1979, rat), or the amygdala (Johnston, 1923; De Olmos et al., 1985, rat). The 
similarities between the BNST and the central nucleus of the amygdaloid com-
plex are striking. Both contain the same type of neurons and terminals (Roberts 
et al , rat, 1980; Woodhams et al , 1983, rat). It can be divided into a lateral 
and a medial part as can the central nucleus, and the pattern of connectivity of 
the BNST and the amygdaloid nucleus is almost the same (Holstege et al., 1985, 
cat). For this reason the BNST may be considered an extra-amygdaloid extension 
located along the course and at the termination of the stria terminalis in the 
basomedial telencephalon. In view of its relationship with the amygdaloid com-
plex and its location the projections arising from this nucleus will be discussed. 
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In the rat, rabbit, and cat the cells of the BNST project predominantly to the 
nucleus mediahs and nucleus centralis of the amygdaloid complex via the bundle 
in which they are embedded (Kapp et al., 1984, rat; Holstege et al., 1985, 
rabbit; de Olmos et al., 1985, cat). In the macaque monkey, however, there is 
no reciprocation of the projections found which the amygdala sends to the 
BNST. This species difference may have to do with technical factors. The fine 
axons connecting the BNST with the amygdala may not accumulate enough 
marker to be detected by standard procedures (Novotny, 1977). 
2.3.3.7 Thalamic afférents 
It is now generally accepted that the thalamoamygdaloid projections originate 
almost exclusively from nuclei along or near the midline of the thalamus and not 
from the principal thalamic nuclei (viz the mediodorsal nucleus and the medial 
pulvinar nucleus), as was thought by former investigators such as Nauta (1962) 
and Krettek and Price (1977a). 
The thalamoamygdaloid fibres arising in the central medial, the interanterome-
dial, and the paraventricular thalamic nuclei diverge to many parts of the amyg-
daloid complex (Fig. 2.4) but more strongly to the nucleus basalis lateralis and 
nucleus centralis medialis than to the nucleus lateralis, nucleus basalis accesso-
nus and nucleus centralis lateralis (Mehler, 1980, Russchen, 1982b, cat; Aggie-
ton and Mishkm, 1984). 
Nonta and Kawamura (1980) have described neuronal labeling in the monkey 
medial geniculate body (a thalamic auditory relay), subsequent to a large HRP 
injection involving most of the amygdala. In other mammals (opossum. Kudo et 
al., 1986; rat, De Olmos et al., 1985, rat; Turner and Herkenham, 1991) a 
geniculatothalamic pathway exists which terminates mainly in the nucleus 
lateralis, nucleus basalis accessonus, and nucleus centralis. A thalamoamygda-
loid pathway linking the parvicellular division of the posteromedial ventral nu-
cleus (Yasui et al., 1987) with a restricted part of the nucleus lateralis and 
nucleus centralis has been established in the cat. Other thalamic nuclei projec-
ting to the amygdala are the nucleus paratenialis and subparafasciculans. The 
former project to the nucleus lateralis, nucleus basalis and nucleus corticahs; the 
latter project very lightly to the nucleus centralis, medialis, and nucleus basalis 
accessonus. 
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The fibres involved in the thalamoamygdaloid connections form two separate 
bundles; 1. the peduncle thalami extracapsular^; 2. the temporopulvinar bundle 
of Arnold. Along the telencephalic section of their course these two bundles 
associate with the ventral amygdalofugal pathway. 
2.3.3.8 Afférents from the brainstem and spinal cord 
The afferent projections from nuclei in the midbrain, pons, medulla oblongata, 
and spinal cord follow the ventral amygdalofugal pathway with the exception of 
the serotinergic fibres from the raphe dorsalis and the noradrenergic fibres from 
the locus coeruleus which reach the nucleus centralis of the amygdaloid com-
plex via both the stria terminalis and the amygdalofugal pathway. 
The nucleus centralis receives input from several areas of the mesencephalon 
viz. the ventral tegmental area, the substantia nigra pars compacta and from the 
locus coeruleus (Fig. 2.4). The dorsal raphe dorsalis projections are more widely 
distributed thoughout the amygdaloid complex (Fallon, 1981) with a moderately 
dense innervaton of the basolateral, cortical, central, and lateral nuclei. One of 
the major midbrain inputs comes from the peripeduncular nucleus (Mehler, 
1980; Russchen, 1982b, cat) and terminates in the central and medial nuclei. 
The lateral parabrachial nucleus is a major source of afférents from the brain-
stem in the monkey and projects to the nucleus centralis (Norita and Kawamura, 
1980). The projections from the medial parabrachial nucleus to the nucleus 
centralis are limited and extremely reduced compared to the equivalent projec-
tions in other mammals such as the rat, rabbit, and cat (Kapp et al., 1984; Diet-
richs, 1985). The projection field is the nucleus centralis. 
2.3.4 Efferente from the amygdaloid complex 
Just as the amygdaloid complex as a whole receives afférents from many sour-
ces, it has also ample efferent projections. 
In the following pages a brief description of the efferent projections from the 
amygdaloid complex to various regions will be given. These fibre categories are: 
1. Efferents to the cortex. 
2. Projections to the hippocampal formation and entorhinal cortex. 
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3. Amygdalostriatal projections. 
4. Efferente to the magnocellular basal forebrain complex (MCBFC). 
5. Projections to the hypothalamus and preoptic region. 
6. Projections to the bed nucleus of the stria terminalis. 
7. Fibres to the thalamus. 
8. Fibres to the brainstem and spinal cord. 
2.3.4.1 Efferents to the cortex 
Several studies describe prominent projections to widespread regions of frontal, 
insular, temporal, and occipital cortices (Mizuno et al., 1981; Tigges et al., 
1982, 1983; Amarai and Price, 1984). Most of the fibres appear to arise from 
the nucleus basalis and pass dorsally through the external capsula to reach the 
insula, the temporal and frontal cortices (Fig. 2.5). The heaviest projections to 
the frontal cortex terminate in the medial and orbital regions which include areas 
14, 13a, and 12 at the medial surface and areas 14, 13a, and 12 at the orbital 
surface. Lighter projections were also seen to terminate in the frontal areas 45, 
46, 6, 9, and 10. Most of these projections arise from the magnocellular basal 
nucleus, lighter projections also arise from the nucleus basalis medialis and the 
magnocellular part of the nucleus basalis accessorius and from the nucleus 
corticalis (Porrino et al., 1981). 
cortex frontalis 
Fig. 2.5 
Efferents of the amygdaloid complex to the cerebral cortex and striatum. 
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The heaviest projections to the insula terminate in the agranular insular cortex 
with a decreasing gradient of termination to more caudally placed dysgranular 
and granular insular areas The amygdaloid origin of the projections to the insula 
is complex some fibres projecting to the agranular part arise from various re-
gions, whereas others are restricted to the nucleus basalis accessonus and other 
basal nuclei (Amarai and Price, 1984) Essentially, all major divisions of the 
temporal neocortex receive amygdaloid projections The most prominent of 
which end in the cortex of the temporal pole (area 38) and the perirhinal cortex 
(area 35 and 36) The dorsal part of the nucleus basalis accessonus pars magno-
cellulans gives rise to projections to the rostral inferior temporal cortex (area 
20), the rostral superior temporal gyrus (area 22) and also to the more caudal 
levels of the inferior temporal cortex (area 20 and 21) Interestingly, from a 
neuroanatomical and functional point of view, none of the above mentioned 
regions which are all related to vision, have reciproke projections to the amygda 
la (Mizuno et al , 1981, Amarai and Price, 1984, Iwai and Yukie, 1987), see 
also chapter 2 section 4 
Finally, area 7 of the parietal cortex, more precisely the areas around the rostral 
intrapanetal sulcus, receives limited amygdaloid projections 
2 3 4 2 Projections to the hippocampal formation and entorhmal cortex 
The heaviest projections to the hippocampal formation emerge from the nucleus 
basalis medialis, the nucleus corticalis and the nucleus basalis accessonus (Fig 
2 6) Far weaker projections originate from the nucleus lateralis, and nucleus 
basalis lateralis (Amarai and Cowan, 1980, Aggleton, 1986, Amarai, 1986, 
Saunders et al , 1988) The fibres from the nucleus basalis accessonus pars 
magnocellulans and cortical nuclei enter the rostrodorsal portion of the subicu-
lum and continue laterally through the fields CA3 and CA2 to end in field CA1 
(Aggleton, 1986, Amarai, 1986, Saunders et al , 1988), extending almost to the 
caudal pole of the hippocampus In addition, there are also projections from the 
nucleus basalis medialis, the cortical amygdaloid transition area and nucleus 
corticalis of the amygdaloid complex to the prosubiculum The most prominent 
projections to the entorhmal cortex originate in the nucleus lateralis, nucleus 
basalis lateralis, and the nucleus basalis accessonus with lighter projections 
originating in the nucleus basalis medialis and corticoamygdaloid area These 
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Fibres appear to terminate in different layers in the rostral entorhinal cortex with 
the greatest density in layers V and VI (Saunders et al., 1988a). The nucleus 
aterahs plays a minor role in the innervation of the hippocampal formation and 
Drojects mainly to the entorhinal cortex (Krettek and Price, 1977b, rat and cat) 
and prosubiculum (Amarai, 1986; Saunders et al., 1988b) 
Efferents of the amygdaloid complex to the hippocampus, ibid legenda fig. 2.3. 
2 3.4.3 Amygdalostnatal projections 
The amygdaloid fibres pass via the longitudinal association bundle and the stria 
terminahs in a roughly topographic manner to widespread areas of the striatum 
and ventral striatum, including the nucleus accumbens, the striatal-like portions 
of the olfactory tubercle, the ventral portions of the putamen, and the ventral 
and caudal parts of the caudate nucleus. The striatum is one of the few struc-
tures without reciprocal projections back to the amygdala. 
The amygdaloid input to the striatum originates primarily from the nucleus 
basalis lateralis (Fig. 2 5); lighter projections arise from the nucleus basahs 
accessonus and the transition area (Veenmg et al., 1980, rat, Groenenwegen et 
al., 1980, cat; Fuller et al , 1987, rat) The fibres of the magnocellular part of 
the nucleus basalis lateralis terminate in the head, body, and tail of the nucleus 
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caudatus Fibres of the nucleus basalis medialis, nucleus basalis accessonus, 
and the corticotransition area terminate in the ventral striatum (Kelley et al , 
1982, rat, Russchen, 1985) A light projection to the ventral pallidum arises 
from the central nucleus, nucleus basalis accessonus, and nucleus basalis medi-
alis 
In many of these areas the amygdaloid fibres terminate in a patchy fashion. 
2 3 4 4 Efferents to the magnocellular basal forebrain complex (MCBFC) 
Although almost every amygdaloid nucleus sends projections to the MCBFC (Fig 
2.7), apparently the heavier projections arise from the caudoventral part of the 
nucleus basalis lateralis, the nucleus medialis, the magnocellular portion of the 
nucleus basalis accessonus and the nucleus centralis, and to a lesser extent 
from the nucleus lateralis, and nucleus corticalis (Kosel and Rosene, 1980; Rus-
schen et al, 1985, Hreib and Rosene, 1986, Irle and Markowitsch, 1986, Aggle-




Subcortical efferents of the amygdaloid complex. 
Field Ch4 receives projections from the nucleus centralis, nucleus basalis media-
lis, nucleus basalis accessonus, and the nucleus basalis lateralis. Ch3 is in re-
ceipt of projections from the nucleus centralis and nucleus medialis Within the 
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Ch4 the heaviest amygdaloid projections terminate in subdi isions Ch4al, Ch4id, 
and Ch4iv. Many fibres pass through Ch1 and Ch2 but there is no clear evi-
dence that amygdaloid projections actually terminate in these areas (Aggleton et 
al , 1987). 
2.3.4.5 Projections to the hypothalamus and preoptic region 
The efferente of the amygdaloid complex to the hypothalamus constitute one of 
its major output channels of this complex 
Almost every amygdaloid nucleus sends projections to the hypothalamus al-
though there are significant differences in the magnitude of the contributions 
made by the individual amygdaloid nuclei (Fig. 2 7) 
Most of the fibres that project to the preoptic region and anterior hypothalamus 
arise from the medial and anterior cortical nuclei and extend caudally from the 
bed nucleus of the stria terminalis (BNST) and rostrally from the ventral amygda-
lofugal pathway to their projection fields The projections are widely distributed 
within the anterior hypothalamus, including the regions immediately lateral or 
dorsal to the paraventricular and preoptic nuclei (Price et al , 1987) 
The ventromedial, premammillary, and supramammillary hypothalamic nuclei re-
ceive prominent projections from the nucleus basalis accessonus and nucleus 
basahs medialis (Krettek and Price, 1978a, rat and cat. Price, 1986). The projec-
tions to the ventromedial nucleus can be divided into a component that termi-
nates in the cell sparse shell around the nucleus, and another component that 
ends in its cellular core (de Olmos, 1972, rat; Price, 1986, Heimer and Nauta, 
1969, rat, Swanson and Cowan, 1979, rat) The fibres ending in the core ap-
pear to enter the hypothalamus via the ventral amygdalofugal pathway, while 
the fibres which end in the shell reach the the hypothalamus via the stria termi-
nais The nucleus centralis and to a lesser extent the nucleus corticalis and 
nucleus medialis give rise to a substantial projection to the lateral hypothalamic 
area (Price and Amarai, 1981) and to the paramammary nucleus which is 
located at the lateral edge of the mammillary nuclear complex The fibres origi-
nating from the nucleus centralis enter the hypothalamus via the stria terminalis, 
the others run via the ventral amygdalofugal pathway. 
The nucleus basalis does not project to the complete lateral hypothalamic area, 
it does however, give rise to a heavy projection to the small lateral tuberai nu-
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deus at the ventral margin of the hypothalamus of the monkey (Price and Ama 
ral, 1987) 
2 3 4 6 Projections to the bed nucleus of the stria terminalis (BNST) 
The projections to the BNST are among the most prominent efferents of the 
amygdaloid complex 
Most of the fibres to the BNST course through the stria terminalis The medially 
situated amygdaloid nuclei, the nucleus corticalis, the nucleus medialis, and 
nucleus centralis medialis project to the medial part of the BNST (Weiler and 
Smith, 1982, rat) The nucleus basalis lateralis and nucleus centralis lateralis 
send projections to the lateral part of the BNST The nucleus basalis accessonus 
projects both to the medial and lateral divisions of the BNST (Weiler and Smith, 
1982, rat. Price and Amarai, 1987) 
2 3 4 7 Fibres to the thalamus 
Except for the nucleus centralis and nucleus medialis, all of the amygdaloid 
nuclei project to the thalamus (Fig 2 7) 
The main target in the thalamus is the rostral half of the magnocellular medio-
dorsal nucleus (Aggleton and Mishkin, 1984, Russchen et al , 1987) The cells 
of origin of the amygdalothalamic fibres are organized in a topographic fashion 
without regarding to the nuclear boundaries Moreover, the termination zones of 
the amygdaloid projections in the thalamus are organized in different quadrants 
Thus, the fibres arising from the ventromedial part of the amygdaloid complex, 
especially the nucleus basalis superficialis and corticoamygdaloid area, primarily 
end in the medial part of the mediodorsal thalamic nucleus, fibres from the 
caudomedial part of the complex, the parvicellular nucleus basalis accessonus, 
and the corticoamygdaloid transition area terminate mainly in the dorsal and 
dorsolateral part of the mediodorsal thalamic nucleus, whereas fibres from the 
magnocellular basal, accessory basal and lateral nuclei tend to end in the ventro-
lateral part (Russchen, 1987) 
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2.3.4.8 Fibres to the brainstem and spinal cord 
The nucleus centralis projects caudal to the hypothalamus to the midbrain, pons, 
and medulla. The fibres of this nucleus, which initially course medially within the 
ventral amygdalofugal pathway, enter the most lateral part of the hypothalamus 
and the tegmental areas of the brain stem caudally The most caudal fibres of 
this so-called amygdalotegmental projection ultimately reach the cervical cord. 
Many fibres leave the initial part of the principal descending bundle in the mid-
brain to terminate in numerous centres including the penpeduncular nucleus, the 
substantia nigra pars compacta, the ventral tegmental area, the cuneiform nu-
cleus, the periaqueductal grey matter, and the raphe nuclei (Aggleton et al., 
1980; Noma and Kawamura, 1980) Caudally the fibres continue through the 
pontine and medullary reticular formation and project to the medial and lateral 
division of the parabrachial nucleus, the locus coeruleus and the area subcoeru-
lea, the dorsal motor nucleus of the vagus, and the nucleus of the solitary tract 
(Gray et al., 1986, rat; Price and Amarai, 1981, Mehler, 1980; Thompson and 
Cassell, 1987, rat; Holstege et al., 1985, cat). 
2.3.5 Intraamygdaloid connections 
The nucleus lateralis sends heavy projections to all divisions of the ad|acent 
nucleus basahs (Fig. 2 8), the nucleus basalis accessonus, and the nucleus 
corticalis (Pitkanen and Amarai, 1991). The nucleus lateralis also sends minor 
projections to the nucleus medialis, nucleus centralis, and the corticoamygdaloid 
transition area (Aggleton, 1985; Price and Amarai, 1987). The nucleus lateralis 
is almost devoid of intraamygdaloid input with the exception of a few intraamyg-
daloid inputs from the nucleus basalis accessonus (Wakefield, 1979; Aggleton, 
1985). The nucleus basalis lateralis gives rise to a series of projections to the 
nucleus basalis medialis and superficialis and to the nucleus centralis, medialis, 
and corticalis. The intrinsic projections to the nucleus basalis lateralis appear to 
originate predominantly from the nucleus lateralis, nucleus centralis medialis, 
and the nucleus corticalis (Pitkanen and Amarai, 1991; Aggleton, 1985). The 
nucleus basalis medialis gives rise to intraamygdaloid connections with the 
nucleus centralis, the magnocellular part of the nucleus basalis accessonus, the 




Prominent sources of projections to the nucleus basalis accessonus include the 
nucleus lateralis and to a lesser extent the nucleus medialis and nucleus cortica-
le (Price et al., 1987; Russchen, 1986a, cat). The nucleus centralis appears to 
be the principal recipient of the intraamygdaloid projections; however, in return it 
gives rise to a few reciprocal fibres to the nucleus corticahs (Price et al., 1987). 
Information concerning the intrinsic connections of the monkey nucleus cortica-
le is limited. In the tracing experiments, mentioned earlier, no injections with 
amino acids were performed in either the cortical nucleus or the penamygdaloid 
cortex. 
There is a clear trend for the intrinsic connections of amygdala to run unidirec-
tionally m a lateral to medial direction. The heaviest projections arise from the 
lateral and basal nuclei while the nucleus centralis, nucleus medialis, nucleus 
corticahs, and the nucleus basalis accessonus (Aggleton, 1985) are the major 
recipients. 
2.3.6 Commissural, interamygdaloid connections 
From observations with axon degeneration experiments in rats it has become 
evident that the stria terminalis constitutes not only a major efferent pathway 
linking the nucleus centralis with structures in the diencephalon but also with 
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commissural projections from the nucleus còrticalis homotopically to the contra-
lateral side (Ottersen, 1982). These fibres course through the ipsilateral stria 
terminalis and after crossing the commissura anterior join the contralateral stria 
terminalis to terminate in restricted areas of the amygdala. 
In the monkey, axon degenerating experiments have given evidence for identical 
commissural connections (Turner and Knapp, 1976) but the projecting areas 
have not yet been determined. 
2.4 Five functional pathways 
It has been suggested that the amygdala acts as a pivotal structure in the inter-
action between cortical areas associated with a modality-specific sensory func-
tion on the one hand and subcortical structures related with endocrine and auto-
nomic functions on the other (Price et al., 1987; Turner and Herkenham, 1991). 
In the following an attempt will be made to illustrate some of the ways in which 
the "linkage" by means of the amygdala can take place. Five possible routes 
over which sensory information is relayed from cortical areas via the amygdala 
to effector areas will be presented. Firstly, cortical areas with specific sensory 
modalities and their projections to the amygdaloid complex will be described. 
¿v>i sensory of 
internal organs 







gust, olfactory, orosensory 
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Fig. 2.9 
Distribution of corticoamygdaloid projections in relation with their modality in the 
amygdaloid complex. 
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There are heavy amygdalopetal projections from modality specific association 
and polysensory convergence areas in the neocortex (Pandya and Seltzer, 
1982). The amygdaloid complex receives unimodal visual information (Van 
Hoesen 1981) originating from the rostral inferotemporal cortex (area 21), and 
polysensory information from two regions in the temporal lobe that are known to 
be visually responsive (Rolls 1984), namely the parahippocampal gyrus and a 
visual association area found in the caudal part of the superior temporal sulcus 
(the middle temporal visual area) Auditory inputs come from the auditory asso-
ciation areas surrounding the primary auditory cortex in the superior temporal 
gyrus (the caudal parts of area 22) and the temporal operculum (Van Hoesen 
1981). Weak somatosensory information is relayed by the posterior and granular 
parts of the insula and projected to the dorsomedial part of the nucleus lateralis 
(Mufson et al., 1981). From the posteroventral portion of the frontal operculum, 
where the primary gustatory cortex is located, projections emerge which termi-
nate in the dorsomedial part of the nucleus lateralis of the amygdala (Van Hoe-
sen, 1981). 
The various projections differ in their distribution to one or more amygdaloid 
nuclei and each amygdaloid nucleus receives different cortical projections (sec-
tion 2.3). The nucleus lateralis receives the most prominent projections (Fig. 
2.9). The input from the auditory association areas even terminates almost 
exclusively within this nucleus (Van Hoesen, 1981) Most of the cortical projec-
tions to the amygdala are bidirectional However, the same dorsal region of the 
magnocellular basal nucleus that receives visual input projects not only to visual-
ly related cortical areas in the inferior temporal cortex but also unidirectionally to 
prestnate and striate cortex of the occipital lobe (Iwai and Yuki, 1987). Evident-
ly there are projections from the amygdala to the primary visual areas which 
seem to be unidirectional (Mizuno et al, 1981; Tigges et al., 1982). The projecti-
on areas in the amygdala appear to be concerned with both the receipt of visual 
information from the cortex and the "feedback" to the visual cortex (Amarai and 
Price, 1984). 
It can be concluded that the visual, auditory, gustatory, and somatic sensory 
information reach the amygdala via separate, modality-specific, cortico-cortical 
and corticoamygdaloid pathways, and that each sensory system influences only 
a restricted sector of the amygdaloid complex (Fig. 2 9). The nucleus lateralis 
appears to be an important termination area for sensory input of various modali-
ties (Van Hoesen, 1981, Turner and Herkenham, 1991) and thus this nucleus is 
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considered to be a major site of sensory convergence in the amygdala. The 
complex can therefore influence and be influenced by sensory information that 
has been processed to various degrees. Moreover, it is capable of conveying 
cortical information via complex intraamygdaloid connections to other areas of 
the brain. The pattern of these interconnections point to the dorsomedial direc­
tion with the nucleus centralis recieving most of the projections from the basola-
teral complex. 
Five postulated functional pathways are shown in Figure 2.10. 










































































































Scematic representation of neocortical sensory specific input to amygdaloid 
subdivisions and its convergence in the amygdala via intraamygdaloid connec­
tions and via efferent projections to the hypothalamus, thalamus, hippocampal 
formation, nucleus basalis of Meynert complex, and brain stem nuclei. Modali­
ties: 1) sensory of internal organs; 2) auditory; 3) somatosensory; 4) gustatory / 
orosensory; 5) visual. 
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1) Information from the cortical association areas is conveyed to the hypothala-
mus via the widespread intraamygdaloid connections to the nucleus centralis 
and the basal nucleus Reciprocal connections from the hypothalamus project via 
the amygdala to the cortical association areas Since these subcortical regions 
are involved in drives and emotions it has been suggested that the amygdala 
modulates the influence of sensory cortical information upon behaviour, emotion 
and autonomic activity. 
2) Cortical areas are linked via the amygdalofugal pathway and stria terminalis 
with the mediodorsal nucleus of the thalamus There are prominent projections 
from the basal nuclei, nucleus lateralis, nucleus basalis accessonus and nucleus 
corticalis of the amygdala to the mediodorsal nucleus of the thalamus (Aggleton 
and Mishkin, 1984; Russchen et al., 1987). Interestingly, these fibres arise from 
those parts of the amygdaloid complex that receive strong direct projections 
from the hippocampal formation and the entorhinal cortex. Within the thalamus 
the amygdaloid projection appears to overlap with the area that receives input 
from the olfactory and entorhinal cortices, the anterior temporal lobe and the 
subicular complex of the hippocampal formation (Russchen et al , 1987). 
The widespread thalamo-amygdaloid connections originate in thalamic nuclei 
which are supposed to be important relays in the various sensory systems- the 
parvocellular part of the nucleus ventralis posterolaterals conveys gustatory 
information to the nucleus lateralis and nucleus centralis (Saper and Loewy, 
1980, Fulwiler and Saper, 1984,), some of the subdivisions of the corpus geni-
culatum mediahs including the subparafasciculans part convey auditory informa-
tion (Blum et al , 1979) and viscerosensations from the thoracic and abdominal 
cavities are projected via the nucleus centromedialis and paraventricular^ thala-
mi to the nucleus centralis of the amygdala (Saper and Loewy, 1980, Fulwiler 
and Saper, 1980). 
It has therefore been suggested that the amygdala, interconnecting the cortical 
areas with parts of the thalamus, completes a cortico-thalamo-cortico circuit by 
means of which sensory information is processed and probably stored (Mishkin 
and Aggleton, 1981; Markowitsch, 1985, 1988; Abeles, 1988). 
3) The amygdala also relays cortical information to the hippocampus (Fig.2.10). 
Although the hippocampus receives major projections from regions of polysenso-
ry convergence (the temporal pole, perirhinal cortex and parahippocampal gyrus), 
it is also influenced by cortical input from several unimodal association areas 
(Amarai, 1987) interconnected via the amygdala The hippocampal formation 
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(prosubiculum and CA1, CA2, and САЗ,) and the entorhinal cortex, reciprocally 
connected with the laterobasal complex, the nucleus corticalis and the cortico-
amygdaloid transition area, are supposed to be involved in the process of conso­
lidation of information from the short-term to the long-term compartment of 
memory (Rawlins, 1983; Rawlins and Tsaltas, 1985; Squire and Cohen, 1984). 
4) Cortical sensory information is relayed by the amygdala to the magnocellular 
basal nucleus of Meynert. Tracer experiments have made it clear that the NMB 
receives projections from the lower brain stem, hypothalamus, thalamus and re­
stricted parts of the neocortex (Russchen et al , 1985) but it also appeared that 
the amygdala has substantial direct connections with the NBM. Therefore it is 
likely that some amygdaloid nuclei (the nucleus basalts, the nucleus basalts 
accessonus and the nucleus medialis) which project to the Ch4 region of the 
NBM, are the major source of relayed cortical information influencing this nu­
cleus (Mesulam and Mufson, 1984) It has been suggested that the Ch4 com­
plex acts as a cholinergic relay for transmitting predominantly limbic and paralim-
bic information to the neocortex and that it is involved in higher mental func­
tions including memory (Bartus et al., 1982; Murray and Fibiger, 1986). 
5) By means of the fifth pathway the amygdala connects the cortical areas with 
pontine structures such as the parabrachial nuclei, and the nucleus of the solita 
ry tract as with medullary structures such as the dorsal motor nucleus (Price and 
Amarai, 1981) Returning projections terminate primarily in the nucleus centralis 
amygdalae with minor projections ending in the nucleus medialis, the nucleus 
basalis and the nucleus basalts accessonus In this pattern of connections (Fig. 
2 9 and 2.10) the nucleus centralis plays a pivotal role. Viscerosensory informa­
tion of the cortical areas is concentrated in this nucleus and conveyed, influen­
cing the function of many brain stem structures. 
Reviewing the connections there is neuroanatomical evidence that cortical and 
limbic information is restructured and relayed by the subdivisions and intercon­
nections of the amygdala and funneled from there to effector organs via the 
basal forebrain and hypothalamus. 
2.5 Neurotransmitters and modulators in the amygdala, a brief survey 
Since Koelie (1954) demonstrated the presence of acetylcholinesterase in the 
amygdala of the rat the knowledge of the neurotransmitter distribution in the 
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amygdala has dramatically increased. Almost all of the available research on 
transmitters and modulators has been done in the rat and the following brief 
description of the neurotransmitters and modulators will therefore be based on 
findings derived from this species (Table 2.3). 
Table 2.3 
Some of the neuromediators occurring in the fibres and terminals as well as in 















































































































































































О, present ¡η регікагуэ; · , present in a considerable number of perikarya; +, 
present in fibres and/or terminals; *, present in a large number of fibres and/or 
terminals. 
Abbreviations: G.A.B.A, gamma-aminobutyric acid; glut./asp., glutamate/aspar-
tate; A.C.T.H, adenocorticotropic acid; V.l.P., vasoactive intestinal polypeptide; 
CRF, corticotropin-releasing factor; vasopr., Vasopressine. 
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2.5 1 GABA and excitatory amino acids 
Gamma ammo-butyric acid (GABA) and the excitatory ammo acids, glutamate 
and aspartate, are thought to play a role m the transmission of intraamygdaloid 
(especially GABA) as well as in efferent projections (glutamate and aspartate). 
The nucleus centralis contains higher concentrations of GABA than other amyg­
daloid nuclei (Ben-Ari et al, 1976). The highest levels of the entire brain were 
found in the stria terminalis and the bed nucleus of the stria terminalis (Ben-Ari 
et al., 1976, Ottersen et al , 1986; Nitecka and Ben-Ari, 1987). The GABAergic 
innervation of the amygdaloid complex is thought to be mainly intrinsic as was 
shown by dissecting methods (Ben-Ari, 1981). The general pattern of GABA 
immunoreactivity in the amygdaloid nuclei suggests that a large number of 
GABAergic penkarya are present in the basolateral region with the nuclei of the 
central and medial regions as the main targets of the GABAergic terminals 
(Nitecka and Ben-Ari, 1987, Carlsen, 1988) It has been argued that GABA is a 
major inhibitory transmitter in many parts of the brain (Ben-Ari and Kelly, 1976). 
In several studies (Tagaki and Yamamoto, 1981; Ben-Ari, 1981; Watson et al., 
1983) evidence has been presented suggesting that also in the amygdaloid 
complex GABA is a major inhibitory transmitter. The immunoreactive neurons 
form a heterogenous group of neurons ranging from 7 μπ\ to 22 μπ\ in diameter. 
Most of the GABAergic neurons are to be found in the nucleus basolateralis. The 
nucleus centralis and the nucleus mediahs seem to be the main targets of the 
GABAergic intraamygdaloid projections and in particular those from the nucleus 
basolateralis In this way the centromedial "excitatory region" is inhibited and 
the amygdaloid influence on some vegetative and endocrine functions reduced 
(Nitecka and Frotscher, 1989). Brioni et al. (1988) demonstrated that neuroche­
mical systems within the amygdala, including the GABAergic system, are invol­
ved in the endogenous regulation of memory storage. In the rat they showed 
that learning and memory can be influenced by injections with GABAergic ago­
nists or antagonists into the amygdaloid complex. 
The roles played by the ammo acids, glutamate and aspartate, have not yet been 
definitively determined but in recent years a role as transmitter has been investi­
gated (Fagg and Foster, 1983; Fagg et al., 1986). The amino acids may serve as 
excitatory transmitter substances used by a large number of neurons in the 
central nervous system (Fonnum, 1984). Excitatory neurons that may use gluta­
mate as neurotransmitter have been localized immunocytochemically using 
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enzymes in glutamate synthesis and metabolism (Fuller et al. 1987). All amygda-
loid nuclei contain moderate to large numbers of neurons with glutamate and 
aspartate immunoreactivity (Ottersen et al , 1986) with the highest concentra-
tion in the nucleus lateralis and the nucleus basalis medialis. The neurons invol-
ved with efferent projections in the amygdaloid complex (McDonald and Pear-
son, 1989) are mostly large pyramidal or piriform cells that clearly correspond to 
the class I neurons observed in Golgi studies (McDonald, 1982). 
2.5.2 Peptides 
There is growing evidence that a wide variety of neuropeptides are present in 
the afferent and efferent pathways that link the rat amygdaloid complex and 
particularly the nucleus centralis with other brain structures (Roberts et al., 
1982; Gray, 1983; Veenmg et al , 1984; Cassell and Gray, 1990). Many of 
these peptides including cholecystokimn (CCK), vasoactive intestinal polypeptide 
(VIP), somatostatin (SOM), substance P, galanm, and enkephalins have neuro-
transmitter/neuromodulator properties (Roberts et al., 1982; Gray and Morley, 
1986a; Shimada et al., 1989; Micevych et al., 1988). In most of the amygdaloid 
nuclei scattered neurons can be stained with antisera to diverse peptides. How-
ever, the nucleus centralis contains one of the richest assortments of peptides 
to be found in the brain (Table 2.3) and many of the peptide-containing neurons 
give rise to subcortical projections especially to the autonomic nuclei of the 
brainstem (Veenmg et al., 1984; Gray et al, 1986b). Roberts et al (1983) 
showed, using the double staining technique and studying six different peptides, 
that no two peptides co-exist in the same fibre or neuron, although many neu-
rons may contain two or more neuromessengers, for example GABA together 
with somatostatin (McDonald and Pearson, 1989). Examination of the morpholo-
gical characteristics of the peptide-immunoreactive neurons revealed that there 
was no relation between specific cell-type and peptide (Cassell and Gray, 1990). 
2.5.3 Monoaminergic and acetylchohnergic inputs 
The localization and sources of the monoamine neurotransmitters including the 
catecholamines dopamine (DA), noradrenahn (NA), and adrenalin (A), the indola-
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mine serotonin (5-HT), as well as acetylcholine (ACh) and histamine (H) in the 
amygdaloid complex will be briefly described. 
The amygdala receives intensive cholinergic innervation from the basal forebrain 
although recently a group of intrinsic cholinergic neurons in the basal nucleus 
has been described (Carlsen, 1990). Large differences in distribution of fibres 
containing choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) are 
found in the amygdala with the nucleus lateralis and basal nuclei containing the 
highest concentrations (Ben-An, 1981; Amarai et al., 1989b). 
The nucleus centralis in particular receives dense dopaminergic innervation from 
cells in the ventral tegmental area and the pars compacta of the substantia 
nigra. Low to moderately dense dopaminergic fibres are present in the nucleus 
basalis lateralis, the intercalated masses and the anterior amygdaloid area (Fal-
lon, 1981). The locus coeruleus and other cell groups of the brainstem send 
noradrenergic input to the amygdala and these fibres are widely distributed with 
a dense innervation of the central and basalateral nuclei (Swanson and Hart-
man, 1975; Fallon, 1981) 
The amygdala also receives serotinergic input from the raphe dorsalis nucleus 
and to a lesser extent from the caudal dorsal raphe, pontine raphe, and medulla-
ry raphe nuclei (Fallon, 1981) These fibres innervate the entire amygdala with a 
moderately dense innervation of the nucleus centralis. 
2.6 Some functional aspects 
2 6.1 Introduction 
In this chapter some functional aspects of the amygdaloid complex will be 
reviewed. First a brief historical survey will be given of the various theories 
concerning the function of the complex and the way in which these data were 
obtained. This survey will be followed by a discussion of various lesion experi-
ments in the monkey and the role the amygdala may play in mnemonic proces-
ses. Finally, data will be reviewed on behavioural and memory-related changes in 
patients suffering from neuropathological processes confined principally to the 
amygdala and some conclusions will be drawn. 
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2 6 2 Historical perspective 
In an early study on the nomenclature, the cytoarchitecture and fibre connec-
tions of the amygdaloid complex, Hilpert (1928) noted that at that time little 
was known about the function of the complex and that it was generally assu-
med that the amygdala was a component of the central olfactory system. On 
the basis of its complex inner structure Hilpert concluded that the amygdala was 
a highly developed organ which processed sensory stimuli that had been modi-
fied by other centres. 
The classical paper by Papez (1935) on the morphological substrate of emotions 
and the study by Klüver and Buey (1937) on the psychic blindness and other 
symptoms following bilateral temporal lobectomy in rhesus monkeys have been 
the stimulus for a growing interest in the neurological basis of behaviour and the 
role the amygdala plays in it 
Papez (1937) formulated his ideas concerning the neural mechanism underlying 
emotion as follows. "The central emotive process of cortical origin may be 
conceived as being built up in the hippocampal formation and as being transfer-
red to the mammillary body and thence through the anterior thalamic nuclei to 
the cortex of the gyrus cinguli The cortex of the angular gyrus may be looked 
on as the receptive region for the experiencing of emotion Radiation of the 
emotive process from the gyrus cinguli to other regions in the cerebral cortex 
would add emotional colouring to psychic process " This chain of connections is 
now known as the "circuit of Papez". There were little data to support his thesis 
and the clinical evidence was more suggestive rather than definite (MacLean, 
1949). 
However, as early as 1937 and 1939 the theory postulated by Papez supposing 
that the "rhinencephalon" plays a fundamental role in the affective sphere was 
supported by the experiments of Klüver and Buey These authors studied beha-
vioural effects resulting from the partial removal of both temporal lobes, inclu-
ding the uncus and the greater part of the hippocampus in macaques. The symp-
toms following bilateral temporal lobectomy in rhesus monkey include: 1) forms 
of behaviour which seem to be indicative for "psychic blindness" or visual 
agnosia: the animal seems to have lost the ability to depend on visual characte-
ristics alone if it wants to know whether an object is eatable or dangerous; 2) 
oral behaviour, strong oral tendencies in examining available objects; 3) hyper-
metamorphosis. a strong tendency to attend and react to every visual stimulus 
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as if the animal was under the influence of some irresistible impulse forcing it to 
react to objects, 4) dissociation of emotional behaviour: there is such a complete 
lack of emotional reaction, that it is almost impossible to stimulate motor, vocal 
or other forms of behaviour in normal extremely dangerous situations; 5) an 
increase in sexual activity The extirpation of only one temporal lobe produced 
none of these characteristic changes. 
The emphasis Papez put on the hippocampus as being the key structure where 
the emotive process is established, is shared by Klüver and Buey. The fact that 
none of these typical symptoms occurred in animals in which the hippocampus 
was left intact supported Papez' theory However, these authors suggested 
further experimentation to confirm this decisive function performed by the 
hippocampus since a preliminary microscopical examination showed that not 
only almost the entire hippocampus with the exception of a dorsomedial strip 
throughout the extent of the lesion and the Brodmann's areas 22, 2 1 , and 20 
were extirpated but also the amygdala and the tail of the nucleus caudatus 
(Klüver and Buey, 1939) 
In attempts to relate particular anatomical structures to behavioural changes 
mentioned by Klüver and Buey later investigators used the same ablation tech-
niques in monkeys, cats, and dogs The temporal lobe could be functionally 
fractionated with respect to some of these changes Lesions in the ventrolateral 
portion of the temporal lobe produced marked impairment in visual discrimination 
with no other apparent symptoms (Chow, 1952) Orbito-temporal lesions or 
more limited anteromedial temporal lesions produced tameness, hypermetamor-
phosis and changes in dietary habits without visual discrimination impairment 
(Pribram and Bagshaw, 1953) 
Although some behavioural changes could be related to specific small lesions of 
the temporal lobe it was not possible to assign a well-defined anatomical locali-
zation to every behavioural component 
Disturbances of emotional behaviour are the most consistent consequence of 
bilateral amygdaloid lesions (Kling, 1972, Kling and Steklis, 1976). 
The effects of the lesions is not consistent across species but differ according to 
the extent of behavioural specializations. This is especially true for primates 
which depend on the correct interpretation of subtle facial expressions and 
alterations in body posture for appropiate social interactions (Rosvold, 1954). 
Kling and Steklis (1972, 1976) demonstrated that monkeys loose their pre-
surgical rank in the social hierarchy after amygdala-ablation, become isolated 
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from the rest of the group and often perish; they avoid normal social contact 
and flee from their human caretaker and, if pursued, from other members of the 
group. The male animals were unable to demonstrate appropietely characteristic 
treat and gestures to communicate with group-members and dominant animals. 
Female monkeys with bilateral amygdaloid lesions are to a severe extent incapa-
ble of displaying normal maternal behaviour and are disrupted in normal social 
interactions (Kling, 1972). These behavioural disturbances could also be demon-
strated by lesions to the temporal polar cortex (Kling and Steklis, 1976; Butcher 
et al., 1970) and it is likely that normal social behaviour is dependent on both 
the amygdala and the temporal polar cortex. 
Learning impairments in primates with bilateral amygdaloid lesions were for a 
long time not considered to be related to the amygdala (Weiskrantz, 1954). 
Some kind of participation of the primate amygdala in mnemonic processes has 
recently been proposed by the studies by Mishkin (1978) with lesions experi-
ments inflicting both the amygdala and the hippocampus. In the following para-
graph the mnemonic function of the amygdala wíl be discussed. 
In contrast to the dramatic alterations in behaviour produced by amygdaloid 
lesions, the changes in somatomotor and autonomic mechanisms are very mo-
dest. The lesions have to be bilateral to produce any effect and often only 
temporary effects are observed Such transient autonomic changes include an 
increase in arterial blood pressure, decrease in hear and respiratory rates, and 
hyperemia and ulcerations of the gastrointestinal mucosa (Anand et al., 1957). 
More recently, Kapp (1979, 1984, and 1986), using stereotactic ablation tech-
niques, demonstrated the important contribution of the nucleus centralis to 
cardiovascular regulation, particularly during emotional states. Lesion experi-
ments involving the central and corticomedial amygdaloid nuclei generally result 
in aphagia and adipsia, whereas lesions that involve the basolateral part of the 
amygdala lead to hyperphagia and hyperdipsia (Rolls and Rolls, 1973; Aggleton 
et al., 1981; Fitzgerald and Burton, 1981, Becker et al., 1984). In these studies 
there was a considerable variation in the duration of the effects. It has been 
suggested that the lesions of various parts of the amygdala shift the balance 
from withdrawal and rejection to approach and acceptance (Schoenfeld and 
Hamilton, 1981). 
The amygdaloid complex also appears to be involved in several aspects of repro-
ductive behaviour as was shown in lesion experiments restricted to the nucleus 
mediahs of the amygdaloid complex (Lehman and Wmans, 1982). The mating 
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behaviour of male hamsters which is highly dependent on olfactory information, 
is abolished in hamsters with bilateral lesions of the nucleus medialis Lesions to 
the olfactory afférents to the amygdala (Powers et al., 1979) produced the same 
effect. The nucleus may act as a relay for olfactory information to effector 
regions of the hypothalamus controlling mating behaviour. 
Electrical stimulation is another technique applicable for study of the function of 
the brain It was originally introduced by Penfield (1936) and used in the surgical 
treatment of focal epilepsy. By stimulating the cortical surface of the brain with 
electrodes Penfield could trace the locations where epileptic attacks were in-
duced and study the pattern of attack. The patients were fully conscious during 
surgery and received only local anaesthesia. Occasionally the electrical stimula-
tion of the temporal lobe produced images which the patients described as cohe-
rent perceptions or experiences The responses could be divided into four cate-
gories auditory, visual, combined visual-auditory, or unclassified responses. The 
results were interpreted by Penfield as if the stimulus elicited memories of past 
experience from their particular locus in the temporal lobe. This pioneering study 
was the first attempt to localize the functional representation within the frontal 
lobe using the electrical stimulation technique. 
The first stimulation experiments of the amygdaloid complex were carried out 15 
years later by Kaada (1951) In this study the author described the somato-
motor, autonomic, and electrocorticographic responses to electrical stimulation 
of the amygdala in primates, cat, and dog. Since then he and others have pu-
blished many reports concerned with the functional aspects of the amygdaloid 
complex. In animals (rat, cat, and primate) stimulation of the amygdaloid com-
plex resulted in a variety of somatic, visceral, endocrine, and behavioural effects 
(Kaada, 1972, Gloor, 1960) In the cat electrical stimulation of a number of 
regions in the amygdala produces not only behavioural effects such as flight or 
defence reactions but also a number of autonomic responses including pupillary 
dilation, micturation, elevation of blood pressure with bradycardia, and increased 
rate of breathing (Kaada, 1972) These autonomic or "defense responses" were 
elicited from several regions of the amygdala but the basal amygdaloid nucleus 
contained the most positive stimulation points. These electrical stimulation sites 
stretched from the basal amygdaloid nucleus, via the nucleus centralis to the 
hypothalamus and the brainstem, parallel the basal amygdaloid nucleus projec-
tions to these structures (Hilton and Zbrozyna, 1963). Reproductive behaviour in 
female which is not dependent on sensory inputs like nest building or retrieval of 
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pups in females can be influenced by steroid hormones changes (Fleming et al , 
1980). The nucleus medialis and nucleus corticalis are rich in cells containing 
high quantities of reproductive steroid hormones (McGinnis et al , 1985) These 
centres are therefore believed to influence other areas of the brain concerned 
with reproductive behaviour The ventromedial hypothalamus, the central gray, 
and the preoptic area which are all reported to be involved in reproductive social 
behaviour (Vochteloo and Koolhaas, 1987) receive projections from the nucleus 
medialis and nucleus centralis Because of the close relationship (they are inten-
sely interconnected) between the amygdaloid complex and the diencephalon it is 
not surprising that this complex has been implicated in the response to stressful 
environmental conditions Data based on electrophysiological recordings (Henke, 
1983, 1985, and 1988) as well as biochemical studies (Bloom et a l , 1982, 
Swanson et al , 1983) point out that stress inputs alter the functional state of 
the amygdala The nucleus centralis of the amygdaloid complex seems to be in a 
strategic position to modify the severity of ulcera induced by stress (Henke, 
1988, and 1990) Within this nucleus various neuropeptides modulate DA-
transmission, whereas benzodiazepines influence GABA-activity (Sullivan et al., 
1989). Rats implanted with electrodes in the central nucleus of the amygdala 
showed different activity profiles some of them corresponding with stress ulce-
ration The benzodiazepine-denved anti-anxiety agent chlordiazepoxide suppres-
sed this activity suggesting that the amygdala may be a important target for this 
kind of drugs 
In cats with lateral lesions of the nucleus centralis amygdalae a significantly 
diminished secretion of ACTH in response to immobilization stress was observed 
(Beaulieu et al , 1987 and 1989) In comparison with intact stressed animals, 
lesions to the nucleus centralis reduced the noradrenergic and the dopaminergic 
activity in response to stress in anterior and lateral hypothalamic areas These 
results support the hypothesis that neurotransmitter systems in the nucleus 
centralis amygdalae play an important role in the control of ACTH secretion in 
response to immobilization stress (Allen and Allen, 1974; Beaulieu et al., 1986; 
Gray et al., 1989). 
It can be concluded that several different techniques applied to the amygdala 
(ablation, stimulation and conditioning) result in various autonomic and endo-
crine effects as well as in behavioural effects The reaction to stress can be al-
tered by lesions to the nucleus centralis (Henke, 1990) The ingestive behaviour 
(Rolls and Rolls, 1973), heart rate conditioning, and respiratory responses can 
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also be influenced (Kapp, 1979; Zhang et' al., 1986). Some of these changes 
especially those of visceral functions can also be elicited by manipulating the 
preoptic region or the hypothalamus. With respect to these functions it is assu-
med that the role the amygdala participates is a modulatory one, influencing the 
neuroendocrinology directly and indirectly in the brain stem or hypothalamus. 
2.6.3 Evidence for the memory function of the amygdala in animal studies 
As early as 1900 Bechterew had linked memory impairment with damage to the 
temporal lobe of the brain, describing a case of a 60-year-old man who had had 
memory disturbances during the last 20 years of his life coinciding with a bilate-
ral softening of the uncus and the cornu ammonis. The observations of memory 
disturbences after removal of parts of the temporal lobe in the treatment of 
epilepsy gave further evidence for the relationship between damage to the 
hippocampal formation and the amygdaloid complex, and amnesia (Walker, 
1957; Penfield, 1958). 
A systematic investigation into the relationship between specific brain structures 
and memory in animals began after reports of cases like H.M. in which a detailed 
description is given of a patient with an amnesic syndrome on the basis of a 
circumscript lesion of the amygdala and the hippocampus (Scoville and Milner, 
1957; Scoville, 1968; Milner, 1972). 
Orbach et al. (1960) demonstrated in monkeys that bilateral resections including 
the amygdala and hippocampus resulted into impairment in the acquisition and 
retention of visual discriminations independent of temporal neocortical damage. 
Whether both the amygdala and the hippocampus or only one of them are 
necessary for normal visual learning and memory has long been a matter of 
dispute. 
In some experiments, lesions including large parts of the amygdala, but sparing 
the hippocampus, markedly suppressed performance in object and place discri-
mination tasks (Jones and Mishkin, 1972). On the other hand, disruption of the 
temporal stem which carries connections of the temporal cortex and amygdala 
but not the hippocampus, did not significantly impair performance in visual 
learning tests (trial-unique, delayed non-matching to sample tasks), whereas 
combined amygdala-hippocampal lesions did (Zola-Morgan et al., 1982). The 
involvement of both structures, the amygdala and the hippocampus, in memory 
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would seem to be established by these experiments However, in the studies in 
which the effects of separate and combined amygdaloid and hippocampal le-
sions were compared, the cortex entorhinalis and penrhinalis was routinely 
removed in the amygdalectomy, and the cortex parahippocampalis was routinely 
removed in the hippocampectomy (Mishkin, 1978, Saunders et al., 1984, Mur-
ray and Mishkin, 1985) 
In recent studies significant memory impairment was observed following primari-
ly bilateral damage to the hippocampus but when both the amygdala and the 
hippocampus with adjacent cortex were lesioned these impairments increased 
dramatically (Zola-Morgan et al , 1989a) The question arises why there is a 
difference between the above mentioned experiments and which of the struc-
tures contributes most to these severe cognition deficits, the amygdala, or the 
cortical regions adjacent to the amygdala. Zola-Morgan et al. (1989) found that 
monkeys with stereotactical lesions to the amygdaloid complex sparing the 
surrounding cortex performed normally on the delayed nonmatching two sample 
task, as well as on three other memory tasks (object retention, concurrent 
discrimination, and delayed response) performed during the 1 5 years following 
surgery. These results suggest that one must look for structures other than the 
amygdala to account for the severe memory impairment following large lesions 
to the medial temporal lobe Therefore, the cortical regions surrounding the 
amygdala, the entorhmal and perirhinal cortex could have an important impact 
on memory. Experiments with combined lesions to the amygdala and the ento-
rhmal cortex (Murray and Mishkin, 1986) and with lesions to the perirhinal and 
parahippocampal cortex sparing the amygdala and the hippocampus (Zola-Mor 
gan et al., 1989) have supported this suggestion 
In summary the results of the stereotactic experiments discussed above unques-
tionably point to a memory function ascribed to the amygdaloid complex How-
ever, the severe memory impairment in monkeys following bilateral temporal 
ablation probably results from the damage to the hippocampus and adjacent 
cortical structures and not from the damage to the amygdaloid complex itself. 
The role of the amygdala m other cognitive functions has been shown in experi-
ments using different test methods 
Gaff an et al (1988) examined visual learning in monkeys which was severely 
impaired by disconnection of the amygdala from the visual association cortex 
indicating that efficient learning depends on an mtrahemispheric interaction 
between the amygdala and the ipstlateral visual-association cortex to it. When 
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an auditory secondary inforcer was associated with the visual stimulus visual 
learning was unaffected after disconnection of the amygdala from visual input. 
Thus, visual learning was impaired both by bilateral amygdalotomy and by 
disconnection of the amygdala from auditory imput, suggesting that in this test 
visual interaction with the amygdala is less important (Gaffan and Harrison, 
1987, Gaffan et al., 1989). The role of the amygdala in attributing reward value 
to objects has been emphasized by other studies (Gaffan et al., 1988; Nishijo et 
al , 1988) and may account for part of the oral behaviour observed in the Klu-
ver-Bucy syndrome 
From these experiments it can be concluded that the role of the amygdala in 
monkeys is not confined to cross-modal associations (the visual and auditory 
sensory input in the above mentioned experiment) but also with the assocciation 
of reward with stimuli (associative learning). 
Retention of recently acquired information can be influenced in rats by posttrai-
ning administration of the adrenal medullary hormone epinephrine (Gold and 
Buskirk, 1973, McGaugh, 1983 and 1989). As epinephrine does not enter the 
brain it has been suggested that the hormone acts on ß-adrenergic receptors of 
afférents to the brain (McGaugh, 1983), for Sotalol, a ß-adrenergic antagonist, 
blocks the posttraining effects of epinephrine. It is now assumed that the memo-
ry effects involve the activation of a noradrenergic system within the amygdala 
(Bennett et al , 1985): intraamygdaloid injections of the noradregenic receptor 
antagonist propanolol or naloxone block the memory enhancing effects of post-
training epinephrine (McGaugh, 1989, Introini-Collison et al., 1989), and the 
drug effects on memory are blocked by lesions to the amygdala as well as by 
lesions to the stria terminalis (Liang and McGaugh, 1983) These experiments in 
rats which influence neuromodulatory systems projecting to the amygdala provi-
de evidence for a memory modulation function attributable to the amygdala 
(Gallagher, 1981) 
Summarizing, it may be concluded from the different experiments in monkeys 
discussed in this paragraph, that memory is impaired or modulated by manipula-
ting the amygdala in various ways; however, a dominant and decisive role for 
the amygdala in memory has never been shown. The importance of the amygda-
la could be its role in cross-modal and object-reward associations. 
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2 6 4 Clinical evidence for the mnemonic function of the amygdala in hu-
mans 
The electrical stimulation experiments described in the previous section provided 
a scientific basis for a stereotactic amygdalotomy in patients exhibiting agres-
sive, assaultive, or self-mutulating behaviour 
Narabayashi et al (1963) preferred the advantages of stereotaxic amygdalotomy 
to temporal lobe resection for the treatment of behavioural disorders (hostile, 
aggressive, and assaultive behaviour) and for the treatment of drug-resistant 
epilepsy. The destruction of the tissue is limited, it could be conducted under 
local anesthesia and he assumed that it could be performed without significant 
neurological deficit in patients with bilateral epileptic foci He reported no beha-
vioural side-effects However, other authors mentioned mnemonic disturbances 
especially regarding recent memory storage (Kim, 1971) Andersen (1978) 
observed retrieval deficits, by using a more precise analysis of cognitive changes 
in 15 patients who underwent unilateral amygdalotomy. With this exception 
there has been no general attempt to systematically examine possible changes 
following amygdalotomy in humans. 
Analysis of the cognitive phenomena evoked by stimulation of the amygdala 
carried out in patients with temporal lobe epilepsy to determine the exact focus 
of the seizures (Penfield, 1936) revealed variable mental phenomena such as 
hallucinations, fear, anxiety, anger, or pleasure. These phenomena were more 
related with the personal history and former events than to the site of amygda-
loid stimulation (Halgren, 1981). The emotional significance of memories seems 
to be the trigger point for their activation (Halgren et al., 1978; Halgren, 1981). 
This was demonstrated by Chapman (1967) who described the way in which a 
21-year-old patient re-experienced an event from his past. By stimulating the 
amygdala this patient could remember a totally forgotten period with a strong 
emotional meaning and could even focus on detailed information. Re-expenen-
cing this period did not seem to faciliate his ability to remember the event under 
conditions of non-stimulation. 
Circumscribed bilateral destruction of the amygdala in humans is very rare. In 
most brain diseases that affect the amygdala, a number of other key structures 
in the anterior temporal region such as the entorhinal cortex, the hippocampus, 
and the temporal stem are also involved The amnestic disturbances in patients 
suffering from Alzheimer's disease are generally attributed to the neuropathologi-
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cal changes not only in the amygdala but also in the hippocampus, nucleus 
basalis of Meynert, and other brain structures. As was described in the introduc-
tion, in some cases of dementia the neuropathological changes are restricted to 
the amygdala and to several other structures in the anterior temporal pole. 
However, it is premature to attribute all of the behavioural changes and memory 
disturbances to the existence of neurofibrillary tangles, senile plaques or cell loss 
and to neglect possible disturbances in other areas which may have been influ-
enced by the disease prior to plaque and tangle formation. 
Recently an interesting report on bilateral amygdaloid damage due to Urbach-
Wiethe disease (1923), also known as lipoid proteinosis, was published (Tranel, 
1990). Urbach-Wiethe disease is a rare autosomal recessive disease characte-
rized by the deposition of hyaline material in the skin and other body tissues 
including the central nervous system Bilateral "bean-shaped" calcifications in 
the region of the anteromedial temporal lobes are pathognomonic and are pre-
sent in approximately 5 1 % of all cases (Hofer, 1967) In these patients the 
globus pallidus, the hippocampus, the nucleus caudatus, and the amygdala can 
be affected In rare cases the amygdala seems to be bilaterally affected in a 
circumscribed fashion without damage to other structures and thus offering the 
opportunity to study neuropsychological changes However, involvement of 
other structures in these patients can not be ruled out autopsy findings (Mee 
nan et al , 1978) in one patient showed that the lesions were more widely 
distributed than macroscopically apparent in CT-scan In his report Tranel descri-
bed the neuropsychological correlates m a patient with bilateral amygdala da-
mage The patient was a 23-year-old woman with a history of occasional spells 
consisting of a funny odor, followed by a sensation of being "detached" and 
watching herself "from above" for a few seconds In addition, she noted that 
her ability to remember day-to-day activities was poor, and that she got lost 
driving around in her hometown. The diagnosis of lipoid proteinosis was esta-
blished by means of biopsy specimens from the skin and tongue showing cha-
racteristic depositions of neutral mucopolysaccharides. Rontgenographic CT 
revealed bilateral mineralization of the amygdala, possibly including the cortical-
transition area, and without any other structural abnormality. Neuropsychological 
examination revealed, administering standanzed memory tests (eg. the Warring-
ton Recognition Memory Test and the Stanford-Bmet Memory Subtest), firstly, a 
defect in nonverbal visual memory Secondly, a disturbance in executive control 
manifesting an inappropriate social behaviour and deficits in abstract reasoning. 
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This case suggests that the human amygdala may participate in nonverbal, 
visuospatial memory, and adequate social interaction. However, there is still a 
possibility that other areas with calcifications due to the Urbach-Wiethe disease 
may also be concerned and may contribute to the cognitive changes and beha-
vioural defects found in this patient 
2 6.5 Conclusions 
We have seen that bilateral amygdaloid lesions fail to produce permanent defi-
cits of the autonomic or somatomotor functions which are so clearly influenced 
by stimulation of the amygdala The amygdaloid complex cannot be essential for 
the integration of these functions which takes place in other areas such as the 
hypothalamus and brain stem Therefore, there seems to be a great difference in 
functional significance between the amygdaloid complex and the hypothalamus 
and the brain stem The amygdala influences the hypothalamus and autonomic 
systems and is implicated in reactons to stress, feeding behaviour, heart rate, 
blood pressure control, reproduction, and social behaviour Animal studies 
suggest that the amygdala may be involved in the integration of sensory stimuli 
from the environment to modulate autonomic, endocrine function and feeding, 
and social behaviour 
Experimental work in nonhuman primates and rats have stressed the importance 
of a memnomc function attributed to the amygdala although there is no full 
agreement by all investigators and some even downplayed the role of the amyg-
dala (Zola Morgan, 1989, Sutherland and McDonald, 1990) 
Circumscribed bilateral damage of the amygdala in humans is very rare, because 
most disease processes or surgical lesions also affect adjacent structures inclu-
ding the cortex entorhinahs and cortex penrhinalis. Reports of bilateral stereo-
tactic amygdalotomy in order to reduce intractible behaviour disturbances re-
vealed a diminished autonomic responsiveness and in general terms an improve-
ment of social behaviour (Narabayashi, 1976, Heimburger et al , 1978, Lee et 
al , 1988a and 1988b). The cognitive consequences of amygdalectomy are not 
well understood and several authors even observed an improvement in concen-
tration and learning efficiency (Luczywek and Meppel, 1976, Anderson, 1978). 
Regarding the role of the amygdala in memory, there have been a few studies in 
humans concerned with the cognitive consequences of amygdaloid damage or 
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amygdalotomy The evidence emerging -from these few reports concerning 
memory, motivation, and visual recognition is still contradictional but it is temp-
ting to consider the human amygdala a main component of the neural substrate 
of memory particularly involved in nonverbal, visuospatial memory, and recogni-
tion of the affective or social significance of stimuli 
2.7 Neuropathological changes in the amygdaloid complex in normal aging 
and Alzheimer's disease, a review of the literature 
2 7.1 Introduction 
In this section some of the morphological changes found in the amygdaloid 
complex with aging and Alzheimer's disease (AD) will be described 
Emphasis will be placed on volume changes, neuronal cell loss, the distribution 
and density of the neurofibrillary tangles (NFT), senile plaques (SP), and congo-
philic angiopathy in relation to the cytoarchitecture of this complex. 
2 7.2 Volume changes 
Age-related reductions of volume of the amygdaloid complex have rarely been 
reported The only study concerning this subject was by Herzog and Kemper 
(1980). They noted a 2% decrease in volume in the normal aged group when 
compared to the younger controls; no significant differences for the subdivisions 
between the two groups were observed. However, in AD the mean volume of 
the amygdaloid and the individual subdivisions of the complex appeared to be 
decreased by 28% (Herzog and Kemper, 1980). In this reduction all of the 
subdivisions were involved particularly the medial, cortical, anterior, central, and 
transitional divisions. 
2.7.3 Neuronal cell loss 
In two cases of dementia (clinical diagnosis senile dementia, and arteriosclerosis 
cerebri) Brockhaus (1939) described pathological changes in the amygdala and 
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noted cell loss in all the subdivisions, although no systematic quantitative analy-
sis was carried out Primarily the small-celled regions of the basolateral complex 
were affected 
There are only two studies available concerning the quantification of cell loss in 
the amygdala and its subdivisions in aging and dementia (Herzog and Kemper, 
1980; Scott et all. 1992). According to the first report (Herzog and Kemper, 
1980), the decrease of cell-packing density in the amygdala is selective: small 
but significant decreases in both cell density and regional volume from 3 to 19% 
in the cortical, medial, and central nuclei of the amygdaloid complex in aging 
with a sparing of the nucleus lateralis, the nucleus basalis accessonus and the 
nucleus basalis medialis. No data are available concerning changes in the num-
ber of neuronal penkarya, nuclei or nucleoli, with increasing age. In the study of 
Kemper and Herzog (1980) the amygdaloid nuclei of four male AD-cases sho-
wed a decrease of 13-70 % in absolute number of neurons when compared with 
the age-matched control group with a preferential involvement of the medial, 
central, and cortical nuclei. The basolateral complex showed a lesser reduction 
in cell number. A relationship was suggested between the ontogenesis of the 
nucleus corticahs, nucleus medialis, and centralis and the vulnerability of these 
subdivisions for cell loss. 
Scott et al. (1992) demonstrated a markedly increased cell packing density in 
the amygdala in AD, an increase that includes both neurons and glia. The inves-
tigated tissue sections showed a great decline for medium and large neurons 
with a stable number of small neurons. 
2.7.4 Senile plaques 
Senile plaques (SP), first identified in the brain of an epileptic patient by Bloq 
and Marinesco (1892), are present in a variety of normal, pathological, and 
experimental situations. They may well be associated with normal aging since 
these structures can be found in small numbers, in many mentally able indivi-
duals particularly after the age of 65 years (Tomlinson et al., 1968; Ulrich, 
1985; Mann et al., 1987, 1990); SP were also observed in aged members of 
other longer living mammalian species such as monkeys. In normal aging the 
plaques are most frequently seen in the hippocampus and the amygdaloid com-
plex (Dayan, 1970; Braak and Braak, 1991) but they also occur in smal numbers 
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in the neocortex. Some of the neurological'disorders with plaque formation are 
Pick's disease (Wisniewsky and Terry, 1973), Creutzfeldt-Jakob disease (Traub 
et al., 1977), and the Guam amyotrophic lateral sclerose-Parkinson-dementia 
complex (Hirano et al., 1966). 
Fig. 2. 11 
a: immature plaque in Yamamoto stained section (400x) 
b: mature plaque in Yamamoto stained section (400x) 
с: burnt out plaque in Yamamoto stained section (400x). 
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The structure of the SP may vary considerably although they are generally 
spherical, and consist of three components, neuntes, glial processes, and extra-
cellular amyloid deposits. The neuntes constitute a nm of dystrophic nerve 
processes, both dendritic and axonal, containing paired helical filaments similar 
to those in NFT, as well as numerous lysosomes, abnormal mitochondria, and 
synaptic endings. Immunohistochemical methods have confirmed that the indivi-
dual neuntes contain neurotransmitter markers so that in a given SP some 
degenerating endings may stain with an antibody to somatostatin, and others 
with antibodies to choline acetyltransferase. The glial component consists of 
microglial, phagocyte and astrocyte processes Within the different plaque types 
these components may vary considerably (Fig 2 11). The immature plaque or 
primitive type of plaque is composed of dystrophic neuntes and glial processes 
with a little amyloid in the core region The mature or classical type plaque is 
distinguished by a central core of amyloid material surrounded by a peripheral 
nm of dystrophic neuntes. The burnt out plaque, sometimes regarded as the 
final stage in plaque evolution, is characterized by the central core as the only 
demonstrable histological feature (Wisniewski, 1983). Numerous staining me-
thods have been applied to demonstrate the SP Various silver techniques im-
pregnate the abnormal crown (Yamaguchi et al., 1990), and the abnormal core 
is visible after staining with thioflavin S and ß protein immunostain (Duyckearts 
et al., 1989). 
There are only a few neuropathological studies on the distribution and quantifi-
cation of plaques in the amygdaloid complex in AD (Brockhaus, 1938; Jamada 
and Mehraein, 1968, Herzog and Kemper, 1980, Brashear et al., 1988; Kromer 
Vogt et al., 1990; Brady and Mufson, 1990; Murphy and William, 1991; Unger 
et al., 1991). These studies reveal that the plaques are unequally distributed 
among the subdivisions of the amygdaloid complex and that particularly the 
nucleus basalis accessonus, the nucleus basalis medialis, and nucleus corticalis 
are consistently affected while the nucleus centralis, nucleus basalis lateralis, 
and nucleus lateralis are relatively spared. 
2 7.5 Neurofibrillary tangles 
The neurofibrillary tangles (NFT) were first described by Alzheimer (1907) in the 
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Fig. 2. 12 
a: neurofibrillary tangles in Congored stained sections under fluorescence 
illumination f400x) 
b: the same field with fluorescence illumination as well as transmitting 
light (400x) 
c: absence of NFT in Congered stained sections with 100% transmitting 
light (400x¡. 
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NFT represent abnormal filamentous accumulations within the penkarya of 
affected neurons consisting at electron microscopical level of clusters of unbran-
ched fibrillary structures twisted into a helix (Kidd, 1973) with a diameter of 
approximately 10 nanometers and with a periodicity of 80 nanometers. On 
morphological grounds these elements are referred to as paired helical filaments 
(PHFs). Using immunological techniques many normal neuronal cytoskeleton 
elements were found in tangles, including neurofilament proteins (Anderton et 
al , 1982; Miller et al , 1986), microtubules (Grundke-lqbal et al., 1979) and the 
microtubule-associated phosphoprotein, tau (Nikuna and Ihara, 1986; Kosik et 
al., 1986; Yen et al , 1987, Papasozomenos, 1989) Direct biochemical analysis 
of NFT are hampered by the insolubility of the fibres At present, data suggest 
that certain tau epitopes within the PHF may be abnormally phosphorylated. At 
present it is still uncertain wether tau is the sole protein constituent of the 
abnormal filaments. 
Morphologically the NFT is thought to develop sequentially in time (Fig 2 12) 
from an intracellular deposition of neurofilaments to the so-called extracellular 
tangle which finally leads to the destruction of the affected nerve cell with the 
"ghost tangle" as a remnant (Bondareff, et al., 1989; Hubbard et al., 1990). 
Apart from AD, NFT have been found in normal aging and in a number of other 
brain disorders including amyotrophic lateral sclerosis, the parkinsonism-demen-
tia complex of Guam (Hirano et al., 1961), Down's syndrome (Schochet et al., 
1973), and dementia pugilistica (Wisniewsky et al., 1970) 
A striking feature of the NFT is its predilection for special brain areas and cell 
groups. In normal aging they are frequently encountered within the hippocam-
pus, amygdaloid complex, and the entorhinal cortex (Jamada and Mehraein, 
1977; Ulrich, 1985; Mann, 1987). Within these areas, the NFT occur predomi-
nantly in large pyramidal neurons. 
Studies concerning the distribution of NFT in the subdivisions of the amygdaloid 
complex in normal aging are very rare. Mann (1987) described the topographic 
distribution of NFT in 30 non-demented patients and reported that when NFT 
occur they are present throughout both the corticomedial and basolateral nuclear 
complexes. In AD the nucleus corticalis, the nucleus basalis accessonus, the 
nucleus basalis mediahs, and the nucleus corticalis are the most heavily affected 
subdivisions with the least amount of pathology found in the nucleus lateralis. 
Brady and Mufson (1990) observed a differential distribution within specific 
amygdaloid nuclei for two morphologically distinct subtypes of NFT. Intracellular 
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tangles were present in the corticomedial-nuclei whereas extracellular tangles 
characterized the basolateral nuclei. 
2.7.6 Granulovacuolar degeneration 
Granulovacuolar degeneration (GVD) is mainly observed in the somata of pyrami­
dal neurons in the hippocampal formation, especially in CA1 and the subiculum, 
although GVD is also reported to be found in other brain structures such as the 
nucleus basalis of Meynert (Jacobs et al., 1985). It is characterized by the 
presence of one or more spherical vacuoles (3 to 5 μττ\ in diameter) with central­
ly a dark granule measuring 0.5 to 1.5 //m (Hirano et al., 1961; Ball, 1977). 
Simchowicz (1911) gave the first description of GVD in his classical report of 
neuropathological changes in AD and suggested a relationship between the NFT 
and the GVD in the hippocampus. Ball and Low (1977) found a negative correla­
tion between the neuron density of the hippocampus and the densities of both 
neurons with NFT and GVD. They not only confirmed Simchowicz' suggestion 
but also emphasized the significance of GVD in relation to cell loss and the 
functional consequences it could have in memory processes. 
GVD is apparently unique to man and is frequently found in normal aging and 
AD as well as in other brain diseases. To my knowledge no reports are available 
concerning the presence of GVD in the amygdaloid complex in aging or AD. The 
precise origin and functional significance of GVD is unknown. On the other 
hand, immunohistological research, using monoclonal antibodies which are 
normally used to stain abnormal neurofilament proteins and tau proteins found in 
SP and NFT, reveals the same reactivity, suggesting that GVD may also contain 
phosphorylated proteins, and may present an abnormality of the cytoskeletal 
structure of the neurons (Dickson et al., 1987). 
2.7.7 Hirano bodies 
In addition to the neuropathological hallmarks of AD, Hirano bodies are often 
seen in this disease in the neurons of the hippocampal formation with a predic­
tion for the CA1 area (Hirano, 1965; Ball, 1978). The Hirano body is an eosino­
philic, ovoid or spherical intracellular structure containing actin (Goldman, 1983). 
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They are immunohistochemically positive for microtubule-associated protein-2 
and tau (Peterson et al., 1988). Hirano bodies occur in aging and in AD, as well 
in several other brain diseases (Hirano et al., 1966; Rewcastle and Ball, 1968; 
Mann et al., 1985). Hirano bodies have never been described in the amygdaloid 
complex. 
2 7.8 Congophilic angiopathy 
In congophilic angiopathy (CA), one of the characterizing pathological changes in 
AD, extracellular amyloid accumulates in the wall of cortical vessels (Scholz, 
1938; Schlote, 1965). With Congored affected vessels stain pink and become 
greenish when viewed in polarized light Pantelakis (1954) called this change 
"congophilic angiopathy" the term now generally being used. The CA involves 
the endothelial cells and the basement membrane of the small pial and intracere-
bral arterioles. Sometimes the intracortical capillaries are also affected, around 
which a ring of amorphous substance may develop Veins are rarely affected 
(Monmatsu et al , 1975), and then usually only small veins in cases with exten-
sive CA. 
The origin of the amyloid found in CA remains unknown although it is very 
similar to the amyloid core isolated from the SP (Masters et al., 1985); a mutual 
origin is assumed (Ikada et al., 1987). 
As far as I know there are no studies available on the distribution of the CA in 
the amygdaloid complex. 
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CHAPTER 3 
MATERIALS AND METHODS 
3.1 Characteristics of brain material 
3.1.1 Cases 
In the present study 9 cases of Alzheimer's disease (AD) and 6 age-matched 
controls (AMC) were examined (Table 3.1). 
Table 3.1 
Brain material 
case age sex dia cause of death ρ m brain fixation duration hemi-
nr (y) gnosis delay weight time dementia sphere 























































































< 1 4 
< 1 2 
< 1 2 
< 1 2 
1 3 5 1 
1 5 7 0 
1 2 5 0 
1 2 6 8 
1 4 7 5 
1 2 8 8 
1 0 7 7 
9 7 0 
1 2 7 5 
8 5 0 
9 8 5 
1 3 5 3 
1 1 0 0 
1 1 6 0 
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R + L 
R 
R + L 
R + L 
R + L 
L 
R 
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R + L 
Characteristics of brain material with neuropathologies! diagnosis, sex, age, 
brain weight, hemisphere available, fixation time, postmortem delay, cause of 
death, and duration of dementia. AD, Alzheimer's disease; C, control; F, female; 
M, male; L, left hemisphere; R, right hemisphere; h, hours; m, months; y, years; 
g, grams; p.m., postmortem delay. 
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The clinical diagnosis of probable AD was confirmed neuropathologically accor-
ding to the Khachaturian criteria (1985), which include minimum numbers of 
plaques and tangles in any microscopic field encompassing 1 mm2 (microscopi-
cal magnification 200x field) per age category in three regions of the neocortex 
(frontal, temporal, and parietal lobes), the hippocampal formation, the basal 
ganglia, the substantia nigra, the cerebellar cortex, and the amygdala. The 
control cases had no record of neurological or psychiatric diseases. 
The relevant clinical and pathological data are summarized in Table 3 .1 . 
3.2 Microscopy 
In the present study the terminology and panellation proposed by Crosby and 
Humphrey (1941) is employed which is mainly based on the density and arran-
gements of neuronal elements stained with Nissl substance. According to their 
panellation ten subdivisions can be recognized: the nucleus lateralis, the nucleus 
basalis lateralis, the nucleus basalis medialis, the nucleus basalis superficialis, 
the nucleus basalis accessorius, the nucleus corticalis, the corticoamygdaloid 
transition area, the nucleus medialis, the nucleus centralis, and the anterior 
amygdaloid area. However, the following reservations should be made: the 
delineation between the anterior amygdala area, nucleus medialis, and nucleus 
centralis was often so unclear and arbitrary, especially in the AD brains, that 
these three areas were considered one nuclear mass i.e. the medialcentral com-
plex. For the same reasons no panellation was made within the nucleus basalis 
accessorius in a pars lateralis and a pars medialis. Our definition of the nucleus 
corticalis was based (according to a recent description by Scott, 1991) on the 
presence of the semilunar gyrus as well as on the arrangements of cells in its 
deeper limits. When the lateral border of the nucleus corticalis with the nucleus 
accessorius was unclear its depth was defined as one-half its length along the 
cortical mantle. Eight distinct subdivisions of the amygdala could readily be 
recognized for quantitative measurements: 
- nucleus lateralis (L) 
- nucleus basalis lateralis (BL) 
- nucleus basalis medialis (BM) 
- nucleus basalis superficialis (BS) 
- nucleus basalis accessorius (BA) 
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- nucleus corticalis (CO) 
corticoamygdaloid transition area (СТА) 
- medialcentral complex (MC). 
3.3 Histological procedures 
The brains were fixed in toto in 4 % formaldehyde during 0 5-12 months. A fixa­
tion time of at least 5 months is recommended, as shorter periods may cause 
tissue swelling or shrinkage (Sass, 1982; Haug, et al , 1984). Different proce­
dures in tissue processing may also result in different volumes of brain structu­
res. The pathological process itself can also affect the resulting volume Moreo­
ver, shrinkage due to the embedding procedure in paraffin is age-dependent and 
is more pronounced in younger persons than in older individuals (Haug, 1986). 
Usually neuron numbers are expressed as neuron density (neuron number per 
unit volume) In this study the absolute neuron number is determined using the 
fractionator principle The counting is not affected by the histological processing 
of paraffin-embedded tissue Therefore it was not necessary to know the extent 
of shrinkage. 
The postmortem interval between death and fixation (in this study varying from 
6-50 hours) can also affect morphological parameters. Autolysis is a common 
artefact resulting from delayed fixation and can lead to cellular désintégration. 
All brains listed showed no signs of autolysis in Kluver-Barrera preparations, 
although some désintégration of particular cell types has to be taken into ac-
count. After embedding in paraffin, serial sections with a thickness of 10 or 20 
//m were cut using a Jung 2050 microtome. The amygdaloid complex was cut 
perpendicular to its longitudinal axis Sections were stained at regular intervals 
of 800 μα\ throughout the rostrocaudal extent of the amygdaloid complex 
The Klüver-Barrera stained sections were used for identification and delineation 
of the different subdivisions and for counting procedures. A modified Bielschow-
sky method (Bielschowsky, 1904, Yamamoto and Hirano, 1986) was used to 
examine and count senile plaques This method obtained the highest count of 
senile plaques compared with other staining methods such as Gallyas, Bodian 
and thioflavine S (Yamaguchi et al., 1988, Lamy et al., 1989). The Congored 
staining (Puchtler, 1989), tested in our laboratory (Lubbers, 1988), was used for 
identification and quantification of the NFT. 
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3.4 Reconstruction and atlas of the amygdala 
After embedding in paraffin, the amygdala was cut in perpendicular sections of 
400 μΓΠ. These sections were stained (Kluver-Barrera) and enlarged using a 
projecting microscope including amygdaloid subdivisions using the anatomic 
boundaries established by Crosby and Humphrey (1941). The three-dimensional 
reconstruction was made from 8-mm-thick styrofoam sheets using the drawings 
of the enlarged serial sections as a template (Fig. 4 1). 
The atlas contains 7 diagramatical line drawings of the amygdala and 7 drawings 
of the cell masses based on the same sections taken from rostral to caudal with 
a distance of 2400 μπ\. Solid lines indicate a clear demarcation between subdivi­
sions and dashed lines represent approximations. 
The cell masses were drawn with the aid of a projection apparatus. Samples 
were taken from characteristic neuron populations in each subdivision The 
actual magnification of the cells represented is 8 8 times that of the section. 
3 5 Quantitative methods 
3.5.1 The sampling item 
When the neuronal cell body is the unit to be counted the overcount due to split 
neurons requires correction. An error in the resulting countings is induced in 
regions where non-spherical cell bodies have a preferential axis of orientation. In 
such cases the plane of sectioning influences the neuronal counts. 
By using the neuronal nucleoli which are small and almost spherical as pointlike 
cell identifiers, this problem is considerably reduced. It is based on the assump­
tion that each neuron contains only one nucleolus and consequently does not 
appear in more than one section. Occasionally, in the amygdaloid complex a 
binucleated neuron was seen but the occurrence of such elements was so rare 
that this can not cause a significant bias Nucleoli are considered to be indivi­
sible particles which, during sectioning, will be pushed either completely into or 
out of the section (Jones, 1937; Cammermeyer, 1968) Thus, no further correc­
tions are needed for split nucleoli whose parts occur in two adjoining sections. 
Without major bias the nucleolus can thus be used as the counting unit. 
All nucleolus counts were performed at a 600x magnification using an ocular 
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grid with a quadrant sampling field of 167x167 μη\2, subdivided into 100 squa­
res of 16.7x16.7 μπ\2 each. The nucleoli often intersect the delineation of the 
ocular counting grid giving rise to the so-called edge effect and leading to an 
overestimation of the total number of cells The exclusion principle of Gundersen 
(1977) offers an unbiased estimate of the density of nucleoli m a section. 
Neuron size was defined as the maximum diameter ( d m „ ) . Focussing at the level 
of the nucleolus, the d m „ of each nucleated neuron within a sample was measu­
red Four size categories (8.3-16.7; 16.7-25; 25-33.3; > 33.3 //m) were chosen. 
Astrocytes and oligodendrocytes could be distinguished from small-sized neu­
rons ( < 1 2 pm) by the characteristic morphology of their nuclei (Glees, 1955; 
Bûcher, 1970). The Oligodendroglia! cell bodies, which are normally smaller than 
5 μττ\ have darkly stained nuclei containing deep-blue spots, whereas the astro­
cytes are larger (4-8 μπη) with nuclei containing light-blue spots. By using the 
d m a x as a measure for neuron size two sources of bias may be introduced. Firstly, 
the d m a x depends on the orientation of the neuron with respect to the section 
plane. Secondly, the possibility of nucleus and nucleolus displacement out of the 
center of the soma is far from theoretical (Born et al , 1987), since both the 
accumulation of lipofuscm in normal and the presence of neurofibrillary tangle 
formations in AD do in fact displace the nucleus and nucleolus towards an 
excentric position 
3 5.2 The sampling design 
The loss of neurons in aging and in dementing diseases has been the subject of 
many studies during the last years The data were, with a few exceptions, 
expressed in terms of neuron density, i.e. neurons per unit volume, per section 
or per standardized segment (Coleman and Flood, 1987). The interpretation of 
the results of such studies is often confusing while nothing is known about the 
total volume of the structure studied. So, nothing can be said about the absolute 
total cell numbers. The numerical density in particular regions may be unchan­
ged, whereas the reference volumes (the volumes of the structure from which 
estimates of the neuron density were obtained) may differ and consequently the 
total neuron number may be increased or decreased (Swaab and Uylings, 1987). 
Not only tissue processing procedures have severe effects on the volume but 
also aging itself and AD. Determining the total neuron number of the structure of 
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research by applying the systematic random sampling method combined with 
Cavahen's principle for estimating the volume proved to be a more accurate 
method. 
The systematic sampling method was introduced by Weibel (1979). The basic 
idea is that neuron numbers can be estimated by taking samples according to a 
previously fixed scheme within a given structure. The systematic random sam­
pling method has proved to be superior to simple random sampling. Ebbeson and 
Tang (1967) showed that the precision of the reliability of the estimated number 
of nucleoli is far more accurate in systematic sampling than in random sampling, 
provided that equal observations were carried out However, if the structure 
contains a certain periodicity, as for instance the neocortex, the results may be 
considerably biased 
A simple and efficient sampling scheme, known as the fractionator (Gundersen, 
1986; Mayhew, 1988, Braendgaard et a l , 1990; Cruz-Orive, 1990), has been 
applied in this thesis. However, the procedure is not exactly similar to the frac­
tionator, in that the fractionator sampling scheme for counting employs disec-
tors (Pakkenberg, 1988) instead of using the nucleolus as counting item, as has 
been done in this study Efficient and reliable sample schemes for the amygda­
loid complex could be designed. Every 40th section was sampled throughout the 
whole rostrocaudal extent of the amygdala, with a random start of the first 
section somewhere between 0 and 800 μπ\: section fraction 1/40= f 1. This 
resulted in about 15 sections for the amygdaloid complex as a whole in age-
matched controls and 12 sections in AD From within these sections 1 sample 
of 167x167 μνη2 per each square of 3x3 mm 2 was systematically taken and 
investigated- area fraction 1/324= f2. This resulted in a total sampling fraction 
(ft) of: f t = f 1 x f 2 = 1/40x1/324 = 1/12960. Total cell number (N): sampled cell 
number (Ση) multiplied with 1 /ft or: 
N = ( f 1 x f 2 ) \ I n 
Gundersen and Jensen (1987) developed formulae to predict the validity of the 
systematic sampling designs described above Using these formulae it was 
possible to optimize the sampling scheme for the amygdaloid complex and to 
correlate the required coefficient of error (CE) with the minimum number of 





















. ' " " , 












The three-dimensional-sampling design with section fraction of 1/40 and area-
fraction of 1/16. Black squares represent counting fields. The numbers indicate 
sections. 
The CE is a measure of the reliability of the count made on a set of sections. To 
reduce the CE a three-dimensional sampling system was applied in our study of 
the amygdaloid complex by taking one sample every 9 mm 2 per section (Fig. 
3.1). 
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Fig. 3.2 
Relation between number of neurons sampled in the systematic sampling design 
and the coefficient of error. 
An amount of at least 200 systematically sampled nucleoli generally resulted in 
a CE less than 5%, or a reliability of > 9 5 % (Fig. 3.2). 
However, in the various subdivisions of the amygdaloid complex in age-matched 
controls and AD-cases, the sampling area was too small, resulting in too high 
CE-values (>0.3) . Therefore, the area sampling fraction was increased by taking 
1 sample/1 mm2 for the smallest part of the complex (the corticoamygdaloid 
area) and 1 sample/1.5 mm2 for the other subdivisions instead of 1 
sample/9 mm2 (for the whole amygdala). 
3.5.3 Volumetric analysis 
The volumes of the amygdaloid complexes and subdivisions were estimated by 
applying Cavaheri's principle. Cavalien's principle implies that the volume of any 
object even those with a very irregular shape can be accurately (CE of less than 
5%) estimated by summation of the cross-sectional areas of only eight to ten 
systematically taken sections and by multiplying it by the distance between two 
sections (Gundersen 1987). The object must then be cut by a set of parallel, 
equidistant section planes with a random start throughout the whole extent of 
the structure, perpendicular to its longitudinal axis (Fig. 3.1). In this study the 
sections containing the amygdaloid complex have been projected using a Bausch 
and Lomb microprojector (magnification: 18x). The boundaries of the amygdaloid 
complex and its subdivisions were then traced from the projected image. The 
area was estimated by point counting m a coherent test system i.e. by randomly 
placing a systematic set of points over the area of interest of the tracing. The 
area associated with each point of the grid and the number of points over the 
area can be used to make an efficient unbiased estimation of the section area to 
be studied (Gundersen, 1987). 
Volumetric estimations of the total amygdaloid complex (12-20 sections availa-
ble) yielded CE-values of less than 5%. 
The extent of the subdivisions of the amygdaloid complex was smaller than the 
complex itself resulting in less sections to be sampled (6-10), and thus a higher 
CE. However, the CE depends not only on the number of sections of a particular 
structure but also on its shape (Gundersen, 1987). In regularly shaped structures 
like the subdivisions of the amygdaloid complex this always leads to quite accu-
rate estimations (CE-values of 0 05 or less) 
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3.5.4 Senile plaques 
For the quantification of senile plaques (SP) the silver method after Yamamoto 
(Yamamoto and Hirano, 1986) was applied. Using this method a high contrast 
between the SP and the surrounding neuropil was obtained. It impregnates both 
the amyloid and the neuritic components of the SP. 
Estimations for plaques density (expressed as the number of SP profiles counted 
in a square mm) were obtained from 20 μπ\ thick sections in the following way: 
from each amygdaloid complex sections were selected with an interval of 1600 
μπ\ and samples were taken every mm2 with a magnification of 160x. The areas 
sampled were plotted and then compared with anatomic boundaries determined 
from the adjacent Klüver-Barrera stained sections. Mean densities were deter-
mined from ± 3 0 samples taken in each nucleus. The primitive plaques, the 
mature plaques and the burnt out plaques were visualized (Fig. 2.11) and distin-
guished: primitive plaques consist of degenerating neurites without a central 
core, classic or mature plaques are characterized by a dense core of amyloid 
surrounded by degenerating neurites and reactive glial cells, compact plaques or 
burnt out plaques consist only of a central amyloid core. The compact plaques 
represent a very small portion of the senile plaques ( ± 1-2%). When present 
they were counted together with the mature plaques. 
3.5.5 Neurofibrillary tangles 
The Congored stain was used in fluorescence microscopy for visualization of the 
NFT (Fig. 2.12). This technique proved to be quantitatively and qualitatively 
superior to the polarized Congored technique (Puchtler et al., 1965), the silver 
impregnation methods (Gallyas and Wolff, 1986), and the thioflavine-S fluores-
cense technique (Schwartz, 1972). 
The Zeiss microscope permitted combined fluorescence and brightfield examina-
tions in the same section and made it possible to recognize not only the nuclear 
boundaries in the sections but also the autofluorescence patterns of lipofuscine 
and elastic fibres. The neurofibrillary tangles were examined with the systematic 
sampling procedure in sections which were taken at a distance of 1600 μττ\ 
throughout the amygdaloid complex with a 400x magnification with a sampling 
area fraction of 1/16. This resulted in minimal 20 samples throughout the ante-
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nor and posterior extent of each nucleus in AD. With the aid of this approach a 
mean density (number/mm2) for the NFT in the whole amygdaloid complex and 
each subdivision was obtained. 
The NFT were not subdivided into neuropil threads (Braak and Braak, 1988), 
intraneuronal neurofibrillary tangles, and the extraneuronally localized ghost 
tangles but were considered one group. Only clear fluorescenting particles, 
representing the intra- and extraneuronal NFT formation, were counted. 
3.5.6 Congophilic angiopathy 
The Congored stain and method to study the neurofibrillary tangles were used to 
describe the prevalence and distribution of the congophilic angiopathy (CA) in 
the amygdaloid complex in age-matched controls and AD. In order to quantify 
the intensity of CA the following scores were introduced: (0) no AC is present, 
(1) moderate CA is present in the microvessel walls, (2) abundant CA is present 
in the cerebral vessels. 
3.6 Statistical analysis 
The counts of the neuron numbers, NFT, and SP ¡η age-matched controls and 
AD were statistically analyzed using the Mann-Witney U test. 
The differences of the parameters in the left and right hemisphere were analyzed 
with the Wilcoxon rank-sum test. 
To verify whether or not all amygdaloid subnuclei were equally affected regar­
ding neuron loss, the following procedure was carried out: 
- neuron loss within each subnucleus was defined as the ratio of the median of 
that subnucleus in AD to the median of the same subnucleus in AMC; 
- to analyse the AD/AMC ratio differences between the subnuclei a 3-way 
nested ANOVA was performed on the log transformed neuron numbers in all 
subnuclei; 
- the dependent variable is the log transformed neuron number; the independent 
class variables are subnucleus (8 levels: L, BL, BM, BS, ΒΑ, CO, СТА and 
MC), case (2 levels: AD, AMC) and subject (13 AD, 10 AMC); 
- the subject is nested in "case" and the interaction term between "subnucleus" 
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and "case" was included in this model. 
Neuron numbers, NFT, and SP within each subdivision of the amygdala and 
neuron numbers, NFT, and SP in all the subdivisions of the amygdala were 
correlated with each other by using the Spearman correlation test. 
In order to correlate the SP and NFT densities with the neuron counts, the NFT 
and SP were expressed as number per volume by multiplying the known volume 
of a particular subdivision with the found density in the analyzed subdivision. 
The correlations between the amygdala and the nucleus basalis of Meynert were 
calculated as follows, within the subdivisions of the NBMC the large ( > 2 5 
microns) putative cholinergic neurons were sampled and correlated with the total 
neuron number of the subdivisions of the amygdala The correlation procedures 
were carried out by covanance analysis with general linear model procedures 
(GLM-SAS) on those available hemispheres containing both the whole NBMC as 
well as all amygdala subdivisions- 9 control and 10 Alzheimer's diseased he-
mispheres. All 48 possible combinations between the 6 NBMC subdivisions and 




In this chapter the gross anatomy of the amygdaloid complex and its subdivi­
sions will be described. An atlas of the amygdala will be provided. Finally the 
results of the morphometric analysis (the volume changes, the neuron numbers, 
the senile plaques and neurofibrillary tangles counts, and the congophilic angio­
pathy scores) will be presented. 
4.1 Anatomy of the human amygdaloid complex 
This chapter is concerned with the description of the external configuration of 
the amygdaloid complex based on a three-dimensional reconstruction model of 
the human amygdaloid complex. 
Fig. 4. 1 ι iimm 
Drawing of the 3-dimensional reconstruction model of the amygdala. R, rostral; 
L, lateral; M, medial; C, caudal. 
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This model (Fig. 4.1 and 4.2) was made from polystyrene material using the 
outlines (with a 18x magnification) of a series of frontal sections, cut perpendi-
cularly at intervals of 400 pm. In addition, a description will be given of the 
characteristics of the main nuclei and areas that constitute the amygdaloid 
complex. 
Fig. 4.2 
Drawing of the 3-dimensional reconstruction model of the amygdala and the 
internal relations of the subdividions in the rostral and caudal part of the com-
plex. R, rostral; L, lateral; M, medial; C, caudal. 
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4.1.1 Gross anatomy of the amygdala 
The amygdala is a complex of nuclei and corticoid structures located in the 
rostromedial part of the temporal lobe. It is situated ventral to the nucleus lenti-
forme, from which it is separated by the basal nucleus of Meynert, and it lies in 
front of the rostral end of the pes hippocampi and medial to the inferior horn of 
the lateral ventricle. The tip of the inferior horn of the lateral ventricle in the 
temporal horn separates the amygdaloid complex from the hippocampal forma-
tion. 
The amygdaloid complex has a somewhat flat oval front pole which soon beco-
mes polygonal by the expansion to the entorhmal cortex. At the rostral three 
quarters, the nucleus is frontally and ventrally separated from the cortex prepiri-
formis by the capsula externa The lateral side is dorsolateral^ irregular and part 
of the nucleus lateralis is sometimes completely separated from the mam body 
by descending radiations of the commissura anterior. The tapered caudal portion 
of the complex merges into the stria terminahs. On sagittal sections the struc-
ture is ellipsoid in shape with a flat pole directed fronto-basally and a tapered 
caudal section directed dorso-caudally 
4.1.2 Subdivisions and cytoarchitecture of the human amygdaloid complex 
Taking into consideration the morphology and presumed phylogeny (Johnston, 
1923; Humphrey, 1968; Bayer, 1980) of the complex as well as recent informa-
tion concerning connections and functions (Kaada, 1972; Amarai, 1986; Price, 
1986; Russchen et al , 1987) it is appropriate to make a tripartite grouping 
comprising: 
1) the baso-lateral group 
2) the cortico-medial group 
3) the nucleus centralis and the anterior amygdaloid area. 
4.1.3 The baso-lateral group 
The nucleus lateralis appears at the frontal pole of the complex and continues 
caudally for approximately three-quarters of the extent of the amygdala (Fig. 
84 
4.3-4.7). It ¡s one of the main divisions of the baso-lateral group and constitutes 
the largest of the subdivisions of the amygdaloid complex. It is an irregularly 
shaped oval structure in horizontal sections which rapidly increases in size to 
reach its maximum extension at the first one third of the complex. This nucleus 
borders laterally and ventrally on the external capsule. The rostrodorsal part of 
the nucleus lateralis is sometimes separated from the amygdala by radiations of 
the commissura anterior. More caudally the medial wall of the temporal part of 
the ventricle forms the limitation of the nucleus. Caudalwards the basal nucleus 
makes its appearance forming the medial boundary of the lateral nucleus from 
which it is separated by fibres of the lateral medullary lamina. The nucleus 
becomes smaller and somewhat elongated as the basal nucleus increases, to 
finally disappear at three-quarters of the dorsocaudal extent of the amygdala. Its 
contour is then irregular and tapered. 
The internal structure of the nucleus lateralis is rather homogeneous. The nu-
cleus contains medium and small sized cells, multipolar in type with a round to 
oval nucleus, a distinct nucleolus and well stained but rather small Nissl gra-
nules. From dorsolateral to ventromedial there is a gradual reduction in magni-
tude and an increase in cell density. Some investigators subdived the nucleus 
lateralis on the basis of cytoarchitectonic criteria into more than one part (Brock-
haus, 1938; De Olmos, 1990; Sims and Williams, 1990). However, the bounda-
ries between the parcellations are indistinct and in most places the nuclear 
masses merge over into each other. In the present study the nucleus lateralis is 
considered as a single entity. Rostrally, numerous fibres cross the dorsolateral 
aspect of the nucleus lateralis to join the white matter of the temporal pole. Far 
less fibres are found in the caudal portion. 
The nucleus basalis is situated between the nucleus lateralis and nucleus basalis 
accessorius, and lies inferior to the nucleus centralis (Fig. 4.3-4.9). Ventrally the 
nucleus borders on the external capsule. The nucleus basalis makes its appea-
rence behind the rostral pole of the amygdaloid complex as a scattered group of 
large cells. At this level the nucleus merges into the nucleus lateralis and no 
clear boundaries can be detected. Caudalwards the nucleus increases in size and 
forms a thick slab of neurons oriented obliquely from ventromedial to dorsolate-
ral in the caudal two-thirds of the complex. It attains its fullest development in 
the mid-third of the complex. The nucleus persists to approximately the caudal 
end of the complex although, at that level it is solely represented by a few cells. 
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Fig. 4.3a 
Fig. 4.3-4.9: drawings of cross-sections from rostral to caudal through the 
amygdala showing the different subdivisions of the human amygdala and adjoi-
ning structures (Fig. 4.3a-4.9a). In de corresponding drawings (Fig. 4.3b-4.9b) 
the amygdala cell masses were drawn at a magnification eight times that of the 
section as a whole. 
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Fig. 4.3b 
It is a more heterogenous structure than the nucleus lateralis. Cytoarchitectional 
differences allow a subdivision of the nucleus basalis amygdaloideus into three 
parts: nucleus basalis lateralis, nucleus basalis medialis, and nucleus basalis 
superficialis. 
The nucleus basalis lateralis lies dorsolateral to the nucleus basalis medialis (Fig. 
4.3-4.7). At one third of its extent the most lateral part extends over the dorsal 
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Fig. 4.4a 
edge of the lateral nucleus to become a distinct cell mass. Myelinated fibres 
separate the nucleus dorsally from the nucleus basalis accessonus and nucleus 
centralis, and ventrally from the nucleus lateralis. Throughout its entire extern 
the border with the medial basal nucleus ventrally is hard to determine. 
The nucleus basalis lateralis maintains the same general relations with surroun 
ding structures untili the last one third of the extent of the amygdala. At this 
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Fig. 4.4b 
point it shows there reduction in size and at the most caudal level it is solely 
represented by a few cells. The cytoarchitecture of the nucleus basalis lateralis 
is characterized by the presence of magnocellular pyramid-like neurons which are 
equally distributed over the structure. Dispersed smaller sized neurons are also 
found. The neurons contain intense stained Nissl granules and a clearly visible 
nucleus with an evident nucleolus. 
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Fig. 4.5a 
The nucleus basalis medialis is bounded laterally by the nucleus lateralis, and 
medially by the nucleus basalis accessonus. Ventrally the nucleus basalis super-
ficialis extends (Fig. 4.3-4 7). It appears approximately at the same level as the 
rostral tip of the nucleus basalis lateralis and continues back to planes just in 
front of the caudal part of the complex. The boundaries between this nucleus 
and the adjacent areas, the nucleus corticalis and the corticoamygdaloid transi-
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Fig. 4.5b 
tion area medially and the nucleus basalts medialis superficialis ventrally, are no 
easy to demarcate in Kluver-Barrera preparations. It is distinguishable from th< 
nucleus basalis lateralis by its cytological picture. The nucleus contains predomi 
nantly medium- and small-sized neurons with occasional large neurons, and thi 
cells are more densely packed than the cells in the nucleus basalis lateralis. Thi 
neurons have a tendency to become smaller from dorsolateral to ventromedial. 
9' 
Fig. 4 6a 
The nucleus basalis superficialis lies ventrally to the nucleus basalis medialis, 
forming a small band of densely packed small multipolar cells (Fig 4 4-4 7). In 
sections through the rostral pole of the amygdala the nucleus occupies a ventro-
medial position within the complex The nucleus merges medially with the corti-
coamygdaloid transition area and laterally with the nucleus lateralis. It extends 
well to the caudal pole of the complex were it has a flattened form. 
an 
Fig. 4.6b 
The capsula externa formes the ventral and rostral boundaries of the structure. 
There is a distinguishable transition from the medium sized cells of the nucleus 
basalis medialis to the small sized, densely packed, darkly stained polygonal cells 
of the nucleus basalis superficialis. The most caudal part of the nucleus is tra-
versed by many fibres, in contrast with the more rostral part which contains 
only few fasicles of fibres. 
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Fig. 4. 7a 
The nucleus basalis accessonus emerges caudally to the rostral pole of the ni 
deus basalis and lies dorsomedially to this structure for much of the rostrocai 
dal extent of the amygdala (Fig 4.4-4.8) Further caudally its lateral boundary ι 
formed by vertically oriented bands of fibre bundles The nucleus corticalis form 
the medial border of the nucleus basalis accessonus throughout the rostrocaud. 
extent of the complex, although, at many levels, the two nuclei merge into eac 
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Fig. 4.7b 
other. In the midportion of its extent the nucleus is overlaid by the nucleus 
medialis. The neurons in the dorsolateral part of the nucleus are characterized by 
their multipolar form, and by their dark appearance in Nissl preparations. With 
regards to their size, they are comparable with the neurons of the nucleus basa-




he caudal aspect of the nucleus is transversed by small bundles of fibres, 
ne nucleus intercalatus consists of several clusters of small neurons, to be 
lund between and within the major amygdaloid nuclei (Fig. 4 8). They are 
cated around the nucleus lateralis, nucleus basalis lateralis and mediahs. These 
usters are frequently situated ventrally to the nucleus centralis mediahs and 
îtween the nucleus basalis accessonus and the nucleus basalis medialis. In the 
D 
Fig. 4.8b 
nucleus lateralis the nuclei are to be found at the rostral pole ventromedial^ in 
the nucleus, clearly visible by the homogenity of the cellmass and the small 
neurons. These nuclei usually contain a few myelinated fibres but are often 
surrounded by a fibrous capsule. 
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Fig. 4.9a 
АЛЛ The cortico-medial group 
The nucleus corticalis is a large heterogeneous region occupying a superficial 
position in the the dorsal part of the uncus of the temporal lobe (Fig. 4.4-4.8). It 
extends from the fissura amygdalae to the fissura entorhinalis and occupies 
somewhat more than two-third of the anteromedial surface of the amygdala. 
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Fig. 4.9b 
Rostrally the fissura amygdalae separates the nucleus corticalis from the cortex 
piriformis, from which it is distinguishable by the less distinct lamination of its 
neurons. Caudally the nucleus forms a thick layer of pyramid cells in close 
relation with the corticoamygdaloid transition zone near the fissura amygdalae. 
Its dorsal boundary is rostrally formed by the anterior amygdaloid area, and in 
the midportion by the nucleus medialis. The lateral boundary is formed by the 
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nucleus basalis accessorius The demarcation between these nuclei is not sharp 
for more than one half of the extent of the amygdala Caudally the fibres of the 
association bundle separates the nucleus corticalis from the nucleus basalis 
accessorius 
The nucleus corticalis lacks the lamination of the cortex entorhinahs or the 
cortex piriformis It contains a superficial molecular layer, an inner cell layer 
composed primarily of darkly stained pyramidal sized neurons, and an underlying 
admixture of pyramidal and polygonal cells Beneath the gyrus amygdalae the 
neurons are densely packed and arranged in palissades The caudomedial part of 
the nucleus forms an elliptical mass with densely packed pyramidal neurons 
clearly demarcable from the adjacent neurons of the nucleus mediahs which 
have a different arrangement Previous workers (Brockhaus, 1938, De Olmos, 
1990) suggested a subdivision of the nucleus corticalis into more subdivisions 
based on the cytological picture and histochemical differences Our material 
yielded no justification for such a panellation of the nucleus corticalis 
The nucleus mediahs occupies a position adjacent to the bottom of the fissura 
entorhinahs in the middle third of the amygdaloid complex and more caudally it 
occupies a position lateral to the tractus opticus Rostrally the nucleus grades 
over into the anterior amygdaloid area without a clear demarcation and its limits 
are difficult to determine The nucleus is bordered dorsally by the corpus stria-
tum, laterally by the nucleus centralis and ventrally by the nucleus basalis acces-
sorius and nucleus corticalis Throughout most of its extent the nucleus mediahs 
is flanked by dense fibres which surround the nucleus dorsally, and ventrally It 
is possible to delineate the nucleus from the surrounding nucleus corticalis by 
the greater density of its main superficial cell layer The neurons are mostly of 
medium size, polygonal, densely packed and arranged in a more or less crescen-
t e shape 
The corticoamygdaloid transition area is externally visible as an eminence be-
tween the fissura amygdalae and the fissura accessorius amygdalae (Fig 
4 4-4 8) Rostrally it is intercalated between the medial basal nucleus pars 
superficialis, the nucleus corticalis and the cortex piriformis This area is most 
extensive in the mid and caudal parts of the amygdaloid complex and consists of 
small to medium sized densely packed pyramidal neurons which at many levels 
seem to be in continuity with the nucleus corticalis 
At the middle segment of the amygdala the nucleus centralis emerges from the 
anterior amygdaloid area and is at this level sometimes continuous with this 
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structure (Fig 4 4-4 8) It extends from the middle half to the caudal end of the 
amygdaloid complex where the nucleus is replaced by the nucleus basalis of 
Meynert 
The nucleus centralis is ovoid in outline and surrounded by a dense capsule of 
fibres This fibre mass clearly separates it from the nucleus accessonus and 
nucleus basalis lateralis ventrally and from the nucleus basalis of Meynert and 
fibres of the commissura anterior dorsally The nucleus mediahs forms the dorso-
medial border of the structure It contains loosely arranged, small- and medium-
sized cells with a pale Nissl staining, sometimes intermingled with large pyramid-
like neurons 
4 1 5 The nucleus centralis and the anterior amygdaloid area 
The anterior amygdaloid area is located at the rostral pole of the complex just 
ventral to the substantia innominata and ventromedial to the inferior claustrum 
More caudally the area is situated dorsally to the nucleus basalis lateralis, nu-
cleus basalis accessonus, and nucleus corticalis from all of which it is clearly 
separated by fibre bundles The medial border of the the anterior amygdaloid 
area with the cortex piriformis rostrally and more caudally with the nucleus 
corticalis is relatively indistinct The nucleus contains small- to medium-sized 
round neurons with a pale Nissl staining 
4 2 Morphologic changes in the amygdaloid complex in Alzheimer's dis-
ease 
In AD the amygdala showes a marked reduction in overall size, concomitant with 
an enlargement of the inferior horn of the lateral ventricle which was often 
present along the entire extent of the amygdala The general atrophy variably 
affected the rostrocaudal extension of the complex Sometimes the amygdala 
appeared to be elongated in the fronto-occipital direction but more often its 
length was decreased Besides the change in external appearance the inner 
structure of the amygdala was often distorted In many amygdalae the nuclei 
were elongated along the dorsolateral-ventromedial axis Some nuclei, for exam-
ple the nucleus lateralis or nucleus basalis superficialis, showed only slight 
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alterations in shape; others, as e.g the nucleus basalis lateralis, were slendered 
and stretched. These changes in shape affected the internal relationship of the 
nuclei; for instance, the nucleus basalis lateralis was displaced dorsolateral^ in 
relation to the nucleus lateralis, the nucleus centralis was caudally displaced in 
the lateroventral direction. Further, in AD the boundaries between the various 
subdivisions of the amygdala had become less distinct. Particularly the nucleus 
mediahs, the nucleus basalis accessonus, and the nucleus basalis medialis were 
often hard to delineate from adjacent structures. The disorganization, shrinkage, 
and distortion of the amygdala differed considerable among the individuals. 
Therefore no reconstruction is presented from the amygdaloid complex in AD. 
4.3 Volume and volume changes in the amygdaloid complex in age-mat-
ched controls and Alzheimer's disease 
4.3.1 Absolute volumes of the amygdala and its subdivisions in Alzheimer's 
disease and age-matched controls 
In the AD brains the mean total volume of the right amygdala was 516±121 
mm3 and in the left amygdala 510 ± 8 1 mm3. The mean total volume of the 
amygdaloid complex in the right hemisphere of age-matched controls was 
805 ± 1 0 4 mm3 and in the left hemisphere 914±185 mm3 (Table 4.1). In the 
AD group the amygdaloid complex as a whole underwent a statistically signifi-
cant decrease of 36% in the right hemisphere ( p<0 0045) and 42% in the left 
hemisphere (p<0.006) as compared with the control group. 
All of the subdivisions showed a statistically significant volume loss except for 
the nucleus basalis superficialis and the corticoamygdaloid transition area (Table 
4.1) In the right amygdala the volume loss of the nuclei varied from 28% in the 
nucleus corticalis to 41 % in the nucleus basalis accessonus. The decrease in the 
left amygdala seems to be more selective were the losses varied from 7% 
nucleus basalis superficialis to 52% in the nucleus basalis medialis. 
Regression analysis performed in the control and AD group did not reveal any 
relationship between volume change and age, duration of illness, and onset of 
the disease, in the whole amygdala or any of the subdivisions 
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Table 4.1 
Mean volume (mm3) of amygdala and subdivisions in age-matched controls and 
AD 
control AD % change 
R L R L R L 









































































































































Volumes in the amygdaloid complex and subdivisions in AD-cases and age-mat­
ched controls in mm3. L, left hemisphere, R, right hemisphere; n, number of 
researched hemispheres; SD, standard deviation, *, ρ<0.05; **, ρ<0.01, 
according to Mann-Withney U-test. 
When the three principal nuclear groups of the amygdaloid complex were com­
pared i.e. the basolateral group, the cortical group (including the nucleus cortica-
lis and the corticoamygdaloid transition area), and the medial-central complex, 
no clear significant difference in volume loss between the AD-cases and the 
controls could be detected (Table 4.2). 
1ПЯ 
Table 4.2 
Mean volume of the whole amygdaloid complex, the basolateral group, the 
cortical group and the medialcentral complex 
Right hemisphere 
controls 
(n = 6) 
AD-cases 
(n = 8) 





805 ± 1 0 4 
612 ± 70 
109 ± 18 
84 ± 4 
516 ± 1 2 1 
390 ± 83 
74 ± 18 
52 ± 13 








medialcentral cc implex 
controls 
(n = 6) 
914 ± 1 8 5 
682 ± 86 
123 ± 21 
109 ± 36 
AD-cases 
(n=8) 
505 ± 81 
381 ± 56 
72 ± 17 
52 ± 16 
% change in AD 
-45** 
-44** 
- 4 1 * 
-52* 
Mean volume and standard deviations for the whole amygdaloid complex and 
the three principal nuclear divisions *, ρ<0.05; **, ρ<0.01, according to 
Mann-Withney U-test. 
4.3.2 Left and right volumes in AD-cases and controls 
Comparisons between the total volume and volumes of the subdivisions of the 
left (n = 4) and right (n = 4) hemispheres within the same brain in AD-cases 
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showed no statistical differences. 
When the volumes of the 4 left and 4 right hemispheres of age-matched controls 
were compared no statistical difference could be demonstrated. 
4.3.3 Fractional occupacy of the amygdaloid subdivisions 
The subdivisions of the amygdala occupy a certain percentage of the total 
volume of the complex, viz the fractional occupacy (Table 4.3). 
Table 4.3 
Fractional occupacy (in percentages) of amygdaloid subdivisions 
control 
R 
(n = 6) 
L 
(n = 4) 
R 
(n = 8) 
AD 
L 
(n = 5) 
-L 36 6 ± 2.7 37.8 ± 0.9 37.8 ± 6.4 39.1 ± 0.9 
-BL 12.6 ± 0.8 12.8 ± 0.9 11.8 ± 1.7 12.0 ± 1.3 
-BM 7.8 ± 2.4 8.6 ± 1.4 7.9 ± 2.2 7.5 ± 3.7 
-BS 7.7 ± 1.7 4.6 ± 0.6 7.8 ± 2.9 7.7 ± 2.0* 
-BA 11.2 ± 1.1 10.7 ± 1.1 10.3 ± 0.6 9.3 ± 1 . 8 
-CO 12.1 ± 1.6 12.3 ± 1.6 12.8 ± 1.4 12.3 ± 1.8 
-СТА 1.5 ± 0 . 5 1.2 ± 0.3 1.6 ± 0 . 3 2.0 ± 0.6 
-MC 10.4 ± 1.2 11.9 ± 2.4 10.1 ± 1.7 10.3 ± 2 0 
Fractional occupacy expressed in percentages of the subdivisions in age-mat­
ched controls and AD-cases of the total complex in the right hemisphere (R) as 
well as in the left hemisphere (LJ. *. ρ < 0.05, according tot Kruskal-Wallis test. 
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This percentage did not change significantly for most of the subdivisions as a 
function of AD. In one nucleus, the nucleus basalis superficialis of the left he­
misphere, there was a statistically significant difference (p<0.05) compared to 
the controls. The fractional occupacy of this nucleus increased from 4.6% in 
controls to 7.7% in AD. Thus relatively, it occupied a significantly greater pari 
of the amygdala in AD, whereas the remaining subdivisions showed small non­
significant changes. 
4.4 Neuron loss and shrinkage in the amygdala in Alzheimer's disease 
Results concern the total neuron numbers of the amygdala and its subdivisions 
in AD and age-matched controls (AMC), total neuron number as a function o1 
neuron size in AD and AMC, and left-right hemispheric comparisons. 
4.4.1 Neuron numbers of the amygdala and its subdivisions in age-matched 
controls and AD-cases 
I controls (π·β) J AD (n-8) I control· (n-4) IAD (ι n-5) 
Fig. 4.10 
Mean neuron numbers in the right and left amygdala in four sizes classes in age-
matched controls and AD. 
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The total number of neurons in AD a r \ nted to 4.7 ± 1 . 3 million in the left 
amygdala, respectively 4.8 ± 1 . 0 million in the right amygdala, in AMC 10.7 ± 
1.1 in the left and 9.8 ± 1.6 in the right amygdala (Fig. 4.10). 
Table 4.4 
Neuron numbers in the subdivisions of the amygdaloid complex in AD-cases 
right hemisphere (n = 8) 









































































left hemisphere (η = 5) 














































Neuron numbers ¡η Alzheimer's disease expressed in thousands. 
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Data on total cell numbers of the атудсЫа and subdivisions are summarized in 
Table 4.4-4.7 The total neuron numbers in AD-cases showed a neuron loss for 
the whole amygdala of 50.5% in the right hemisphere ( p < 0 01) and of 56.3% 
in the left hemisphere (p<0.05). In all of the subdivisions of the amygdala there 
is a significant neuron loss ranging from 70.4% in the nucleus basalis accesso-
nus of the right hemisphere to 35.5% in the nucleus lateralis of the right he­
misphere. 
Table 4.5 
Neuron numbers in the subdivisions of the amygdaloid complex in age-matched 
controls 












































































































Neuron number in age-matched controls expressed in thousands. 
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Table 4.6 
Total neuron numbers in the amygdala and subdivisions distributed over four size 































































































4 6 % 
1 4 % 
2 1 % 
-55% 
-22% 
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Mean neuron numbers ± standard deviation expressed in thousands in age-
matched controls and Alzheimer's disease. The mean neuron numbers in Alzhei­
mer's disease are also expressed as percentage of age-matched controls. *, 
ρ<0.05, **, p<0.01, according to Mann-Whitney U-test. Left hemisphere. 
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Table 4.7 
Total neuron numbers of the amygdala and its subdivisions distributed over four 
size classes in age-matched controls and AD 
SI26 
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5 2 0 ' 
2 0 7 ' 
141 • 
1 7 0 ' 
1 5 5 · 
2 2 3 ' 
6 9 ' 
1 8 9 ' 
981 • 
3 6 % 
5 1 % 
6 4 % 
4 7 % 
7 0 % 
5 6 % 
5 8 % 
4 9 % 
5 1 % 
Right hemisphere. For legends, see Table 4.6. 
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4.4 2 Neuron number as a function of neuron size 
In AD the amygdala showed a considerable neuron loss in all size classes except 
for the smallest size class (Fig. 4 10). In the subdivisions of the amygdala the 
same pattern in neuron loss was demonstrated in the largest size classes (Table 
4.6 and 4.7). In contrast, several subdivisions showed an increase in total 
neuron numbers of the smallest size class This increase was only significant in 
one subdivision (the nucleus basalis lateralis of the left hemisphere) 
4.4.3 Differential neuron loss between the amygdaloid subdivisions 
Ranking the ratios of the medians of AD to AMC in diminishing sequence, three 
clusters of amygdaloid subnuclei can be recognised (Table 4.8). Cluster A (L) 
significantly differs from cluster С (СТА, CO, BM and BA; p-levels < 0 . 0 5 , 
< 0 0 1 , < 0 0 0 1 , respectively), whereas cluster В (BS, BL, MC) overlaps both A 
and C. This diminishing sequence of the ratios of the medians of AD to AMC, 
alsmost completely parallels the ratios of the means of AD to AMC, the latter 
expressing the actual neuron loss (Table 4.8) 
Table 4.8 























median (95% CI) 
(0 414-0 804) 
(0 331-0 643) 
(0 314-0 609) 
(0 310-0 602) 
(0 276-0 536) 
(0 260-0 504) 
(0 223-0 432) 










4.4.4 Left-right hemisphere comparisons 
No significant differences were found between neuron counts of the left and 
right hemispheres either in the age-matched controls or in AD-cases. 
4.5 Senile plaques 
Senile plaques (SP) were observed throughout the entire amygdaloid complex m 
all AD-cases (Table 4.Э). 
Table 4.9 
Density distribution of neuntic plaques in the amygdaloid complex in Alzheimer's 
disease 










































































































































Distribution of senile plaques expressed in SP/mm2 per section of 20 цт thick­
ness. 
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Within the amygdala of age-matched controls no senile plaques were found. 
There was a characteristic pattern of SP distribution in the amygdaloid complex 
of AD-cases with a heavy accumulation in all the nuclei except for the nucleus 
lateralis (Fig. 4.11). 
plaques per sq. mm. 
L BL BM BS BA СО СТА MC 
^ Н right η = В Шш left η = 5 ! 
Fig. 4. 11 
Mean densities of SP in subdivisions of the amygdaloid complex expressed in 
SP/mm2. n, number of subjects. 
The nucleus basalis lateralis and the medialcentral complex showed moderate 
involvement. The SP densities of the left and right amygdala in complete re­
searched brains often differed considerably in all the subdivisions but the distri­
bution pattern of the SP within the subdivisions remained the same. Three types 
of senile plaques were distinguished: atypical plaques, mature or classical pla­
ques and compact or burnt out plaques. The mature heavily stained plaques 
were most common in the nucleus corticalis, the corticoamygdaloid transition 
area, nucleus basalis accessorius, nucleus basalis medialis and the nucleus 
basalis superficialis (Table 4.10). They were relatively sparse in the nucleus 
basalis lateralis, nucleus lateralis and the medialcentral complex. The atypical 
plaques were more numerous and more dispersed over the various subdivisions 
than the classical plaques. Particularly in the nucleus lateralis and the nucleus 
basalis lateralis the atypical plaques tended to exceed the mature and the com­
pact plaques numbers (Table 4.10). 
No correlation could be detected between the senile plaques densities and the 
1 1 1 
estimated duration of the illness. Neither was there a relation between the 
distribution pattern of atypical and mature plaques and the duration of the 
disease. 
Table 4.10 
Distribution of atypical, mature and compact plaques in the amygdaloid complex 
in AD-cases 
atypical mature and compact 
plaques plaques 
L R L R 
(n = 5) (n = 8) (n = 5) (n=8) 
-L 0.4 ± 0 4 2 1 ± 0.3 0.2 ± 0 2 1 8 ± 1.2 
-BL 1 9 ± 1 5 2 7 ± 2.3 0.2 ± 1 0 2 0 ± 1.8 
-BM 2 9 ± 2 7 4 3 ± 3 7 1 7 ± 1 7 3.9 ± 2 . 6 
-BS 2 7 + 2 8 3 4 ± 2 1 2.2 ± 0 8 3 6 ± 2.1 
-BA 2.2 ± 2 1 3.4 ± 3.8 2.5 ± 2 0 3 8 ± 3 . 1 
-CO 2.3 ± 1.7 3.2 ± 3 9 3.4 ± 2.4 4.4 ± 3.5 
-СТА 2.1 ± 1.9 2.0 ± 2.5 2.4 ± 1 3 2.2 ± 0.8 
-MC 1.1 ± 1.0 3 2 ± 2 9 0 9 ± 1 . 4 1 3 ± 0.4 
The mean density ± standard deviation expressed as number SP/mm2 per sec­
tion of 20 μm thickness. L, left hemisphere; R, right hemisphere. 
4.6 Neurofibrillary tangles 
Results on neurofibrillary tangles (NFT) are summarized in Table 4.10 and 4 . 1 1 . 
All Alzheimer's cases revealed NFT in the amygdaloid complex, whereas in the 
age-matched controls no NFT were observed. The densities of the NFT in the 
subdivisions varied considerably among the individual cases (Table 4.11). 
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Table 4.11 
Distribution of neurofibrillary tangles in the amygdaloid complex 
left hemisphere (n = 5) 














































right hemisphere (η = 8) 









































































Mean density ± standard deviation of neuritic tangles expressed as NFT/mm2 
section of 20 цт thickness in the subdivisions of the amygdaloid complex in all 
investigated cases. 
The mean densities of NFT formation showed a characteristic distribution pat­
tern. The highest densities were found in the nucleus basalis accessorius, the 
nucleus corticalis, and the corticoamygdaloid transition area (Fig. 4.12) in the 
left as well as in the right hemisphere. 
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NFT per iq mm 
I right In = 8) i lift (n = 5l 
Fig. 4.12 
Mean densities in Neurofibrillary tangles (NFT) in subdivisions of the amygdala 
expressed in NFT/mm2. n, number of subjects 
Relatively few NFT were seen in the nucleus basahs superficialis of either the 
left or the right hemispheres The nucleus lateralis, nucleus centralis, and nu 
deus basalis lateralis were moderately affected by NFT (Table 4 12) 
Table 4 12 
Mean density of neurofibrillary tangles in the amygdaloid complex in Alzheimer's 
disease 
L 
(n = 5l 
R 









23 1 t 9 2 
25 0 ± 22 3 
31 8 ± 21 5 
16 6 + 12 7 
51 9 ± 35 7 
39 6 ± 13 2 
42 θ ± 22 7 
26 0 ± 20 6 
11 5 ± 102 
22 8 ± 16 6 
107 ± 9 2 
10 7 ± 9 1 
37 8 ± 152 
36 9 ± 16 4 
36 9 ± 16 0 
108 ± 7 8 
Mean density ± standard deviation expressed as NFT/mm2 section of 20 pm 
thickness, in the subdivisions of the amygdaloid complex 
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No correlation could be detected between the numbers of NFT and age of onset 
or duration of the illness (p>0.2) . In the limited series of brains in which the 
amygdala of both sides could be investigated (left η = 4 , right η = 4) no statistical 
significant difference in distribution of NFT in the whole amygdaloid complex or 
in the subdivisions between the left and the right hemisphere (p>0.3) could be 
demonstrated. 
4 7 Congophilic angiopathy 
Results on the congophilic angiopathy (CA) are summarized in Table 4.13. 
Table 4.13 
Congophilic angiopathy in the amygdaloid complex in Alzheimer's disease 










































































































































Distribution of congophilic angiopathy in the subdivisions of the amygdaloid 
complex. CA scores; (0), absence of CA; (J), CA weakly present; (2), CA abun­
dant. 
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When present the CA was not homogeneously distributed throughout the amyg­
daloid complex. It appeared that CA affects penetrating vessels 50 to 200 μη\ in 
diameter which are predominantly present in the dorsolateral side of the amyg­
dala. Smaller vessels are rarely affected. No subdivision with a preferential distri­
bution of CA could be detected. No correlation with age of onset or duration of 
the disease was shown. Comparison of the left and right hemisphere revealed no 
differences in CA distribution in the amygdala or its subdivisions. 
4.8 Correlations of neuron numbers, neurofibrillary tangles, and senile 
plaques in the subdivisions of the amygdala in Alzheimer's disease 
Table 4.14 
Spearman correlations of neuron numbers with neuropathological determinants 

























































































































































Statistical significance: *, ρ<0.05; **, ρ<0.01; ***, ρ<0.001. 
NFT, neurofibrillary tangles; SP, senile plaques. 
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A negative correlation was shown between the neuron numbers and the NFT in 
most of the corresponding subdivisions (Table 4.14). However, only in one sub­
division viz. the nucleus basalis accessonus, this correlation proved to be statis­
tically significant (r = -0.59, p = 0.035). When the NFT formation in one particu­
lar subdivision was correlated with neuron numbers of the other subdivisions the 
next statistically significant correlations were found: 1) the NFT formation in the 
nucleus basalis accessonus appears to correlate with the neuron numbers in res­
pectively the nucleus basalis mediahs (r = -0 59, p = 0.037), the centralmedial 
complex (r = -0 58; p = 0 034), and nucleus corticalis (r = -0 56; p = 0 049), 2) 
the NFT formation in the nucleus basalis superficialis correlates with the neuron 
numbers in the nucleus basalis accessonus (r = -0.55; p = 0 . 0 4 9 ) , 3) the NFT for­
mation in the nucleus basalis lateralis correlates with the neuron numbers in the 
nucleus accessonus (r = -0.7; ρ = 0.01) and the neuron numbers in the nucleus 
basalis mediahs (r = - 0 . 6 1 ; ρ = 0.027), 4) the NFT formation in the nucleus basa­
lis mediahs correlates with the neuron numbers in the nucleus basalis superficia­
lis (r = 0.77; p = 0 002). 
Table 4.15 
Spearman correlations of NFT in amygdaloid subdivisions with SP in amygdaloid 
subdivisions 









































































Statistical significance: *, p<0.05; **, ρ < 0.01; ***, p<0001. 
NFT, neurofibrillary tangles; SP, senile plaques. 
i i q 
The correlation between SP in CM and neuron numbers in BS (Table 4.14) was 
significant only in one nucleus viz. the nucleus basalis superficialis (r = -0.63; 
p = 0.02). 
Finally, the correlation between SP and NFT was analysed (Table 4.15). A 
significant correlation was found between the SP in the nucleus corticalis and 




In this section it will be attempted to answer the questions formulated at the 
end of section 1 of the present thesis 
5 1 Is it possible to define the boundaries of the human amygdaloid com­
plex and its subdivisions? 
In the present study the terminology and panellation proposed by Crosby and 
Humphrey (1Э41) is employed, which is mainly based on the density and arran­
gements of neuronal elements as observed in Nissl-stained sections. According 
to our observations most of these subdivisions can readily be recognized and 
delineated in the human amygdala However, the boundaries between the ante­
rior amygdaloid area, nucleus medialis, and nucleus centralis were indistinct in 
many places, especially in the brains of patients with Alzheimer's disease These 
three cell masses were therefore considered as a single nuclear mass, the me 
dialcentral complex. Hence, in the present study, the following eight subdivisi­
ons of the amygdala appeared to be distinguishable and have been subjected to 
a quantitative analysis. 
- nucleus lateralis, 
- nucleus basalis lateralis, 
nucleus basalis medialis, 
- nucleus basalis superficialis, 
- nucleus basalis accessonus, 
- nucleus corticalis, 
- corticoamygdaloid transition area, 
- medialcentral complex 
5.2 Do the total volume of the amygdaloid complex and the volume of its 
subdivisions change in AD and in age matched controls7 
Volumetric studies on the amygdaloid complex in normal brains and AD complex 
revealed a reduction of 3 6 % for the whole complex in the right hemisphere, and 
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of 45% in the left hemisphere. The volume changes in the basolateral group, the 
cortical group and the medialcentral group subdivisions were of the same order 
No selective atrophy of any of the amygdaloid nuclear subdivisions was found 
The fact that the reduction in volume of the amygdala in AD is much larger than 
that of the brain as a whole (we found an average loss in brain weight of 22% 
in AD) suggests a selective vulnerability of the amygdala. Volume changes have 
not received much attention in reports focused on the neuropathology of the 
amygdala in AD Herzog and Kemper (1980) found a reduction of 25 7% for the 
whole amygdala with a preferential involvement of the corticomedial group 
(reduction of 35%) and a lesser volume reduction of the basolateral group 
(24%). The least affected subdivision in their study was the nucleus basahs 
medialis, which showed a volume reduction of 13 8%. More recently Brady and 
Mufson (1990) reported reductions of 35% for the whole complex, 5 1 % for the 
basolateral complex and 42% for the nucleus lateralis. The most thorough study 
on volume changes in the amygdala in AD is that of Scott et al. (1991). These 
authors reported that magnocellular regions of the amygdala showed proportio-
nally greater size reductions as a fraction of total volume than did other areas. In 
our study, such a selective atrophy of magnocellular regions, could not be 
demonstrated. These different results may be due to the larger sample size used 
in the present study, a different panellation of the amygdaloid complex and 
different brain material (mean age of age-matched controls and AD-cases, diffe-
rent selection of hemispheres studied). The volume reductions, found in our 
study and in the studies mentioned above, could not be correlated with age, 
duration of illness, brain weight, or gender. This does not mean that the severity 
of the amygdaloid atrophy in AD is unrelated with these four variables. The 
pronounced volume loss in the amygdala may be explained by the severe neuron 
loss and neuron shrinkage in most of the subdivisions (Chapter 4), accompanied 
by other AD-related neuropathological changes (SP and NFT formation) 
5.3 Is there a significant neuron loss in Alzheimer's disease compared to 
age-matched controls and are some cell populations more affected 
than others? 
In the present thesis for the first time data concerning the absolute neuron 
numbers in the whole amygdala as well in its subdivisions were provided. The 
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total neuron numbers in the left and right amygdala in AD (4.7 ± 1 . 3 million 
respectively 4.8 ± 1 million) were significantly lower than in the age-matched 
controls (10 7 ± 1.1 million and 9 8 ± 1.6 million). The results of the neuron 
counts of the subdivisions in AD and in age-matched controls show an overall 
decrease of neuron numbers in a varying degree (35.5% - 70.4%) with a diffe­
rential greater neuron loss in the nucleus basalis accessonus, nucleus basalis 
mediahs, nucleus corticalis, and the corticoamygdaloid transition area. A lesser 
neuron loss was found in de nucleus lateralis. Furthermore, by classifying the 
neurons into four size classes, data could be presented concerning the neuron 
loss and/or shrinkage in particular size classes. The cell loss in size class III and 
IV (size classes 25 0-33 3 //m and > 3 3 3 pm) was massive and in size class II 
(16.7-25.0 μη\) the greatest reduction in absolute neuron numbers was found. 
An increase of total neuron numbers in the smallest size class was found in the 
nucleus lateralis and nucleus basalis lateralis, which is indicative for cell shrinka­
ge. These results extend previous findings of amygdala changes in AD: there is 
severe neuron loss with a selective involvement of several subdivisions as well 
as a differential involvement of cell classes indicative for neuron shrinkage 
In previous studies concerning age-related and AD changes in neuron numbers in 
the amygdala qualitative and semi-quantitative data were provided (Brockhaus, 
1938; Herzog and Kemper, 1980; Tsuchida and Kosaka, 1990). In the frequent­
ly cited study of Herzog and Kemper (1980), on the amygdaloid changes in 
aging and dementia, quantitative data are presented concerning changes in cell-
packing densities in the subdivisions of the amygdala. An AD related decrease in 
cell-density was demonstrated in all of the subdivisions together with severe 
volume changes of the subdivisions, resulting in a much greater cell loss than 
could be demonstrated by density measures alone (Herzog and Kemper, 1980). 
These authors suggested a severe cell loss with preferential involvement of the 
nucleus mediahs with a 7 0 % decrease in absolute number of neurons and of the 
medial portion of the central nucleus and the cortical nucleus with a cell loss of 
approximately 6 6 % and 6 1 % . However, the values of the neuron density in this 
report were striking, because the densities reported were extremely low, with 
mean values ranging from 20 to 391 neurons/mm3 (resulting in total neuron 
numbers of maximal 400.000 for the whole amygdaloid complex). One metho­
dological difference between their and our study may account for the disparity 
of the results. It is possible that they counted only one size category of the 
neurons. We counted all nucleolated neurons, regardless of their size or staining 
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properties, within the counting grid, in order to avoid the possibility that changes 
in neuron size in AD might influence the estimated neuron number Recently, 
Scott et al (1992) demonstrated a markedly increased cell packing density in 
the amygdala in AD, an increase that includes both neurons and glia When the 
data in this study were corrected for structural atrophy, the investigated tissue 
sections showed a great decline for medium and large neurons with a stable 
number of small neurons, supporting the concept that many large amygdaloid 
neurons shrink and are thus counted as small neurons The report of Scott et al 
(1992) confirms the results presented in our study, demonstrating AD-related 
severe cell loss in the amygdala with the greatest decline for medium and large 
neurons However, methodological differences between their and our study 
prevented further comparison of results Scott et al (1992) examined only the 
magnocellular basal nucleus and the deep portion of the cortical nucleus in one 
section near the rostrocaudal midplane of the amygdala Cell packing densities 
were semiautomatically determined and total numbers were determined by 
multiplying densities with nuclear areas With these procedures no total neuron 
numbers could be presented No other studies are available concerning the 
extent of the neuronal loss in the AD amygdala 
With the aid of the antibody Alz 50 (Wolozm et al , 1986, Wolozin and Davies, 
1987), Unger et al , (1991) demonstrated a widespread neuronal involvement of 
the amygdaloid complex in AD without a preferential localization In that study it 
was postulated that if the Alz-50 reactive neurons reflect an early stage in 
cytoskeletal alterations which ultimately lead to neuronal degeneration and 
death, the amygdala would show a neuron loss throughout all of its subdivi-
sions Our results concerning the distribution of cell shrinkage and neuron loss in 
the amygdaloid complex in AD affirm this suggestion 
Our finding that the average neuron number in the amygdaloid complex in AD 
differs significantly from that in age matched controls, although some overlap 
was present, indicates that AD is a disease entity and not part of normal sene-
scence The almost complete disappearance of neurons in the largest size cate-
gory may point to the selective vulnerability of large neurons in the amygdala 
Other reports on amygdala cell loss in AD (Scott et al , 1992) and on the pepti-
dergic neurons in the amygdala in dementia (Unger et al , 1988) were also 
indicative for large neuron shrinkage and in accordance with our results The cell 
shrinkage and severe cell loss detected in the amygdala was similar to the 
morphometric alterations reported for neurons in the hippocampus, neocortex, 
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and nucleus basalis of Meynert complex (Terry et al., 1981, Hyman et al., 1984, 
1986; Hubbard et al., 1990; Van Hoesen and Hyman, 1990; Vogels et al., 
1990; De Vries, 1990). 
5.4 What are the distribution profiles of the neuropathological markers of 
Alzheimer's disease (AD), neurofibrillary tangles (NFT) and senile pla-
ques (SP), in the amygdaloid complex and do these distribution profi-
les differ from those observed in age-matched controls7 
In all of the investigated AD-cases NFT formation was present in the amygdala. 
Generally, the NFT changes in the amygdala revealed a preferential involvement 
for the nucleus basalis accessonus, nucleus corticalts, and corticoamygdaloid 
transition area without adhering strictly to the cytoarchitectonic boudanes of the 
cell masses. The inter-individual differences in distribution pattern were often 
considerable which made it hard to assess a specific distribution pattern of NFT 
formation in the amygdala. The results rather provide information concerning the 
overall involvement of the amygdala. 
The results concerning the distribution of neurofibrillary tangles (NFT) generally 
agree with previous reports (Jamada and Mehraem, 1968, Brady and Mufson, 
1988; Unger et al., 1991) that emphazise the severe involvement of the nucleus 
corticalts, nucleus basalis accessonus and the corticoamygdaloid transition area. 
In more extensive studies (Jamada and Mehraem, 1968; Kromer Vogt et al., 
1990) this phenomenon is even more pronounced 
The NFT formation is closely related with age. neurofibrillary tangles appear in 
increasing numbers with increasing age (Jamada and Mehraem, 1976; Mann, 
1985b; Braak and Braak, 1991), however, above the age of 80 years they 
decline in number with advancing age (Mann et al., 1987) Information concer-
ning the distribution patterns of NFT in the amygdala in ageing is restricted 
(Murphy et al, 1990, 1991; Price et al., 1991). There is evidence that not the 
distribution pattern but the density of the NFT formation discerns normal aging 
from AD. It is remarkable that in none of the age-matched controls of our study 
NFT formation was observed. 
The density profiles of senile plaques in the amygdala showed a characteristic 
pattern with a heavy involvement of the medioventral subdivisions and a mode-
rate involvement of the nucleus lateralis and the medialcentral complex, al-
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though often individual differences were observed. When the SP were divided 
into two classes, atypical and mature plaques (including burnt out plaques) it 
appeared that the mature and burnt out plaques were more frequent in the 
nucleus corticahs, nucleus basalis accessonus, nucleus basahs mediahs and 
nucleus basahs superficialis The atypical plaques were more concentrated in the 
nucleus lateralis and in the medialcentral complex 
The distribution patterns of SP found in this study confirm to a considerable 
extent previous reports (Jamada and Mehraem, 1968; Brashear et al., 1988, 
Hedreen, et al., 1988, Kromer Vogt et al., 1990; Unger et al., 1991). In the 
present study high densities of SP were found m the amygdala of all investiga-
ted AD-cases which is in accordance with the suggestion of Mann et al. (1988), 
that the amygdala together with the hippocampus and entorhinal cortex is one 
of the regions most affected with SP in AD. There are however some differen-
ces between the studies mentioned above and the present results concerning 
the location of maximal changes Brashear et al., (1988), measuring the SP 
densities in the amygdala of 4 AD patients, found the highest densities m the 
nucleus corticahs, and the corticoamygdaloid transition area, with lesser involve-
ment of the nucleus basahs lateralis and nucleus mediahs. The difference in 
topographic pattern noted by Brashear and his co-workers, as compared to our 
results, may be due to the limited number of cases investigated by them and to 
a different staining technique. We examined the distribution of senile plaques 
using the modified Bielschowsky technique (Yamamota, 1986) This method 
succesfully stains the various types of SP· in the mature plaque the swollen 
neuntes and the central core, in the primitive plaques the darkly stained rods and 
dots containing amorphous amyloid deposits. The thioflavin S staining used by 
Brashear et al. (1988) has a different affinity for the atypical and mature plaques 
resulting in different plaque densities (Lamy et al., 1989). 
By classifying SP into atypical plaques and mature plaques a different distribu-
tion pattern for each of these elements was found with particularly in the nu-
cleus lateralis and the nucleus basahs lateralis higher densities of atypical pla-
ques and in the medial areas higher densities of mature and burnt out plaques. 
These results are consistent with results in other reports (Brady and Mufson, 
1990; Murphy et al , 1991). SP were not observed in any of the age-matched 
controls of our brain material. This is probably a coincidental finding because it 
is known that the amygdala is one of the brain structures with the highest SP 
densities in normal aging (Kemper, 1982). The different plaque components are 
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supposed to be related to plaque development and plaque evolution (Wisniewsky 
and Terry, 1973), starting with the primitive plaque and ending with the burnt 
out plaque, the final stage in their evolution. If this assumption concerning the 
formation of SP is correct, our finding that the preponderance of mature plaques 
in the nucleus basalis accessorius, the nucleus corticalis, and the nucleus basalis 
medialis would imply that plaque formation commences in these subdivisions. 
5.5 Can the various neuropathological phenomena observed in the amyg-
daloid complex in AD be correlated with each other? 
The causal relationships between neuron loss and the neuropathological hall-
marks of AD i.e. senile plaques, neurofibrillary tangles and congophilic angio-
pathy are not precisely known. Investigations into the occurrence and densities 
of NFT, SP and CA throughout life in the cortex have led to the following hypo-
thetical relationships (Fig. 5.1): 
mechanisms: 
1: intracellular paired helical filaments (PHF's), accumulating in the soma 
of the neurons, lead to dysregulation of cell metabolism, atrophy, loss 
of connections, and ultimately neuron death (Bondareff et al., 1989). 
2: PHF's and abnormal proteins, accumulated in the somata, can be 
transported, within the axons to the terminals where they can lead to 
degeneration of target neurons and retrogradely, within dentrites, to 
afferent neurons (Saper et al., 1987). 
3: the SP ß-amyloid has a neurotoxic effect and induces biological chan-
ges in the dendrites and soma of neurons and leads to atrophy, loss of 
connections, and ultimately to neuron death (Mann, 1985). 
4: the SP ß-amyloid has a toxic effect on the axon terminals of the neu-
rons leading to atrophy and loss of connections (Hardy et al., 1986). 
5: in certain regions of the brain ß-amyloid leaks through the capillary 
walls leading to angiopathy, followed by SP formation which induces, 
after the uptake process in the dendrites, PHF-formation in the soma 
of the neuron (Joachim et al., 1988). 
6: the ß-amyloid from the SP induces biological changes in the axons of 
neurons leading to PHF formation and ultimately to NFT in the soma. 
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Fig. 5.1 
Possible pathogenetic mechanisms in AD: 1¡ PHF's, atrophy, neuron death; 2¡ 
retrograde and anterograde PHF transport; 3) ß-amyloid of the SP leads to 
neuron loss; 4) ß-amyloid of the SP leads to atrophy of the axon terminals; 5) ß-
amyloid, leaked through the capillary wall, induces PHF in dendrites and perika-
ryon; 6) ß-amyloid, leaked through the capillary wall, induces PHF formation in 
axon terminals, ultimately leading to NFT formation in the perikaryon, 
a, soma; b, axon; c, terminals; d, senile plaque; e, perivasculair ß-amyloid depo-
sition. 
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To explore the influence of NFT formation on the neuron content in AD, the 
relationships between the neuron counts and NFT numbers within the various 
subdivisions of the amygdala has been examined (Tables 4.13-4.14). The neu-
ron counts were compared with the NFT numbers and by applying the Spearman 
correlation coefficient a negative correlation between neuron numbers and NFT 
was found within most of the divisions. In the nucleus basalis accessonus, i.e. 
the site of the most severe neuron loss, this correlation proved to be statistically 
significant, which indicates the presence of a relationship between neuron and 
NFT counts within that subdivision (mechanism 1). 
If NFT formation in AD is one of the mean factors leading to cell atrophy and cell 
death, it is still possible that no significant correlation can be detected between 
the NFT and the neuron numbers. For, an efficient phagocytosis may lead to a 
rapid disappearance of affected neurons but may also lead to a stabilized "turno-
ver" of the NFT formation (Probst et al , 1982; Mann, 1985c; Yamaguchi et al., 
1987). 
The known interconnections of the amygdaloid complex in relation with NFT and 
neuron numbers (mechanism 2). 
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When an unknown "agens" in AD insults neurons with NFT formation as a non-
specific response, the absence of the relationship between NFT and neuron 
numbers can also be explained (Ball, 1982) Why this relationship could not be 
shown in all of the subdivisions may have to do with the biological variance of 
neuron numbers and NFT densities in the amygdaloid complex. Besides, PHF's 
and abnormal proteins can be transported anterogradely within the axons to the 
terminals where the release of PHF or PHF precursor lead to degeneration of 
target neurons (mechanism 2) A comparable retrograde mechanism, leading to 
degeneration of neurons impinging upon the PHF-affected neurons is also con-
ceivable (cf. Saper et al., 1987, Kowall and Kosik, 1987, Wolozm et al , 1990, 
Butcher and Woolf, 1990) 
In order to test the occurrence of mechanism 2, the correlation between NFT 
formation and neuron numbers in and among subdivisions were studied The re-
sultant data are listed in Table 4 13 A statistically significant negative correla-
tion was found between the NFT formation in the nucleus basalis accessonus 
and neuron numbers in the nucleus basalis medialis, nucleus corticalis, and the 
medialcentral complex. This may imply that pathogenetic mechanism 2 may well 
have been operative using the interconnecting fibres as vehicle (Fig 5 2) Be-
cause the nucleus basalis accessonus is supposed to be the most affected nu-
cleus (Fig 5 3) such a spread of the disease seems plausable However, in some 
subdivisions we found more significant correlations between neuron numbers 
and NFT (Table 4 13) This may have to do with less intensive connections, 
with less density of NFT, and with type of neuron in the various subdivisions 
Only one significant correlation could be detected between SP and neuron num-
bers (Table 4.14). Generally, in our material we did not find evidence for patho-
genetic mechanism 3, which supposes a neurotoxicity of the SP ß-amyloid by in-
ducing biological changes in the soma of the affected neuron A relationship be-
tween congophilic angiopathy (CA) and NFT or SP is presumed (Mount)oy et al., 
1982; Joachim et al , 1988) in the occipital cortex In our study no correlations 
could be detected between any of the neuropathological changes and the occur-
rence of CA (mechanism 5 and mechanism 6), nor did we generally find a corre-
lation between NFT and SP (Table 4 14) The possibility that m certain regions 
of the brain systemically derived ß-amyloid leaks through the capillary walls 
leading to angiopathy and the formation of the amyloid cores of SP, and that ß-
amyloid may induce, after the uptake process, PHF-formation in the axons and 
soma of the affected neuron (mechanism 4) could therefore not be confirmed 
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Fig. 5.3 
Neuron loss (visualized with "lossed neurons"), and distribution of senile pla-
ques, and neurofibrillary tangles in the amygdaloid complex. 
5.6 Is it possible to correlate the neuron loss, SP, and NFT in the amygda-
loid complex with the neuropathological changes observed in other 
brain regions affected by AD? 
The Janivo program, started in 1985, was set up as a multidisciplinary research 
program to study the various mechanisms of brain dysfunction and dysregulation 
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leading to Alzheimer's disease. Within the frame of this program five key regions 
of the brain which are known to be affected in AD were investigated: the neo-
cortex (Broere, 1990), the nucleus basalis of Meynert (Vogels, 1990), the brain-
stem monoaminergic structures (van Domburg, 1990), the hippocampal forma-
tion (de Vries, 1990) and the amygdala (Vereecken, 1993). In these structures 
volume changes, neuron loss, and prevalence of SP and NFT, were studied in 
normal aging and in Alzheimer's disease (Table 5.1). 
Table 5.1 
Brain material used for correlation studies 
Amygdala Neocortex Hippocampus NBM Brainstem 
R 
R + L 
R + L 
R + L 
R + L 
R + L R + L 
L 
R 
R + L 
R 
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R + L 
R + L 
R + L 
R + L 
R + L 
R + L 
R + L 
R + L 
R + L 
The brain material conjointly studied in the JANIVO research program. N, age-
matched controls; AD, Alzheimer's disease; L, left hemisphere; R, right hemi-
sphere. 
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All projects mentioned above are finished, hence it is now possible to study the 
pattern of changes in those five brain areas in relation with the anatomic inter-
connections of these structures. 
The results concerning the neuropathological changes in AD-cases in the diffe-
rent hippocampal subfields (de Vries, 1990) confirm to a considerable extent 
those reported in the literature (Hyman, 1986; Van Hoesen GW and Hyman, 
1990). There is a consistent pattern of neuron loss, NFT and SP, investing 
certain regions in the hippocampus. As regards neuron loss, an overall cell loss 
of 30% was shown with about a 70% loss in the CA1 region. In the molecular 
layer of the gyrus dentatus high densities of SP were observed and in the CA1 
area high densities of NFT and SP were found. In contrast, the CA4, and the 
CA3 portions contained a much lesser density of NFT and SP but still significant-
ly more than in age-matched controls. New information was also provided: the 
subiculum, and the CAT area (Cornu Ammonis, subfield 1 ' only in the rostral 
sections) were heavily affected by NFT and SP, and a tendency to a rostrocau-
dal gradient in NFT and SP density was shown (with a higher density in the 
rostral part of the hippocampus). 
The parahippocampal cortices (entorhinal cortex and perirhinal cortex) showed a 
consistent and specific pattern of alterations in AD-cases. The SP densities were 
6 to 7 times higher than those observed in the hippocampus. The mean NFT 
density in the parahippocampal cortices was the same as was calculated for the 
hippocampal formation. 
As has already been mentioned, in the amygdaloid complex the individual subdi-
visions showed a differential involvement in neuropathological alterations in AD. 
The nucleus basalis accessorius, the nucleus basalis medialis, and nucleus 
corticalis showed severe neuron loss, and high NFT and SP densities. The nu-
cleus lateralis, the medialcentral complex and the nucleus basalis superficialis 
were less severely affected by these pathological changes (Chapter 4). These 
patterns of pathology in the hippocampal formation and the amygdaloid complex 
can be related with the connectivity of both structures (Chapter 2). Our results 
show that those areas with projecting neurons, interconnecting the hippocampal 
formation and the amygdaloid complex i.e. the CA1 and entorhinal cortex in the 
hippocampus, and nucleus basalis accessorius, nucleus basalis medialis and 
nucleus corticalis in the amygdala, are particularly vulnerable to SP, NFT, and 
neuron loss. 
From the data provided it may therefore be concluded that the neuron loss, NFT 
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and SP formation take place in those specific neurons and areas which are cru-
cial for reciprocal connections between the amygdaloid complex and the hippo-
campus The neuropathological alterations may have been caused by the patho-
genetic mechanisms 1- 6 (section 5 6). Statistical analysis could not be per-
formed by the lack of mutually investigated brains (Table 5 1 ) 
In the thesis of Broere (1990) the SP, NFT and CA formation in the neocortex in 
AD were studied. The distribution patterns of these neuropathological changes 
in 20 different cytoarchitectonic fields, spread over eight regions and areas were 
investigated and described Interestingly, the densities of SP and NFT in the 
neocortical areas and cortical layers varied considerably between the cases 
investigated. Conclusive neuropathological patterns could only be detected from 
the mean densities of all the investigated cases Using the Yamamoto staining 
method and the Congo-red fluorescence technique a laminar distribution of the 
SP was demonstrated. Most SP were seen m layers II, III, and V. The areas in 
the temporal lobe studied (areas 8, 20, 2 1 , 22, 37 L and 37M) showed the 
highest concentrations of SP The investigated areas in the frontal lobe (areas 8, 
10 and 11) and in the gyrus cinguli (areas 23 and 24), showed a lower concen-
tration of SP However, Area 8 proved to be the most affected area in the 
cortex. The primary sensory (areas 17 and 42) and motor cortices (area 4) 
displayed the lowest densities of SP in the neocortical areas studied. The NFT 
formation in the neocortex also showed a laminar distribution involving primarily 
layers II, III and V Temporal areas (areas 20, 2 1 , 22, 37L, and 37M), areas of 
the gyrus cinguli (areas 23 and 24), and the insula were intensively invested 
with NFT. In the primary sensory (areas 17 and 42) and motor cortices (area 4) 
the lowest densities of NFT were found 
In Chapter 2 of the present thesis the connections between the amygdala and 
the neocortex are described In the temporal cortex the origin of the amygdalo-
petal projections are located in the pyramidal neurons of layers ll-lll and V The 
amygdalo-cortical projections end near the border between layers I and II, with 
additional projections to layer V and VI (Aggleton et al , 1980) When the lami-
nar distribution of SP and NFT m the temporal cortex is considered (Broere, 
1990), the particular involvement of layer II, III, and V may be of great impor-
tance for the functional relationship of the amygdala and the neocortex. Exami-
nation of the subdivisions in the amygdala with the strongest (reciprocal) con-
nections with the temporal cortex, viz the basal complex, revealed severe 
neuron loss, and high SP and NFT densities (mechanism 2-5). The moderate 
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neuropathological changes in the nucleus lateralis (neuron shrinkage, low densi-
ties of NFT and SP) can be explained by the fact that retrograde degenerative 
mechanisms (mechanism 2, 4, and 6), affecting the basal nuclei, cannot, vìa in-
terconnections, influence the neuropathology in the nucleus lateralis. The almost 
absent changes in the unidirectionally (amygdalofugally) connected primary 
sensory areas may be related to mechanism 1 and 3, in which the projecting 
neuron may atrophy without inducing NFT and SP in the terminal areas. 
Table 5.2 
Non-human primate hodology between nucleus basalis of Meynert complex and 
amygdaloid complex 
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Connections: + + + major, + + substantial, + minor, - weak. Chi + 2: medial 
septal nucleus and vertical limb nucleus of the diagonal band of Broca; Ch3: 
horizontal limb nucleus of the diagonal band of Broca; Ch4: nucleus basalis of 
Meynert; Ch4al, Ch4am, Ch4i and Ch4p: respectively the anterolateral, ante­
romedian intermediate and posterior part of Ch4. 
No relation could be detected between NFT and SP pattern in the association 
areas in the temporal cortex and amygdaloid subdivisions, for instance the 
nucleus lateralis, the nucleus centralis and the nucleus basalis lateralis. 
In the nucleus basalis of Meynert complex (Vogels et al., 1990) the main neuro­
pathological change is neuron shrinkage rather than neuron death with differen-
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tial involvement of particular subdivisions In AD an overall neuron loss of only 
15.5% for the whole NBMC was found and in the Ch4, as the most affected 
subdivision, a neuron loss of 19.5 % could be demonstrated. Numerous NFT 
and few SP were demonstrated in all the subdivisions with an increase of dege­
nerative changes in rostrocaudal direction (from Ch1 +Ch2 to Ch4). 
The amygdala and the nucleus basalis of Meynert complex (NBMC) are connec-
tionally closely related (Table 5.2). The subdivisions of the amygdala with severe 
neuropathological changes receive and give rise to prominent projections to the 
NMBC. To study the relationship of these changes in both structures the neuron 
loss, NFT, and SP formation in AD were correlated using the Spearman multiva-
riant analysis. A significant correlation was shown between the neuron numbers 
in those subdivisions of both the NBMC and the amygdala which are known to 
be densely interconnected i.e the Ch4 subnuclei of the NBMC with the nucleus 
basalis accessonus and nucleus basalis lateralis of the amygdaloid complex 
(Table 5.3). No significant correlations could be demonstrated between neuron 
numbers of subdivisions of the NBMC and amygdala that are not or only weakly 
connected except between the nucleus basalis accessonus and the Ch4 of the 
NMBC. 
Table 5.3 
Correlation diagram between neuron numbers in NBMC and amygdaloid complex 
BA BL BM BS CE CO СТА L 
C h 1 + 2 
Ch3 . · . . . . . . 
Ch4al - ** -
Ch4am ** * * * - - (*) -
Ch4i * · · _ 
Ch4p . . . . . . . . 
Statistical significance: *, ρ <0.05; **, ρ <0.01; ***, ρ <0.001. according 
to general linear models procedures (GLS-SAS) 
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These data suggest that in AD neuroanatomical pathways between the amyg-
dala and the NBMC are involved in the spread of the disease and result in ante-
rograde and retrograde degenerative mechanisms (mechanism 1) the subdi-
visions of the amygdala which contain high densities of neuropathology (nucleus 
basalis accessonus and nucleus basalis lateralis) represent one of the primary 
targets of AD, and the projecting neurons of the NBMC wich innervate these 
nuclei are secondarily affected via retrograde axonal degeneration or anterograde 
via axonal transport by amygdaloid projecting neurons to Ch4 subdivisions 
No statistically significant correlations could be detected between the NFT and 
SP, between NFT and neuron loss, and between the SP and neuron loss in both 
structures 
In the human brainstem monoaminergic structures in AD for all nuclei a severe 
neuron loss ranging from 40% in the nucleus raphe dorsahs to 70% in the locus 
coeruleus was demonstrated (Van Domburg, 1990) In all the monoaminergic 
nuclei the neuron loss had a close relationship with the NFT Relatively few SP 
were found in the nucleus raphe dorsalis, locus coeruleus and the nucleus teg 
mentí pedúnculo pontinus, whereas relatively many SP were seen at the dorsal 
border of the substantia nigra, ventral tegmental area and the nucleus penpendi-
culans. These latter areas receive strong afferent projections from the nucleus 
basalis of Meynert, the paralimbic areas and the amygdala The main source of 
projections from the amygdala to the human brainstem monoaminergic structu 
res is the nucleus centralis In this nucleus, as was shown in this thesis, a 
neuron loss of 4 9 % could be demonstrated in AD with low densities of SP and 
NFT 
From these data it can be derived that the brunt of the disease is presumably 
located in the tightly interconnected complex formed by the amygdala and the 
hippocampus (Mann, 1985, Esin et al , 1990) From here the disease may well 
spread over the neocortex along the direct connections which the amygdalohip-
pocampal complex entertains with many neocortical areas (Fig 5 4 and 5 5) 
The nucleus basalis of Meynert, the nucleus raphe dorsalis, and the locus coeru-
leus may be affected via their connections with the amygdala, retrogradely via 
their cortical projections or via both cannels (Pearson, 1985, German et al , 
1987, Van Domburg, 1990) 
It is likely that the severe neuropathological changes in the amygdala affect the 
intimate anatomical relationships between the above mentioned structures This 
deprives the amygdaloid complex of its major input and output links to specific 
137 
Fig. 5.4 
Main connections involved in AD of the structures investigated in the "JANIVO" 
research program. 
AM, amygdaloid complex; H, formatto hippocampi; NBMC, nucelus basalt's of 
Meynert complex; NRD, nucleus raphe dorsahs; NLC, nucleus locus coeruleus; 4-
38, areas according to Brodmann. 
cortical and subcortical structures and may lead to a functional disconnection of 
the complex. Although we did not study the correlations between neuropatholo-
gical and neuropsychological profiles observed in each case, the results can be 
interpretated in perspective of what is already known about the symptomatology 
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Fig. 5.5 
Neuropathological changes observed in neocortical and subcortical structures 
investigated in the "JANIVO" research program. 
of the disease and supposed function of the structures investigated. For exam-
ple, the severe and consistent changes in the hippocampal formation and neo-
cortex in combination with those in neuroanatomically related areas in the amyg-
dala are likely to play a major role in the memory impairment, often one of the 
earliest signs of the disorder. The lack of initiative, impairment of decision ma-
king, and planning, possibly a consequence of the primary memory disturbance, 
probably also reflects damage in prefrontal cortices (Squire, 1987). The desinte-
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gration of somatosensory, visual, and verbal information, leading to impairments 
such as apraxia and visuospatial deficits, may reflect the high degree of patholo­
gy observed in multimodal association areas in the parietal and frontal lobes of 
the neocortex as well as in the basolateral complex of the amygdala Further, it 
is reasonable to hypothesize that the manifest inappropriate behavior in AD 
patients, as for instance, disturbances in "executive control", are related with 
changes in the amygdala (Chapter 2) 
5 7 Can the data collected on the neuropathology of the amygdala in AD 
be related with the molecular pathology of Alzheimer's disease7 
Alzheimer's disease is now recognized as a syndrome characterized by a typical 
progression of a range of features In the first stage, impairment of memory for 
recent events is usually the first feature Disorientation in time and place, fre 
quently occurs Personality characteristics are maintained and obvious mani 
festations of memory or cognitive decline are rarely present At this stage de­
pression, fatigue, and impaired concentration may be present The cognitive 
changes are not severe enough to interfere with occupational or social perfor­
mance In the second stage, short and long-term factual memory impairs but 
also other higher cortical functions, such as abstract thinking, praxis, perception, 
ability to learn skills, judgment, language use, resulting in disturbances m social 
performance Paranoid symptoms, apathy, anxiety, agitation, and even aggressi­
on toward family members occur Personality changes take place, not as epiphe-
nomena to the cognitive decline but rather as manifestations of the underlying 
neuropathological changes in the brain Epileptic insults, Parkinson-like features 
such as increased muscle tone or akinesia, and hemiparesis may be seen In the 
final stage, the cognitive deterioration is complete, accompanied by many neuro­
logical deficits such as double incontinentia, unsteady gait, myoclonus, and 
spasticity Life may continue for one or more years in an almost entirely vegeta­
tive state. 
Neuropathologically the disease is characterized by senile plaques, neurofibrillary 
tangles, and congophihc angiopathy as well as neuron loss in several brain 
areas At present the causes of AD are still obscure, except for diseases in 
which heredity may offer aetiological clues Two of them are promising, the 
first, familial AD (FAD), in which patients have a genetic defect ι e a mutation 
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on chromosome 21 and the second, Down syndrome, in which the patients have 
trisomy of chromosome 21 
The classical plaque of AD contains a central deposit of extracellular amyloid 
fibrils (the core), surrounded by dystrophic neuntes (both dendrites and axonal 
terminals), and activated microglia and astrocytes The sequence of involvement 
of these elements in plaque formation and their (causal) relation with neurofibril-
lary tangles, cell loss, and AD is not well understood. The main component of 
the amyloid fibrils, amyloid lì-ρ rote ι η (AßP), is supposed to be the causative 
agent of AD (Selkoe, 1991; Frautschy et al., 1991, Kowall et al., 1991). Patho-
genetic mechanisms in familial AD and in Down syndrome have led to this 
hypothesis. It was demonstrated (Kang et al., 1987) that AßP is a proteolytic 
fragment of a 15 times larger ß-amyloid precursor protein (ßAPP). In Down 
syndrome, the duplication of chromosome 21 that contains the ßAPP gene leads 
to an accelerated deposition and an excess of extracellular AßP In some fami-
lies, in which AD transmission take place with an autosomal dominant pattern 
(FAD) the disease is linked with mutations on chromosome 21 (St George-Hys-
lop et al. 1987). This gene defect may alter ßAPP mRNAs, resulting in an excess 
of mutant ßAPP polypeptides and enhanced AßP production. 
The ßAPP proteins (some isoforms are known) have been identified in brain, 
nonneuronal tissues, and cultured cells as a complex group of membrane asso-
ciated proteins (Selkoe et al , 1988) comprising 695-750 amino acids. The AßP 
includes a fragment of 28 residues just outside the membrane plus a transmem-
brane fragment of 11-14 residues. Their expression in virtually all cells and 
tissues suggest that they have multiple functions, although these are not well 
understood. The origin of the ß-amyloid deposition is an unresolved question. 
The neuronal origin for extracellular amyloid is supported by the finding that 
ßAPP undergoes fast axonal transport (Koh et al , 1990) and by the juxtaposi-
tion of amyloid fibrils in classical plaques to degenerating neuntes (Masters et 
al., 1985). However, virtually all cells in the nervous system express ßAPP. A 
second possibility for the ß-amyloid deposition in SP comes from ultrastructural 
findings of Miyakawa et al (1982) who found evidence that ß-amyloid might 
originate from microvessels They demonstrated the presence of a capillar, 
bearing amyloid at its basement membrane, in the core of every SP subjected to 
serial sectioning. 
Recent data concerning the biochemical and molecular genetic characteristics of 
the lesions in AD allow the following hypothesis on the pathogenesis in this 
141 
disease. The amyloid precursor protein ßAPP is inserted in the cytoplasma 
membrane and cleaved by the ßAPP secretase (Kosik, 1992) into residues of 15 
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Fig. 5.6 
Cleavage of amyloid precursor protein a) constitutive cleavage (preventing AßP 
production), b) alternative proteolytic pathway normally used at low levels 
containing intact AßP (Adapted from van Gooi, 1992). 
This cleavage produces fragments that do not contain intact AßP and can there-
fore not result in amyloid deposits. These fragments can be detected in brain 
and cerebrospinal fluid. Recent studies (Estus et al , 1992; Haass et al., 1992) 
have shown that ßAPP can also be processed by an endosomal-lysosomal path-
way (Fig 5.6), and that via this alternative intracellular route the entire sequen-
ce of AßP can be derived The factors that facilitate cleavage in the endosomal-
lysosomal compartment are unknown. It has been speculated that the gene 
alterations in FAD and Down syndrome may alter ßAPP proteins and inhibit the 
secretase cleavage of ßAPP in favor of the alternative intracellular cleavage. It is 
suggested that in these two diseases, after decades of gradual accumulation, 
142 
the amyloid deposits become increasingly fibrillar and compact (Ogimori et al., 
1989). In some parts of the brain (in particular the neocortex, limbic structures 
and several subcortical nuclei) this maturation or evolution of ß-amyloid proteins 
becomes associated with plaque formation (Rozemuller et al , 1990), accompa-
nied with activation of astrocytes and microglia. It is likely that the appearance 
of ß-amyloid in some parts of the brain induces toxic effects on surrounding 
neuronal processes (Whitson et al , 1989, Koh et al., 1990). 
The mechanism by which the ß-amyloid proteins undermines the viability of 
neuron is not well understood Recent investigations into the biological activi-
ties of ßAP in cultured hippocampal neurons (Pike et al., 1991, Cotman et al., 
1992) revealed that ßAP is neurotoxic in vitro and may increase neuronal vulne-
rability to a variety of insults by an as yet undetermined mechanism (Yanker et 
al., 1990). The results of in vivo experiments (Podlisny et al., 1992), are equivo-
cal: Podlinsky et al. (1992) could not detect a specific neuronal, neuntic or glial 
response after injection of synthetic ßAP into primatic cerebral cortex, whereas 
Kowall et al. (1991) observed neuronal toxicity after injection of ßAP in the rat 
hippocampus and neocortex in a manner that resembles AD cytopathology. 
Nonetheless, one of the results of the presence of ß-amyloid proteins on the 
surrounding neuronal processes could be the ßAP uptake according to an endo-
cytotic pathway. Following internalization, cytoskelatal alterations, including 
abnormal phosphorylation of the microtubule-associated protein, tau, in the 
axons, and secondary, neurofibrillary tangles formation in the cell bodies may be 
induced (Selkoe, 1991, Hardy and Higgins, 1992) 
The gene mutations in APP so far described are responsible for only a small 
proportion of AD-cases 
One of the effects of ß-amyloid proteins on the surrounding neuronal processes 
can be the induction of cytoskeletal alterations, including changed microtubule-
associated proteins in the axons, and secondary the formation of neurofibrillary 
tangles in the cell bodies (Selkoe, 1991) 
Electron microscopical studies have shown that neurofibrillary tangles (NFT) 
consist of clusters of fibrillary structures twisted into a helix. On morphological 
grounds these structures are referred to as paired helical filaments (Kidd, 1963). 
In AD the neuronal lesions are characterized by accumulation of NFT in neuronal 
cell bodies and in some of the altered neuntes in the senile plaques. 
The analysis of paired helical filaments (PHF) is hindered by the marked insolubi-
lity of the filaments Immunocytochemical studies demonstrated the presence of 
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antigenetic determinants shared by several normal cytoskeletal elements and 
unique antigenic determinants, not found in normal neural tissue. 
Antibodies to neurofilament proteins, particularly antibodies to phosphorylated 
epitopes of the high and middle molecular weight neurofilament polypeptides, 
also label PHF (Rasool, et al., 1984, Cork et al., 1984) suggesting that compo-
nents of PHF might be derived from neurofilament proteins. Antibodies raised 
against isolated PHFs were shown to label the microtubule-assocciated protein, 
tau (Kosik et al., 1986). In turn, most of the polyclonal and monoclonal antibo-
dies to mammalian tau were found to detect some or most PHF-containing 
neurons in AD brains (Brion et al., 1985; Wood et al., 1986) Studies with tau 
antibodies suggest that certain tau epitopes may be abnormally phosphorylated 
(Grundke-lqbal et al., 1986; Ueda et al., 1990). Whether the accumulation of 
altered tau proteins in PHFs affects the normal function of tau as a microtubule-
binding protein and the function of the affected neuron or represents a by-pro-
duct of a dying neuron is not yet clear 
The result of PHFs formation may be a severe damage of cell metabolism and 
ultimately neuron death, resulting in a decline and loss of synaptic terminals 
leading to multiple neurotransmitter deficits and other biochemical changes 
(Rasool et al., 1986, Hardy et al., 1986; Mann et al., 1987; Unger et al., 1988; 
Fowler et al., 1992). These changes are supposed to take place in certain neu-
ron populations which are relatively vulnerable for PHF formation. The intense 
mterconnectivity of the early affected areas may lead to a selfperpetuating 
process and may result in the "spread" of the disease via orthograde or retro-
grade axonal pathogenetic mechanisms. The clinical manifestations are sup-
posed to become apparent once a threshold of nerve cell damage and neuron 
loss is reached and when the compensating mechanisms, for example, outgrow 
of neuntes, are exhausted (Terry, 1981; Katzman et al, 1988) 
The question is now whether our observations fit the theory outlined above. 
Our data show severe volume loss, neuron loss as well as neuron shrinkage, 
high densities of SP and NFT in the amygdala and often congophilic angiopathy. 
It is likely that this structure contains populations of neurons more sensitive to 
pathologic changes in AD compared to other areas of the brain. The differential 
vulnerability of the nucleus basalts corticahs, nucleus basahs accessonus and the 
nucleus basalis mediahs of the amygdala in AD, as is shown in this study, could 
reflect the influence and importance of the neuroanatomical connections in AD 
(mechanism 2 and 6). Those subdivisions in the amygdala which are intimately 
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connected with the hippocampal formation viz. the nucleus corticalis, nucleus 
basalis accessorius and nucleus basalis medialis show large numbers of NFT and 
SP and are marked by severe neuron loss. The nucleus centralis and the nucleus 
lateralis, which are far less involved in AD, have minor connections with the 
hippocampal formation. The substantial intrinsic connections of the amygdaloid 
complex may act as vehicles for the spreading, leading not only to an invol-
vement of large-sized pyramidal-type neurons but also of smaller cells in all the 
subdivisions. Also indicative for the importance of neuroanatomical pathways is 
the correlation found between neuron numbers in the amygdala and NBMC and 
their connectivity. 
The correlation between the NFT and SP, as suggested in the hypothesis descri-
bed above, could not be demonstrated in this thesis. Our findings suggest that 
the development of SP may occur independently of NFT pathology in affected 
neurons and areas in AD. Other studies (Probst et al., 1989; Price et al., 1991) 
support this suggestion. 
More research has to be done to investigate the relationship between NFT, SP, 
and neuron loss. The search for the earliest changes characteristic of AD will 
have to concentrate on nondemented elderly cases. In such cases, sometimes 
substantial pathologic changes can be found without any detectable cognitive 
decline (Ulrich, 1985; Price et al., 1991). The disease process may already well 
be advanced and these cases are probably at the theshold for clinical detection 
of dementia. In these elderly subjects the distribution and correlation of NFT and 
SP would be of particular interest. The examining of the neuron loss in neocorti-
cal areas and limbic structures would also throw light on the interactions of 
NFT, SP and neuron loss. 
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CHAPTER 6 
SUMMARY AND CONCLUSIONS 
In 1907 Alzheimer described the clinical and neuropathological features of a 
case of dementia starting at an age of 51 years. He showed with the application 
of new silver techniques the presence of abnormal changes now referred to as 
senile plaques and neurofibrillary tangles. Kraepelin (1908) suggested to accept 
this disorder as a new disease entity and to designate it as Alzheimer's disease. 
The disease selectively impairs some neuropsychological functions with relative 
sparing of others, indicating that functions are affected differentially by the 
pathological changes. Neuropathological studies (Brun and Gufstafson, 1967; 
Hoper and Vogel, 1976; Price et al., 1991) have shown that there are consistent 
and severe changes in the hippocampal formation, cortical association areas and 
the amygdaloid complex. The least changes occur in the primary sensory areas 
and motor cortices. In the classical study of Blessed and al. (1968) the number 
of senile plaques in the neocortex of aged subjects correlated well with the 
mental status tests, suggesting a causal relationship between the number of 
senile plaques and cognitive impairments. However, the understanding of the 
relationship between senile plaques (SP) and neurofibrillary tangles (NFT) to 
neuropsychological changes is far from complete. The relationship between the 
NFT and SP and their influence on neuron numbers remains unclear. 
Against this background we decided to study the neuropathological changes in 
the amygdala, hoping to elucidate possible pathogenetic mechanisms in AD. 
Chapter 2 is concerned with the nomenclature, connections, neurotransmitters, 
functions, and neuropathological changes (in AD) in the amygdaloid complex. 
The amygdala is a structure, which is connected, by a vast network of fibres, 
with other brain areas. In a brief review the hodology of the amygdala is descri-
bed. Through this complex network of connections with neocortical, subcortical, 
and brain stem nuclei the amygdala is supposed to integrate sensory stimuli 
from the environment to influence autonomic, neuroendocrine, and emotional 
responses. Lesion experiments, electrical stimulation experiments, and clinicalpa-
thological evidence suggest that the amygdala is involved in mnemonic functions 
providing emotionally charged cues to retrieve remote memories that are signifi-
cant for the individual and in clinical pathological responses. 
The amygdala is one of the most affected structures in AD, in combination with 
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the hippocampus, probably responsible for the early syptoms viz. the memory 
disturbances and retrival problems 
Chapter 3 ("materials and methods") deals with the used histological, morpholo-
gical, stereological, and statistical procedures. On the basis of a study of normal 
Nissl and Klüver-Barrera material, the amygdala was subdivided into the follo-
wing eight subdivisions: nucleus lateralis, nucleus basalis lateralis, nucleus 
basalis accessonus, nucleus basalis medialis, nucleus basalis superficialis, nu-
cleus corticahs, medialcentralcomplex, and corticalamygdaloid transition area. A 
systematic sampling design was employed through a dissected part of the 
cerebral hemisphere, containing the whole amygdala In equidistant sections 
neurons were systematically sampled, a procedure which is theoretically and 
experimentally superior to other sampling methods. 
In chapter 4 ("results") an atlas of the amygdaloid complex, comprising dra-
wings of seven equidistant sections of the amygdala, is presented. The quantifi-
cation of volume loss, neuron loss, densities of neurofibrillary tangles, densities 
of senile plaques, and occurrence of congophilic angiopathy in the amygdala in 
AD and in age-matched controls is provided. The volumina of the whole amyg-
dala in AD showed a decrease of 45% in the left hemisphere and 36% in the 
right hemisphere compared with age-matched controls. The volume loss in the 
subdivisions ranged from 7% in the nucleus basalis superficialis to 52% in the 
nucleus basalis medialis. 
In AD the total number of neurons appeared to be 4 7 ± 1.3 million in the left 
amygdala, respectively 4.8 ± 1 . 0 million in the right amygdala. The neuron 
number of normal amygdalae was derived from age-matched controls. The total 
numbers in normal amygdale appeared to be 10 7 ± 1 1 million in the left and 
9 8 ± 1.6 million in the right amygdala. Hence, a neuron loss of 56.3% for the 
left amygdala and 50 5% for the right amygdala in AD was found, being more 
severe than previously have been reported. The subdivisions showed a neuron 
loss ranging from 35 5 % in nucleus lateralis of the right amygdala to 70.4% in 
the nucleus basalis accessonus of the right amygdala. The neurons were subdi-
vided into 4 size categories in order to detect changes in neuron size In all of 
the subdivisions the neuron loss in the largest cell classes was massive In the 
smallest size class an increase in neuron numbers was detected in the nucleus 
basalis lateralis and the nucleus lateralis, in both hemispheres. The massive 
reduction of cell numbers in the larger cell classes may be caused be athrophy 
and cell death. The shrinkage of larger neurons may results in a shift from the 
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largest cell classes to in the smallest cell class and explains the increase in 
neuron numbers in the smallest cell class found in the nucleus lateralis and 
nucleus basalts lateralis Left-right hemispheric comparisons were made to 
detect hemispheric predominance specifici íes in AD pathology No left-right 
hemispheric differences were detected 
With regard to the senile plaques, a specific distribution pattern in the amygdala 
in AD was shown, although there were considerable mtenndividual differences 
The more medially situated subdivisions viz the nucleus basalis accessonus and 
thr nucleus corticalis showed the highest densities of SP 
Magnocellular subdivisions showed a high density of NFT The highest densities 
were found in the nucleus basalis corticalis, nucleus basalis accessonus and 
nucleus basalis medialis 
Concerning the Congophilic angiopathy (CA), no distribution pattern or concen-
tration of CA in a particular region in the amygdala could be detected 
The neuron numbers, NFT, and SP in the subdivisions were correlated, using the 
Spearman correlation test. A significant negative statistical correlation could be 
detected between neuron numbers and NFT densities in the nucleus basalis 
accessonus 
Chapter 5 ("general discussion") The data concerning the volume changes and 
distribution patterns of NFT and SP in the amygdala are in general consistent 
with previous findings (Jamada and Mehraem, 1968; Kromer and Vogt, 1990; 
Murphy, 1990, 1991; Scott et al , 1991) Some new findings concerning the 
neuron numbers can be added In this thesis for the first time absolute neuron 
numbers in the amygdala and in subdivisions in four size classes were determi-
nated A severe and constant neuron loss was demonstrated in the greatest cell 
classes, indicating a massive cell death combined with cell shrinkage Neurons in 
the smallest size class showed moderate cell loss or even an increase in absolute 
neuron numbers, indicating a larger vulnerability for cell death and/or shrinkage 
of neurons in the greater size classes 
Investigations into the occurrence and densities of NFT, SP and neuron loss 
have led to the following pathogenetic mechanisms. 
1) PHF formation leading to athophy and finally neuron death; 
2) the affected neurons can anterogradely or retrogradely induce PHF in other 
neurons; 
3) systematically derived ß-amyloid in de perivascular walls leads to SP forma-
tion and induces degenerative changes in dentntes and axons; 
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4) ß-amyloid of SP induces pathological changes in dentrites en axons. 
When we try to integrate the above described mechanisms in the results of the 
projects of the JANIVO program, i.e. the hippocampal formation (de Vries, 
1990), the neocortex (Broere, 1990), nucleus basalis van Meynert (Vogels, 
1990) and the monaminergic structures of the brainstem (van Domburg, 1990) 
the following pattern emerges: The brunt of the disease is located in the tightly 
interconnected complex formed by the amygdala and hippocampus. From here 
the disease may spread over the neocortex along the direct connections which 
the amygdalohippocampal complex entertains with many neocortical areas. The 
nucleus basalis of Meynert, the nucelus raohe dorsalis, and the nucleus locus 
coeruleus may be affected via their connections with the amygdala, retrogradely 
via their cortical connections or via both channels. 
1 Д Р 
SAMENVATTING EN CONCLUSIES 
In 1907 beschreef Alois Alzheimer de klinische symptomen en de typische 
neuropathologische kenmerken, gevonden bij een patiente die op 51-jarige 
leeftijd was gaan lijden aan een dementieel syndroom, waaraan ze na een ziekte-
duur van 4 jaar was bezweken. 
Door het toepassen van een nieuwe zilverkleunngstechniek toonde hij in de 
schors van de grote hersenen de aanwezigheid van de veranderingen, die nu 
seniele plaques en neurofibrillaire tangles genoemd worden, aan. Kreapelin 
(1908) beschouwde deze stoornis als een nieuwe ziekteentiteit en stelde voor 
daaraan de naam "ziekte van Alzheimer (AD)" te verbinden. 
De ziekte tast bepaalde neuropsychologische functies selectief aan, terwijl 
andere functies relatief gespaard blijven. Neuropathologische studies (Brun en 
Gufstafson, 1967; Hooper en Vogel, 1976; Price et al., 1991) hebben aan het 
licht gebracht dat bij AD steeds ernstige veranderingen in de hippocampus, in de 
associatievelden van de neocortex en in kernen van het amandelkerncomplex 
aanwezig zijn. In de primaire sensorische schorsgebieden en in de motorische 
schors worden slechts geringe veranderingen aangetroffen. In het klassieke 
onderzoek van Blessed et al (1968) kon het aantal seniele plaques (SP) in de 
neocortex bij oudere personen goed gecorreleerd worden met intelligentietests, 
waarmee een causaal verband gesuggereerd werd tussen het aantal plaques en 
cognitieve achteruitgang. Of een zodanige relatie ook tussen de neurofibri l lar 
tangles (NFT) en de uitkomst van neuropsychologische testen bestaat, is niet 
bekend. Mogelijk is er een verband tussen NFT, SP en het neuronenaantal in AD. 
Tegen deze achtergrond besloten we de ziekelijke veranderingen in de amygdala 
bij AD te bestuderen in de hoop langs deze weg mogelijke pathogenetische 
mechanismen te achterhalen. 
Hoofdstuk 2 betreft de nomenclatuur, verbindingen, neurotransmitters, functie 
en neuropathologische veranderingen in de amygdala bij de ziekte van Alzheimer. 
De amygdala is een structuur welke door een uitgebreid netwerk van vezels met 
andere hersengebieden in verbinding staat In een kort overzicht is de hodologie 
van de amygdala beschreven. Door het complexe netwerk van verbindingen met 
neocorticale gebieden, subcorticale gebieden en kernen in de hersenstam is de 
amygdala in staat sensorische stimuli, komend van buiten het individu, te inte-
greren met autonome, neuroendocrine en emotionele reacties. Experimenten 
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waarbij gebruik is gemaakt van laesies en elektrische impulsen en beschrijvingen 
uit de kliniek maken het aannemeli|k dat de amygdala betrokken is bij geheugen-
functies waarbi| aan voor het individu belangrijke gebeurtenissen uit het verleden 
een bepaalde emotionele lading wordt toegekend. 
De amygdala is een van de meest aangedane gebieden bij de ziekte van Alzhei-
mer. De stoornissen in dit kerncomplex en in de aanpalende hippocampus zijn 
waarschijnlijk de oorzaak van de in het algemeen zeer vroeg optredende ge-
heugenstoornissen. 
In hoofdstuk 3 worden de in ons onderzoek gebruikte morfologische, histologi-
sche, stereologische en statistische procedures beschreven Op basis van bestu-
dering van normaal Nissl en Kluver-Barrera materiaal werd de amygdala onder-
verdeeld in de volgende 8 deelgebieden de nucleus lateralis, de nucleus basalis 
lateralis, de nucleus basalis accessonus, de nucleus basalis medialis, de nucleus 
basalis superficialis, de nucleus corticalis, het mediocentrale complex en het 
corticoamygdaloide overgangsgebied. BIJ ons onderzoek werd gebruik gemaakt 
van een "systematic sampling design", een methodiek welke betrouwbaarder is 
dan andere telmethoden. Met deze samplmgmethodiek werden neuronen in 
equidistante coupes systematisch geteld 
Hoofdstuk 4 omvat een atlas van het amandelkerncomplex, bestaande uit teke-
ningen van 7 equidistante coupes Daarnaast worden kwantitatieve gegevens 
betreffende het volumeverlies, neuronenverlies, de dichtheden van NFT en SP en 
het vóórkomen van congofiele angiopathie in de amygdala bij de ziekte van 
Alzheimer en bij "age-matched controls" (AMC) gepresenteerd. Het gemiddelde 
volume van de gehele amandelkern bij AD blijkt ten opzichte van AMC in de 
linkerhemisfeer met 45%, en met 36% in de rechterhemisfeer af te nemen. Het 
volumeverlies in de deelgebieden varieerde van 7% in de nucleus basalis superfi-
cialis tot 52% in de nucleus basalis medialis. 
De linkeramygdala bevatte bij AD gemiddeld 4 7 ± 1 3 miljoen neuronen en de 
rechteramygdala 4.8 ± 1 0 miljoen neuronen Het neuronenaantal m de normale 
amygdala bedroeg aan de linkerzijde 10.7 ± 1.1 e n 9 8 ± 1 6 aan de rechterzij-
de. Daaruit volgt een neuronenverlies in de linkeramygdala van 56.6% en in de 
rechter van 50 5%. Een neuronverhes van zodanige omvang werd in de litera-
tuur tot nu toe niet beschreven. In de deelgebieden kon een selectief neuro-
nenverlies aangetoond worden variërend van 35% in de rechter nucleus lateralis 
tot 70 4 % in de rechter nucleus basalis accessonus. Teneinde veranderingen in 
de grootte van neuronen te kunnen detecteren, werden deze elementen mge-
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deeld in 4 klassen. In alle deelgebieden was het verlies in de grootste celklasse 
zeer aanzienlijk. In de nucleus basalis lateralis en de nucleus lateralis werd, 
zowel aan de linker- als aan rechteramygdala, een toename in neuronenaantal in 
de kleinste celklasse aangetoond. Het enorme neuronenverlies in de grotere cel 
klassen wordt waarschijnlijk veroorzaakt door atrofie en celdood. Celschrompe-
ling van grotere neuronen kan resulteren in een verschuiving van elementen uit 
de klasse der grootste neuronen naar die van de kleinere neuronen. Aldus kan de 
toename van het aantal neuronen in de kleinste celklasse binnen de nucleus 
basalis lateralis en nucleus lateralis worden verklaard. Links/rechts-vergelijkmgen 
zijn gemaakt om mogelijke verschillen in pathologie tussen de linker- en rechter-
amygdala te ontdekken. 
Voor wat betreft de SP kon er een specifiek distributiepatroon in de amygdala bij 
AD worden aangetoond, ofschoon er aanzienlijke intenndividuele verschillen 
waren. In de meer mediaal gelegen deelgebieden, namelijk in de nucleus basalis 
accessorius en de nucleus corticalis werden de grootste dichtheden van SP 
aangetroffen. De magnocellulaire deelgebieden (nucleus corticalis, nucleus 
basalis accessorius en nucleus basalis medialis) bevatten de grootste dichtheden 
aan NFT. 
Wat betreft de congofiele angiopathie (CA) kon geen distributiepatroon of con-
centratie van CA in een bepaald deelgebied in de amygdala worden aangetoond 
De neuronenaantallen, NFT- en SP-dichtheden, aangetroffen in de deelgebieden, 
werden gecorreleerd met behulp van de Spearman correlatietest Een significante 
negatieve correlatie werd gevonden tussen neuronenaantallen in de nucleus 
basalis accessorius en NFT dichtheden in de nucleus corticalis, nucleus basalis 
medialis en het mediocentrale complex 
Hoofdstuk 5. De data betreffende de volumeveranderingen en distributiepatronen 
van NFT en SP in de amygdala bij AD komen grotendeels overeen met die in de 
literatuur (Jamada en Mehraein, 1968, Kromer en Vogt, 1990; Murphy, 1990, 
1991, Scott et al., 1991, 1992) Nieuwe gegevens betreffende neuronenaantal-
len konden echter worden toegevoegd In dit proefschrift worden voor het eerst 
absolute celaantallen gepresenteerd, verdeeld in vier celklassen in de amygdala 
en zijn deelgebieden, bij patiënten overleden aan AD en bij AMC. Deze laatste 
bevinding kan wijzen op de minder grote kwetsbaarheid voor AD pathologie in 
vergelijking met grote neuronen. 
Mede op grond van gegevens vanuit de literatuur kan aannemelijk gemaakt 
worden dat bij de AD de volgende pathogenetische mechanismen werkzaam zijn. 
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1) Paired helical filament (PHF) formatie leidt tot atrofie en celdood. 
2) De aldus getroffen cellen kunnen op hun beurt zowel anterograad als retro-
graad tot degeneratie van andere neuronen leiden. 
3) Het systematisch aangemaakte ß-amyloid hoopt zich op in pericapillaire 
ruimten en leidt aldus tot plaquevorming. Het in de plaque aanwezige fi-
amyloid lokt degeneratieve veranderingen in zowel dendrieten als axonein-
den uit. 
4) Het in SP aanwezige ß-amyloid leidt tot ziekelijke veranderingen in aangren-
zende dendrieten en axoneinden. 
Bezien wij de resultaten van ons onderzoek van het amandelkerncomplex en dat 
van andere onderzoekingen, verricht aan hippocampus (de Vries, 1990), neocor-
tex (Broere, 1990), nucleus basalis van Meynert (Vogels, 1990) en monoaminer-
ge structuren in de hersenstam (van Domburg, 1990) in het licht van de zojuist 
genoemde pathogenetische mechanismen, dan roept dat het volgende beeld op: 
AD manifesteert zich het eerst in het complex, gevormd door de amygdala en de 
hippocampus (Fig. 5.4 en 5.5). De ziekte breidt zich vervolgens via de directe 
verbindingen die dit complex met de neocortex onderhoudt naar laatstgenoemde 
structuur uit. Vervolgens zouden de verbindingen die de nucleus basalis van 
Meynert (NBM), nucleus raphe dorsalis (NRD) en locus coeruleus (NLC) met de 
schors onderhouden het vehiculum voor uitbreiding van de ziekte over deze 
subcorticale gebieden kunnen zijn. Daarnaast kunnen bij de uitbreiding van het 
ziekteproces ook de directe verbindingen die de amygdala met NBM, NRD en 
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